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1. INTRODUCTION 
1.1. ,-Unsaturated carbonyl compounds and inflammation 
Natural products with an ,-unsaturated carbonyl substructure are ubiquitous in nature. In 
the wide world of plants many dietary phytochemicals possess ,-unsaturated carbonyl 
substructures – such compounds are commonly referred to as Michael acceptors. 
From the first endeavors to reduce the global burden of cancer, they have been in the spot 
light of research. Basically, strong oxidants such as hydroxyl radical, lipid peroxidation 
derivatives or peroxynitrous acid can cause DNA damage resulting in mutagenesis and tumor 
formation. Michael acceptors are capable of trapping those radicals directly or inducing anti-
oxidant enzymes. Therefore, they are reported to retain chemopreventive potential and to 
exhibit chemoprotective properties.
1
 
Besides their role in carcinogenesis, ,-unsaturated compounds have also been closely 
related to the pathogenesis of inflammation-associated disorders.
2
 Many mechanisms have 
been discussed to account for their ability to intervene in the multistage process of 
inflammation, but the analysis of inflammation-associated signal-transduction pathways has 
revealed intracellular signaling cascades to be a common molecular target for anti-
inflammatory phytochemicals. However, numerous events are involved in relaying 
intracellular signals, and their highly sophisticated interplay is the prerequisite for the fine-
tuning of cellular homeostasis. Abnormal stimulation or silencing of upstream signal 
transducers can result in pathogenic processes. In order to restore normal signaling 
mechanisms or to prevent malignant processes, phytochemicals can act as modifiers of signal 
transduction pathways to elicit their beneficial effects. 
In this regard, two major redox-sensitive transcription factors, nuclear factor-kappa B (NF-
B) and nuclear factor-erythroid-2-related factor 2 (Nrf2), have been discussed as the most 
frequently addressed target molecules.
3
 Hence, modulating the function of these transcription 
factors can prevent such malignant aberration and potentiate detoxification processes and 
cellular anti-oxidative defense mechanisms. 
Oxidative stress is closely linked to inflammation – a state in which a greater amount of 
oxidants is produced than can be scavenged. Under physiological conditions a certain oxidant 
production is normal, and efficient scavenging mechanisms are available. However, if these 
mechanisms break down or if they are overwhelmed by excess of oxidants, the cellular 
antioxidant capacity is insufficient turning into inflammatory processes. Most important 
INTRODUCTION 
 
2 
 
oxidants include reactive oxygen species (ROS) and reactive nitrogen species (RNS) such as 
superoxide anion, hydroxyl radical, nitric oxide, peroxynitrous acid, lipid peroxyl and alkoxyl 
radicals, but also -oxo-aldehydes and 4-hydroxyalkenals. 
Generation of oxidative stress is the predominant trigger for the activation of NF-B, which in 
turn upregulates pro-inflammatory gene expression.
4
 NF-B, classically a heterodimer of p65 
and p50 proteins, represents a prominent transcription factor, which is ubiquitous in 
eucaryotic cells and plays a pivotal role mediating pleiotropic effects of various external and 
internal stimuli.
5
 It plays a central role in general inflammatory as well as immune responses. 
Normally, NF-B is kept inactive in the cytoplasm by binding to the inhibitor IB 
(Figure 1). IB itself is controlled by a family of mitogen-activated protein kinases 
(MAPKs) such as IB kinase (IKK), extracellular-signal-regulated kinase 1/2 (ERK1/2) or 
p38, which activate the dimeric complex by phosphorylation of serine residues on IB. 
Subsequent ubiquitination and degradation of IB by the 26S proteasome liberates NF-B, 
which then translocates to the nucleus where it binds to specific promoter regions of the 
DNA. Subsequently, the transcription of pro-inflammatory genes is activated encoding 
enzymes such as inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2), various 
cytokines like interleukin-1 (IL-1), interleukin-6 (IL-6) and tumor necrosis factor- (TNF-
), and adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1). Thus, an 
aberrant overexpression of NF-B is closely related to inflammation-associated processes. 
 
Figure 1: Expression of pro-inflammatory compounds through NF-B activation 
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Cellular protection against oxidative toxicities is mediated by the Keap1/Nrf2/ARE pathway. 
The transcription factor Nrf2 plays a crucial role in the regulation of the genes of detoxifying 
or antioxidant proteins.
6
 Transcriptional induction leads to the expression of several 
cytoprotective proteins, also known as phase 2 enzymes. Classically, they catalyze the 
conjugation of activated xenobiotics to increase their solubility and facilitate their excretion. 
But in a broader sense, other functionally diverse proteins can be included, which all 
commonly result in cytoprotection against electrophiles and oxidants. Amongst them, 
glutathione transferase (GST) and glutathione peroxidase (GPx) are the most prominent 
examples since the most abundant electron-donor glutathione (GSH) is used as substrate for 
the conjugation with 4-hydroxyalkenal and toxic products of lipid peroxidation in the case of 
GST and for the scavenging of peroxides in the case of GPx. Glutamate cysteine ligase (GCL) 
catalyzes the synthesis of GSH, and heme oxygenase-1 (HO-1) generates carbon monoxide 
and biliverdin/bilirubin, which are also important direct antioxidants. Further members of the 
group of functionally diverse phase 2 enzymes, which are regulated by Nrf2, are UDP-
glucuronosyl transferase (UGT), NAD(P)H:quinone oxidoreductase-1 (NQO1), ferritin and 
thioredoxin. 
 
Figure 2: Induction of phase 2 enzymes through Nrf2 activation 
The induction of phase 2 enzymes proceeds via a common molecular mechanism (Figure 2). 
In resting cells Nrf2 is sequestered in the cytoplasm forming a complex with the repressor 
Kelch-like ECH-associated protein 1 (Keap1). Keap1 is a zinc metalloprotein, which is 
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anchored to the actin cytosceleton. Associated with Cullin 3 (Cul3) it binds Nrf2 tightly 
presenting it for ubiquitination and proteosomal degradation. Covalent modification or 
oxidation of highly reactive cysteine residues of Keap1, which serve as critical sensors for 
inducers, results in conformational changes diminishing the affinity of Keap1 for Nrf2.
7
 
Phosphorylation of Nrf2 by protein kinases such as phosphatidylinositol 3-kinase (PI3K), 
protein kinase C (PKC), c-Jun NH2-terminal kinase (JNK), extracellular-signal-regulated 
kinase (ERK) or p38 are believed to facilitate the dissociation of the complex. Nrf2 is released 
and migrates to the nucleus where it binds as heterodimeric complex with small MAF 
transcription factors to the antioxidant-response element (ARE) of the DNA to stimulate gene 
expression.
8
 
,-unsaturated carbonyl compounds are potential reaction partners for nucleophiles, which 
add to the electrophilic -carbon of the unsaturated system. For that reason, they can act as 
potent inducing agents as they can form Michael adducts with critical cysteine residues, 
which are located at the periphery of Keap1 leading to the release of Nrf2 and subsequent 
induction of anti-inflammatory and cytoprotective phase 2 enzymes (Figure 2). Additionally, 
modification of cysteine residues at the p50 subunit of NF-B by ,-unsaturated compounds 
can stabilize the NF-B-IB complex, which prevents the dissociation and translocation of 
NF-B to the nucleus (Figure 1). Moreover, IKK can also be targeted abrogating 
phosphorylation of IB. Suppression of NF-B mediated induction of pro-inflammatory 
genes is therefore another effective pathway for chemopreventive phytochemicals. 
Furthermore, in combination with phenol substituents ,-unsaturated compounds do not only 
have Michael acceptor activity, they also have significant relevance as antioxidants. The 
antioxidant activity can be attributed to excellent radical scavenging properties of phenolic 
Michael systems. They can undergo oxidation either enzymatically or spontaneously to form 
phenoxyl radicals and quinones, which are again electrophilic Michael systems. Quinone 
derivatives can in turn oxidize sulfhydryl groups of Keap1 leading to disulfide bond 
formation and subsequent oxidative activation of the Keap1-Nrf2 complex. Formation of 
disulfide bridges can also be mediated by ROS, which are formed upon reduction of quinones 
via redox-cycling. In the aforementioned cases the phenol moiety rather participates in the 
interaction with the cysteine residues than the Michael system. 
Consequently, phenolic Michael acceptors can be referred to as indirect antioxidants as they 
can promote the upregulation of cytoprotective enzymes resulting in antioxidative effects. 
Being redox active themselves, phenolic Michael acceptors can also be considered as potent 
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direct antioxidants. Due to this dual protective role, phenolic Michael acceptors can be 
designated as bifunctional antioxidants.
9
 
Multiple beneficial effects are closely related to the structural features of ,-unsaturated 
compounds. Phytochemicals containing phenolic Michael acceptors are very attractive for 
their use as anti-inflammatory agents. Modulation of the activity of transcription factors 
provides a unique strategy and a promising novel therapeutic approach for the treatment or 
prevention of inflammatory disorders. 
1.2. Examples of ,-unsaturated phytochemicals for therapeutic applications 
Extracts of plants are widely used in the traditional medicine of various cultures for their 
beneficial effects in the prevention and therapy of cancer and inflammatory disorders. Hence, 
numerous in-vitro assays and in-vivo studies have been performed to identify their 
biologically active ingredients and to investigate their molecular mode of action. Some 
representative examples of ,-unsaturated phytochemicals are given (Figure 3). 
Curcumin, the yellow ingredient from turmeric (Curcuma longa L.), has been extensively 
used for the examination of its therapeutic potential. Curcumin has been reported to react with 
NF-B directly via thiol modification and to inhibit its activation by interfering with IB 
degradation.
10
 The blockade of IB degradation is a frequently addressed approach to 
attenuate NF-B activation.11-16 Extraction of the total RNA of liver and small intestine of 
mice, which were given a single dose of curcumin, revealed a great number of induced genes, 
which were identified to be Nrf2-dependant.
17
 In addition, high levels of Nrf2 and increased 
expression of GST and NQO1 was observed in benzo[a]pyrene-treated mice.
18
 The up-
regulation of the phase 2 enzyme HO-1 through Nrf2 activation was found in different types 
of cultured cells 
19-23
 and in liver.
24
 Furthermore, enhanced expression of GST P1 mRNA
25
 
and GCL on mRNA and protein level
26
 was reported. Various studies with curcumin 
analogues such as demethoxy- and bis-demethoxycurcumin have also been performed.
27,28
 To 
date, several clinical trials are on-going using curcumin as drug or dietary supplement for the 
treatment of various cancer types, ulcerative colitis, osteoarthritis or Alzheimer’s disease. 
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Figure 3: Biologically active phytochemicals with an ,-unsaturated carbonyl substructure 
Chalcones have shown to be excellent anti-inflammatory and antioxidant compounds 
providing a broad structural diversity. Xanthohumol, a prenylchalcone derived from hops 
(Humulus lupulus L.), is just one out of many different chalcone derivatives. It exhibits potent 
chemopreventive activity by Nrf2 mediated induction of NQO1.
29
 It was also reported to 
modify cysteine residues of IKK and NF-B, which leads to the suppression of the NF-B 
activation pathway (Figure 1).
30
 
Quercetin, a member of the flavonoid family, proved to protect cells from oxidative stress- 
induced death with high efficacy. The up-regulation of Nrf2 and enhanced expression of   
HO-1 was observed.
31
 HO-1 up-regulation was also reported to protect human hepatocytes 
from ethanol-induced oxidative stress.
32
 An increased Nrf2 mRNA and protein level as well 
as inhibited ubiquitination and proteosomal degradation of Nrf2 was found resulting in an 
enhanced NQO1 activity.
33
 
Zerumbone is a sesquiterpene compound present in tropical ginger (Zingiber zerumbet 
Smith). In presence of several proinflammatory stimuli, zerumbone effectively suppresses 
NF-B-IKK signaling by attenuating IB degradation in RAW264.7 murine macrophages.34 
It is also a potent inducer for phase 2 enzymes such as GCL, GPx and HO-1 in rat liver 
epithelial cells via the Nrf2-pathway
35
 and abolishes NF-B and IKK activation induced by 
various stimuli.
36
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1.3. Fine tuning the Michael acceptor activity 
The beneficial effects of many Michael acceptors on inflammatory disorders are undisputable. 
However, other concerns such as cytotoxicity have to be taken into account if ,-unsaturated 
compounds are supposed to be implemented in therapeutic applications and drug discovery. 
Since nature uses many different nucleophiles to trigger biological effects, other off-target 
pathways may be equally affected leading to cell damage and cytotoxic side effects. With 
respect to such severe consequences ,-unsaturated compounds have always been 
controversial in drug development. Thus, tailormade compounds are needed to gain enhanced 
Michael acceptor specificity.
37
 
 
Figure 4: Introduction of substituents X in -position of the ,-unsaturated carbonyl 
substructure enables the fine tuning of its reactivity 
This can be achieved by fine tuning the reactivity of the ,-unsaturated carbonyl unit. 
However, effective control of the chemical behavior of the enone entity affords an acurate 
analysis of its underlying reactivity. Several experimental and theoretical studies revealed 
intriguing correlations between the physicochemical properties of the enone substructure and 
the observed reactivity. Measurement of 
13
C NMR chemical shifts of the -carbon of a series 
of drug-like molecules was used to determine the electrophilicity of the reactive center.
38
 
Together with biological testing the results allowed the compounds to be classified as Michael 
acceptors, redoxactive or photoisomerizable substrates. Increased electrophilicity favored the 
Michael addition pathway, whereas decreased electrophilicity favored photoisomerization 
processes. In a model system with prostaglandines the proposed Michael addition reactivities, 
which were based on 
13
C NMR studies, could be confirmed by calculated LUMO coefficients 
and net atom charges.
39
 An interesting study showed that the tendency of 30 plant 
phenylpropenoids and synthetic analogues to release electrons linearly correlates with the 
potency to induce NAD(P)H:quinone oxidoreductase-1 (NQO1).
40
 The electron-releasing 
power was expressed by calculated EHOMO values. It was found that a smaller EHOMO value, 
meaning a lower reduction potential, results in a greater inducer potency. EHOMO and ELUMO 
values were also used to establish structure-activity relationships with synthetic chalcones.
41
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Compounds with high EHOMO values proved to be better electron donors and effective radical 
scavengers. 
These examples show that NMR spectroscopic analyses and in silico methods can serve as 
powerful tools to predict the reactivity of ,-unsaturated carbonyl compounds with respect 
to their anti-inflammatory, antioxidant or radical scavenging properties, and facilitate the 
rational design of biologically active molecules. 
The reactivity of the enone substructure is predominantly determined by the substitution 
pattern of the carbon-carbon double bond. Pharmaceutically active natural products often 
exhibit phenolic substituents on the -carbon such as in chalcones or flavonoids. Substitution 
at the -position, however, is not frequently observed. Nevertheless, the introduction of 
different substituents X at the -position of an ,-unsaturated compound should also have a 
strong influence on the reactivity of the Michael acceptor (Figure 4). Depending on the nature 
of the substituent X, the electronic properties of the enone system can be adjusted. In that 
way, enones could be directed to display specific reactivities such as Michael addition or 
radical scavenging. This concept opens up the possibility to create a library of variable 
Michael acceptors with fine tuned activity as a versatile tool to control biological function. 
In the literature this approach has not been explored extensively. A few examples indicate that 
variation of the substituents in -position of ,-unsaturated compounds can have a strong 
impact on biological activity of the examined compounds (Figure 5). Honda et al. showed that 
stepwise introduction of substituents in oleanane triterpenoids 5-10 resulted in changes of 
biological activity.
42
 Compounds were screened for inhibition of NO-production induced by 
interferon-γ in mouse macrophages. In particular, the -cyano-substituted derivative 7 proved 
to exhibit high potency, which could be even augmented by a further semisynthetic 
triterpenoid derived from oleanolic acid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid 
(CDDO) (11). The conjugate nucleophilic addition to one of the Michael systems was found 
to proceed selectively and reversibly using dithiothreitol (DTT).
43
 In another example 
Lawrence et al. described the effect of different -substituents on the biological activity of 
chalcones 12-14 exhibiting antimitotic properties caused by inhibition of tubulin 
polymerization. A high potency of the fluoro-derivative 12 in contrast to the ethyl ester 14 or 
nitrile substituted compound 13 was observed.
44
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Figure 5: Literature precedents of -substituted enones to increase biological activity 
 
1.4. Limnophilaspiroketone as a point for inspiration 
In this study a natural product, called limnophilaspiroketone (15), served as starting point for 
subsequent investigations (Figure 6).  
 
Figure 6: Natural product limnophilaspiroketone (15) 
Limnophilaspiroketone (15) was isolated from aerial parts of Limnophila geoffrayi Bon. 
(Scrophulariaceae) collected in Thailand (Figure 7). This edible plant is considered as a 
vegetable in northeastern parts of Thailand and is also used as an antidote for the 
detoxification of poisons.
45
 Moreover, it is applied for its antipyretic, expectorant and 
galactogogue properties in the local traditional medicine. Interestingly, limnophilaspiroketone 
was isolated as a racemate although racemic natural products are rarely observed. 
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Figure 7: Pictures of Limnophila geoffrayi Bon. 
Until now no report on its biological activity is available. But, due to its structural features, 
limnophilaspiroketone represents an attractive molecule for the investigation of its 
prospective biological activity. Containing two orthogonal ,-unsaturated carbonyl moieties 
and a phenolic substituent, this natural product is an interesting compound in terms of 
potential Michael acceptor and antioxidant activity. Moreover, there is no substituent in -
position of the ,-unsaturated carbonyl unit in the 3(2H)-furanone part of the molecule. In 
case biological activity can be explored, further derivatization on the -carbon is possible, 
which allows for the fine tuning of the reactivity of the enone subunit and the successive 
refinement of biological activity. 
1.5. Natural products with a 3(2H)-furanone moiety 
3(2H)-Furanones represent an important subgroup of ,-unsaturated compounds. A great 
number of natural products contain this structural entity and display interesting properties in 
terms of biological activity. A few selected examples are presented herein. 
The first example of naturally occurring 3(2H)-furanone was bullatenone (16), isolated from 
Myrtus bullata Banks & Sol. in 1954 by Brandt (Figure 8).
46
 However, the structure was not 
assigned correctly until 1958 when Parker et al. revised its previously assumed structure and 
also accomplished its total synthesis.
47
 
The 1-oxaspiro[4.4]non-2-ene-4-one motif, which is also present in limnophilaspiroketone 
(15), can be found in jatrophone (17), a macrocyclic tumor inhibitor from Jatropha 
gossypiifolia L.
48
 Synthetic access to this natural product was provided by Smith III
49
 and 
Hegedus.
50
 The first asymmetric synthesis of optically active (+)-jatrophone was done in the 
Wiemer group.
51
 Other important natural products with similar spirocyclic core structures can 
be found in the family of phelligridins, for instance phelligridin E (18), which was isolated 
from ethanolic extracts of Phellinus igniarius Quél.
52
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Figure 8: Bullatenone (16) and naturally occurring spirocyclic 3(2H)-furanones 
Another 3(2H)-furanone of this class, inoscavin A (19), contains a spirocyclic core structure 
with a furan heterocycle (Figure 9). The same framework is present in trachypsic acid (20), a 
metabolite produced by Talaromyces trachyspermus SANK 12191 (Shear) Stolk & Samson 
that inhibits tumor cell heparase.
53
 
 
Figure 9: Spirocyclic 3(2H)-furanones with a furan unit 
Pseurotins are a class of natural products with a 1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione 
unit (Figure 10). A γ-lactam is attached at the spiro-carbon of the 3(2H)-furanone. Pseurotin 
A (21), isolated from the fermentation broth of Pseudeurotium ovalis Stolk,
54,55
 has shown 
apomorphin-antagonistic activity,
56
 chitin synthase
57
 and monoamine oxidase inhibitory 
activity,
58
 cell differentiation inducing activity
59
 as well as inhibitory effect on 
immunoglobuline E production.
60
 Due to the densely functionalized core structure of 
pseurotin A, its total synthesis posed significant challenges. It was achieved by Hayashi
61
 and 
by Tadano
62
 almost simultaneously.  
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Figure 10: Spirocyclic 3(2H)-furanone with a lactam unit 
Apart from the previous mentioned 3(2H)-furanones, a broad variety of other compounds are 
known. Geiparvarin (22) for instance, isolated from the leaves of Geijera parviflora Lindl., 
was first synthesized by Jerris and Smith.
63
 Besides the 3(2H)-furanone entity it contains a 
coumarin fragment and displays significant anti-tumor activity (Figure 11). Eremantholides 
such as eremantholide A (23) from Eremanthus elaeagnus Schultz-Bip. are germacranolide 
sesquiterpene lactones with a 3(2H)-furanone moiety as part of a complex polycyclic ring 
system.
64
 The trypanocidal,
65
 anti-inflammatory
66
 and anti-tumor
67
 activity of these natural 
products have prompted many researchers to complete total syntheses of eremantholide A 
(23).
68-70
 
 
Figure 11: 3(2H)-Furanones without spirocyclic core structure 
 
1.6. Approaches for the synthesis of 3(2H)-furanones 
Numerous strategies for the construction of 3(2H)-furanones are available to date. Classical 
methods have been frequently applied, but in the last decades transition-metal catalyzed 
approaches have gained more and more importance. These achievements greatly expand and 
further complement the hitherto existing pool of available methodologies. The most important 
strategies providing synthetic access to the 3(2H)-furanone core are discussed below 
(Scheme 1). The importance of the different pathways is underlined by selected examples, 
which have been employed in the synthesis of natural products. 
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Scheme 1: Synthetic strategies for the construction of 3(2H)-furanones 
’-Hydroxy 1,3-diketones have been widely used as precursors for spirocyclic and various 
other 3(2H)-furanones (Scheme 1, pathway A). As they are prone to cyclize under acidic or 
basic conditions, they are ideal substrates giving the desired product directly. Seminal works 
on the conversion of ’-hydroxy 1,3-diketones under acidic conditions were reported by Sher 
et al.
71
 This generally applicable and simple reaction was successfully implemented in several 
natural product syntheses. The 3(2H)-furanone core of geiparvarin (22), for example, was 
established in this way by Smith et al. (Scheme 2).
63
 Aldol reaction, oxidation with Collins’ 
reagent and acid catalyzed cyclization-dehydration afforded the furanone 26 from TMS 
protected ’-hydroxy 1,3-diketone precursor 24. Subsequent steps including the coupling of 
the coumarin motif yielded the natural product 22.  
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Scheme 2: Synthesis of geiparvarin (22) by Smith et al.
63
 
This particular method was also applied in the total synthesis of eremantholide A (23) by 
Boeckman and coworkers (Scheme 3).
68
 γ-Lactone 27 was treated with mild acid to effect the 
ring closure to furanone 28. Further steps included the installation of the hemiacetal followed 
by the ring closure of the macrocycle to yield eremantholide A (23). 
 
Scheme 3: Synthesis of eremantholide A (23) by Boeckman et al.
68
 
Spirocyclic furanones have also been generated using this method. Pseurotin A (21) was 
synthesized from benzylidene-γ-lactam 29, which was coupled with aldehyde 30.61 Oxidation 
and purification by thin layer chromatography yielded the spirocyclic 3(2H)-furanone 32 
directly. From this stage of the synthesis the natural product was obtained just in additional 
four remaining steps (Scheme 4). 
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Scheme 4: Synthesis of pseurotin A (21) by Hayashi et al.
61
 
In the synthesis of jatrophone (17) ’-hydroxy 1,3-diketone 33 served as precursor for the 
generation of the spirocyclic framework. Closure of the macrocycle in 34 gave access to the 
natural product (Scheme 5).
49
 
 
Scheme 5: Synthesis of jatrophone (17) by Smith et al.
49
 
-Acyloxy ketones have proven to be versatile building blocks for the generation of 3(2H)-
furanones (Scheme 1, pathway B). Under basic conditions they react intramolecularly to 
build up the cyclic ring structure. Among various examples also spirofuranones have been 
accessed. Ester 35, for instance, undergoes a Knoevenagel type condensation upon treatment 
with NaHCO3 to afford highly substituted 3(2H)-furanone 36 (Scheme 6).
72
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Scheme 6: Synthesis of 3(2H)-furanones from -acyloxy ketones72 
An analogous route towards 3(2H)-furanones was established by Wiemer and coworkers.
51
 
They used γ-(acyloxy)--ketophosphonate 37, which undergoes a Horner-Wadsworth-
Emmons-type condensation to afford the heterocyclic structure 38.
73
 Applying this strategy in 
natural product synthesis gave access to jatrophone (17) (Scheme 7).  
 
Scheme 7: Synthesis of jatrophone (17) by Wiemer et al.
51
 
Further developments have been made to provide convenient access to 3(2H)-furanones. The 
heterocyclic products are also available from -halo-1,3-diketones (Scheme 1, pathway C). 
This strategy has been used in the cyclization of 6-halo-1,3,5-trioxo compound 41, which can 
be easily obtained from -chloroacetic acid chloride (40) and 1,3-bis(trimethylsilyloxy)-1,3-
butadiene 39 to form furanone 42 (Scheme 8).
74,75
  
 
Scheme 8: Synthesis of 3(2H)-furanones from -halo-1,3-diketones74,75 
An efficient and practical one-pot synthesis was established using 1,2-diarylethanones 43 and 
2-bromoisobutyryl cyanide (44) (Scheme 9).
76
 By choosing the soft isobutyryl cyanide as 
electrophile C-acylation was observed predominantly. With excess base ring closure 
happened spontaneously to yield furanones 45. 
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Scheme 9: One-pot synthesis of 3(2H)-furanones from 2-bromoisobutyryl cyanide and 1,2-
diarylethanones
76
 
4-Hydroxy-alk-2-ynones are extensively investigated as starting materials for their conversion 
to 3(2H)-furanones (Scheme 1, pathway D). Various methodologies are reported. An early 
example used diethylamine to mediate the ring closure in the total synthesis of bullatenone 
(16) (Scheme 10).
47
 
 
Scheme 10: Synthesis of 3(2H)-furanones from 4-hydroxy-alk-2-ynones
47
 
4-Hydroxy-alk-2-ynones 47 was available from propargyl alcohol 46 via Grignard reaction 
and subsequent oxidation with Collins’ reagent. It was assumed that diethylamine attacks at 
the -carbon of the triple bond followed by ring closure, “oxotropic rearrangement” of the 
cyclic intermediate and final extrusion of diethylamine (intermediates 48 to 50) to afford 
bullatenone (16). 25 years later, the total synthesis of bullatenone (16) was once again 
addressed using polymeric Hg/Nafion-H reagent, which gave the natural product in 
quantitative yield.
77
 The corresponding acetals of 4-hydroxy-alk-2-ynones were successfully 
converted into 3(2H)-furanones using H2SO4 in MeOH.
78
 From starting material 51 the 
spirocyclic furanone 52 was obtained with BF3∙OEt2 in presence of catalytic amounts of 
mercuric oxide and trichloroacetic acid (Scheme 11).
79
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Scheme 11: Synthesis of 3(2H)-furanone 52 from acetal 51
79
 
In principle, 4-hydroxy-alk-2-ynones can be considered as -hydroxy-1,3-diketone 
equivalents since the latter can be easily obtained by hydration of the triple bond. However, as 
the reaction mechanisms do not imperatively run through the intermediate diketone species, 4-
hydroxy-alk-2-ynones are categorized separately. Recently, a transition metal catalyzed 
approach using the combination of (p-CF3C6H4)3PAuCl and AgOTf was reported to be a 
powerful catalyst system to mediate the intramolecular cyclization of γ-hydroxyalkynone 53 
to generate 3(2H)-furanone 57 under very mild conditions (Scheme 12).
80
  
 
Scheme 12: Transition metal catalyzed approach to 3(2H)-furanones from 4-hydroxy-alk-2-
ynones
80
 
The following mechanism was proposed: Initial π-coordination of the active gold species and 
subsequent intramolecular Michael addition gives rise to a transient epoxide intermediate, 
which cyclizes to yield the desired product (intermediates 54 to 56). 
Another transition-metal catalyzed synthesis of 3(2H)-furanones was accomplished by Kirsch 
and coworkers (Scheme 1, pathway E).
81
 They performed a AuCl3- or PtCl2-catalyzed 
domino reaction of alkinyl carbonyl compound 58, which undergoes a heterocyclization -               
1,2-migration cascade (Scheme 13). Initiated by the π-activation of the triple bond by the 
transition metal (intermediate 59), this reaction is believed to proceed via an oxonium ion 60, 
which triggers a subsequent 1,2-shift to afford the final product 61. 
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Scheme 13: Synthesis of 3(2H)-furanones by a heterocyclization – 1,2-migration cascade81 
Shortly after this publication, an extension of this methodology to access nitrogen-containing 
heterocycles such as pyrrolones, indolizines and indolizinones was reported by Sarpong and 
coworkers.
82
 
1-Hydroxy alk-3-ynones are also important building blocks for the synthesis of 3(2H)-
furanones (Scheme 1, pathway F). Baldwin et al. showed in their seminal work on rules for 
ring closure that alkyne 62 readily cyclizes to yield bullatenone (16) under basic conditions 
(Scheme 14).
83
 
 
Scheme 14: Synthesis of 3(2H)-furanones from 1-hydroxy alk-3-ynones
83
 
1-Hydroxy alk-3-ynone 64 can be generated in situ in an enantioselective way from enynone 
63 via asymmetric dihydroxylation reaction. In presence of HgO it cyclizes spontaneously to 
the desired product 65 (Scheme 15, A).
84
 Alternatively, a gold catalyzed cyclization of 2-oxo-
3-butynoates or disubstituted diones 66 in presence of oxygen nucleophiles offers a 
straightforward route towards 3(2H)-furanones 68 (Scheme 15, B).
85
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Scheme 15: Synthesis of 3(2H)-furanones from enynones
84
 and from 2-oxo-3-butynoates
85
 
A striking process for the synthesis of 3(2H)-furanones was developed by Gouverneur et al. 
(Scheme 16).
86
 This reaction involves a Wacker-Heck sequence, which is initiated by the 
activation of the triple bond in alkyne 69 by the transition metal followed by 5-endo ring 
closure to give palladium intermediate 70. Further Heck-type carbopalladation with ethyl 
acrylate affords intermediate 71, which undergoes -elimination to release the final furanone 
72. After reductive elimination of the palladium hydride species, Pd(0) is reoxidized with 
molecular oxygen. 
 
Scheme 16: Synthesis of 3(2H)-furanones via a Wacker-Heck sequence
86
 
The broad pool of available methodologies renders the synthesis of many naturally occurring 
compounds possible. In this way, highly complex structures can be accessed in sufficient 
amounts in order to fully elucidate their biological effects. Consequently, quantities of 
biologically active compounds are provided, which might be powerful candidates for 
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medicinal applications. Many ,-unsaturated carbonyl compounds have shown to possess 
chemoprotective, anti-inflammatory and antioxidative effects. Therefore, the synthesis of the 
,-unsaturated 3(2H)-furanone limnophilaspiroketone (15) and related natural product 
analogues is envisioned and discussed herein. 
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2. AIM OF THE PRESENT STUDY 
This work is aimed to explore a novel and straight forward strategy towards the total synthesis 
of limnophilaspiroketone (15). 
From a synthetic point of view this natural product reveals several challenges to overcome. 
Firstly, the formation of the spirocyclic framework affords a deliberate retrosynthetic analysis, 
which is a prerequisite for the feasibility of the planned pathway. Secondly, the 
stereoselective introduction of substituents forming quaternary stereocenters still poses a 
common problem in asymmetric synthesis although a broad pool of concepts using various 
chiral ligands and catalysts is available to date. And furthermore, the highly oxygenated 
natural product calls for ambitious methodologies for the introduction of multiple oxygen 
functionalities in a very condensed framework. 
Due to its structural features, limnophilaspiroketone (15) represents also an attractive 
molecule from a biological point of view. Containing two orthogonal ,-unsaturated 
carbonyl moieties and a phenol substituent, this natural product is a promising structure in 
terms of potential Michael acceptor and antioxidant activity.  
For an investigation of the appropriate synthetic route towards the 3(2H)-furanone framework 
a natural product derived simplified model compound is envisioned, which should be easy to 
synthesize. 
Moreover, a library of -modified enones of this model compound is supposed to be 
generated via simple low step transformations from one common precursor. For 3(2H)-
furanones the influence of the substituent in -position of the ,-unsaturated carbonyl 
system on the chemical reactivity against nucleophiles has not been studied so far. Thus, 
experiments are planned to elucidate potential Michael acceptor activities. 
RESULTS AND DISCUSSION 
 
 23 
 
3. RESULTS AND DISCUSSION 
3.1. Retrosynthetic approach towards the total synthesis of limnophilaspiroketone 
Aiming for an effective and streamlined synthesis, particularly protecting-group-free reaction 
sequences as well as redox and atom economic transformations were envisioned in the 
retrosynthetic analysis of limnophilaspiroketone (15). 
The envisaged approach considers a late-step introduction of the two methoxy substituents 
attached at the ,-unsaturated carbonyl moiety (Scheme 17). This seems to be advantageous 
since it directly establishes the correct functionality found in the final product. Although the 
methoxy groups should be only slightly reactive, this alleviates the need to carry them 
through the synthesis and circumvents the possibility to interfere in other crucial steps. In 
detail, they can be introduced for example by an iodination, oxidation, methylation, 
methoxylation sequence according to a known procedure
87
 from the saturated ketone 73. 
Deprotection of the phenol moiety affords the correct structure of the natural product. 
 
Scheme 17: Late-step introduction of the methoxy substituents and deprotection of the 
phenolic moiety to give the final natural product 
The formation of the spirocyclic framework represents the key step in the design of the 
proposed synthesis. For the generation of the 3(2H)-furanone an example of a 5-exo trig 
cyclization was chosen (Scheme 18).
47
 During this transformation four consecutive reaction 
steps take place representing a very step efficient and straightforward transformation. This 
method allows for an elegant installation of the desired framework and does not interfere in 
the previously established stereochemistry by racemization or epimerization processes. 
Furthermore, the synthesis of the corresponding cyclization precursor 74 seems to be facile 
and convenient. 
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Scheme 18: 5-exo trig cyclization for the formation of the spirocyclic 3(2H)-furanone 
The required alcohol functionality in the precursor 74, which is essential for this cyclization 
process, could be established by a DMSO mediated oxidative ring opening reaction of 
epoxide 75 first examined by Trost in the synthesis of taxanes (Scheme 19).
88
 It is expected to 
proceed in a highly regioselective manner. This example can also be referred to as an efficient 
step since it combines two separate procedures, namely an acid or base induced ring opening 
reaction and subsequent oxidation of the secondary alcohol. Moreover, it minimizes the use of 
reagents and environmentally critical oxidants. 
 
Scheme 19: Oxidative ring opening of the epoxide to form the -hydroxy ketone motif 
Epoxide 75 could be derived from acetylene 77 and the corresponding Weinreb amide of 
protected p-hydroxy benzoic acid 76, which could be connected via simple alkyne addition 
after deprotection of the acetylene 77. Hydrolysis of the nitrile in methanolic solution would 
yield the desired methyl ester. The masking of the phenol motif in the acid derivative 76 is an 
inevitable measure. The use of an aldehyde as coupling partner instead of a Weinreb amide is 
also attractive, however, this affords a further step for the reoxidation of the generated 
diastereomeric alcohol. Alternatively, the acid chloride would also form the desired product, 
but it is commonly avoided due to its high reactivity resulting in unspecific product 
formation. 
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Scheme 20: Combination of the phenolic part and the acetylenic fragment 
The synthesis commences with simple cyclopent-2-enone (78), which serves as starting 
material for the synthesis of the corresponding acetylene 77 (Scheme 21). -Iodination and 
subsequent Sonogashira coupling with TMS acetylene, asymmetric epoxidation and 
cyanohydrin reaction would afford the intermediate 77 in 4 steps. At first glance, it might 
appear that two protecting groups are included. But, as both TMS groups are imperatively 
necessary to allow the attachment of the alkyne and the cyanohydrin reaction to proceed, no 
additional steps for the introduction of the TMS groups are required. As a consequence, the 
differentiation between both TMS groups is a major challenge if the carbon based silyl group 
has to be selectively removed in presence of the silyl ether. To achieve this, a new 
methodology has to be developed. 
 
Scheme 21: Planned synthesis of acetylenic fragment from simple cyclopentenone 
In total, this retrosynthetic plan aimes for an efficient synthesis of limnophilaspiroketone (15) 
in about 14 consecutive steps. Non-strategic redox reactions, functional group 
interconversions and protecting group manipulations are supposed to be kept at a minimum 
leading to a short and streamlined synthesis. 
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3.2. Synthesis of the chiral cyclopentyl building block 77 
The cyclopentyl part in the spirocyclic framework is characterized by a highly functionalized 
substitution pattern. Not only the degree of substitution, but also the chiral nature of this 
building block renders the synthesis nontrivial. To start with cyclopent-2-enone (78) is a 
versatile starting point since it allows various transformations on the ,-unsaturated carbonyl 
function (Figure 12).  
 
Figure 12: Considered reactions for the functionalization of cyclopentenone 
A Baylis-Hilman type reaction was considered to address the -functionalization at the ,-
unsaturated carbonyl moiety. As this necessarily implies a Michael addition mechanism, the 
conjugate 1,4-addition is also a suitable possibility for chemical modifications. 1,2-addition 
reactions such as a cyanohydrin reaction allow for an introduction of nucleophiles to the 
carbonyl group. Furthermore, the double bond is suitable for an epoxidation or 
dihydroxylation reaction, which can also be accomplished asymmetrically. However, a 
method has to be found to overcome the unfavorable electron deficient character of the double 
bond. Generally, an increased ring strain in a 5-membered ring in contrast to a 6-membered 
ring might be a drawback and a limiting factor for many reactions resulting in moderate 
reaction yields.  
3.2.1. Introduction of an acetylene functionality 
Since decades, the discovery of new methodologies for C-C bond formation has been in the 
focus of many research groups providing the possibility to build up complex carbon based 
structures. Amongst the C-C bond forming reactions the well known Sonogashira cross-
coupling of acetylenes with aryl or vinyl halides is widely used in natural product synthesis 
since acetylenes represent an important intermediate in organic synthesis. To introduce the 
desired acetylene functionality, a prefunctionalization of cylopentenone (78) was required 
(Scheme 22). 
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Scheme 22: Iodination and Sonogashira cross coupling to yield acetylene 80 
For this purpose a literature known direct iodination of cyclopent-2-enone (78) was 
performed.
89
 Subsequent Sonogashira cross coupling reaction
90
 with TMS acetylene 
proceeded smoothly to give the desired alkyne 80 in 91% yield. Alternatively, the same 
procedure was investigated using the corresponding 2-bromo-cyclopent-2-enone (81), which 
is easily available in one step from the common starting material 78 by bromination and HBr 
elimination. However, the cross coupling reaction turned out to be more critical and did not 
proceed as cleanly as in the previous case (Scheme 23). 
 
Scheme 23: Bromination and Sonogashira cross coupling. 
a
estimated by NMR 
 
3.2.2. Asymmetric epoxidation reactions 
Achiral versions of epoxidation reactions on cyclic ,-unsaturated ketones using 
nucleophilic reagents such as H2O2 or t-BuOOH are widely used. Diastereoselective 
epoxidation reactions on chiral substrates are also often applied. These reactions proceed 
under substrate control, in which the inherent stereochemistry directs the newly formed 
epoxide to the desired direction. Numerous methods are reported on enantioselective 
epoxidation reactions of ,-unsaturated ketones. Unfortunately, most cyclic enones have 
shown to be insufficient substrates for these methods giving only poor enantioselectivities. 
Prominent examples are the Julia-Colonna epoxidation using polyamino acids as chiral 
ligands
91
 or chiral phase transfer catalysts with alkaloid derived quaternary ammonium salts 
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such as cinchona derivatives.
92-97
 Further examples using guanidine ligands
98,99
 and chiral 
peroxide oxidants
100,101
 were reported. 
For the first time the group of List systematically addressed the enantioselective epoxidation 
of cyclic enones and provided a promising solution to this problem.
102
 Using catalytic diamine 
salts (10 mol%) in combination with hydrogen peroxide (1.5 eq.) at 30 - 50 °C in dioxane for 
20 - 48 h, various cyclic enones could be successfully epoxidized to the corresponding ,-
epoxyketones. However, in contrast to 2-cyclohexenones and 2-cycloheptenones, 2-
cyclopentenone (78) exhibited lower reactivity giving the corresponding epoxide 82 in 33% 
yield and 78% enantiomeric excess (Scheme 24). Moreover, -substituted enones were 
unreactive under these conditions. 
 
Scheme 24: Catalytic asymmetric epoxidation of 2-cyclopentenone (78) by List et al.
102
 
Although there are powerful methodologies for the enantioselective epoxidation of electron 
deficient cyclic olefins available, no solution exists for -substituted 2-cyclopentenones. 
Due to the lack of satisfactory methods, the focus was initially laid on chiral ketones as 
catalysts. The Shi asymmetric epoxidation using a chiral fructose-derived ketone catalyst in 
presence of oxone as the oxidant appeared to be the most promising approach since it has 
shown to have a very broad substrate scope.
103
 A wide variety of olefins including 
trisubstituted olefins,
104
 enynes,
105
 electron deficient alkenes such as ,-unsaturated esters106 
and even an example of an ,-unsaturated ketone107 yielded high enantioselectivities.  
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Although different chiral catalysts were used in these precedents, the investigations started 
with the standard catalyst 85 since it is most frequently applied and can be easily synthesized. 
It was prepared according to a known literature procedure
108
 in a simple two step sequence 
starting from cheap D-fructose (83). Ketalization and subsequent oxidation of the remaining 
alcohol function afforded the chiral ketone 85 (Scheme 25). 
 
Scheme 25: Preparation of the Shi catalyst 85 from D-fructose (83)
108
 
 
Scheme 26: Proposed mechanism of the Shi epoxidation 
The Shi epoxidation is based on the reaction of chiral ketone 85 with oxone 
(KHSO5∙½KHSO4∙½K2SO4) leading to intermediate 86 (Scheme 26). Basic conditions are 
required to facilitate the deprotonation to the corresponding anion 87, which subsequently 
forms the catalytically active dioxirane 88. Dioxirane 88 reacts with olefins to yield the 
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corresponding enantioenriched epoxides. Since the ketone 85 is regenerated, it can be used in 
catalytic amounts. 
The stereochemical outcome of this epoxidation reaction can be rationalized by analyzing the 
possible transition states (Figure 13). Two different transition state geometries are possible: A 
spiro transition state (A-D) where the olefin is orientated in a perpendicular position to the 
dioxirane, and a planar transition state (E-H) where dioxirane and olefin are arranged in the 
same plane. Transition states B-D and E-G are disfavored by destabilizing steric interactions. 
Transition states A and H are sterically favored.  
 
Figure 13: Spiro transition states (top row) and planar transition states (bottom row) in the 
asymmetric epoxidation of trisubstituted olefins using the Shi catalyst 85 
As the favored transition states (A and H) result in the opposite stereoisomer, electronic 
factors have to be considered for a valuable prediction. Due to stabilizing interactions of an 
oxygen lone pair with the * orbital of the alkene, the spiro transition state should be 
preferred over the competing planar transition state where these interactions are geometrically 
not feasible (Figure 14). Furthermore, the alkyne substituent on the -substituted 2-
cyclopentenone 80 should lower the energy of the * orbital and therefore strengthen the 
secondary orbital interactions. 
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Figure 14: Electronic aspects of possible transition states for the epoxidation of olefins 
Taken all together, the sterically and electronically favored spiro transition state A should 
result in the formation of the (2R, 3R)-configured epoxycyclopentanone derivative 89 when 
olefin 80 is used as a substrate for the asymmetric Shi epoxidation (Scheme 26). 
 
Scheme 26: Expected stereochemical outcome of the asymmetric Shi epoxidation on 2-
cyclopentenone derivative 80 using chiral catalyst 85 
Alkyne substituted 2-cyclopentenone 80 was subjected to the epoxidation reaction. The 
desired product was obtained in 73% yield when chiral ketone 85 was used (Table 1, entry 1). 
Unfortunately, the expected stereochemical preference was not observed, instead, the 
epoxycyclopentanone 89 was just isolated as a racemic mixture. Since the reactivity appeared 
to be sufficient, the commercially available oxazolidinone containing chiral ketone 90 was 
applied. A better sterical differentiation of the olefin substituents was envisaged in that way. 
However, catalyst 90 was found to be ineffective giving lower yields and no stereoinduction. 
The same was found with D-camphor (91), which was also used instead of the fructose-
derived catalysts 85 and 90 (Table 1, entries 2 and 3). 
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Table 1: Shi epoxidation reactions on 2-cyclopentenone 80 with different chiral ketones 
 
entry catalyst yield 89 [%] ee [%] 
1 
 
73 0 
2 
 
46 0 
3 
 
17 0 
 
Moreover, the acetylene substituent was protected with Co2(CO)8 to increase the steric bulk in 
the olefin. Subsequent asymmetric Shi epoxidation with ketone 85 failed, no conversion was 
observed. When the reaction time and the reaction temperature were increased, only 
polymerization products were observed (Scheme 27). 
 
Scheme 27: Protection of the alkyne moiety in cyclopentenone 80 and subsequent Shi 
epoxidation 
Epoxidation reactions on electron deficient olefins are generally slow. Being electrophilic in 
nature, dioxiranes might be consumed unproductively by reacting with oxone to form the 
corresponding ketone or by decomposition during prolonged reaction times. Nevertheless, 
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significant conversion was observed giving the product in 73% yield in the case of catalyst 
85. This observation can be explained by a competing dioxirane formation with the ketone 
present in the substrate. This leads to an effective epoxidation catalyzed by the substrate itself 
being substrate and catalyst in one. However, no chiral induction is expected in this case. This 
indicates that well designed catalysts are required to effectively epoxidize ketones as shown in 
an intriguing example by Shi.
107
 The development of novel sugar based chiral catalysts with 
an enlarged substrate scope including ketones is strongly desired. 
Encouraged by a remarkable result by Adam
109
 who was able to convert isoflavones to the 
corresponding epoxides using Jacobsen’s chiral Mn(III)-salen catalyst 94, the focus of the 
epoxidation of -substituted 2-cyclopentenone 80 was shifted to this methodology. The 
Jacobsen asymmetric epoxidation has proven to be a versatile tool for a wide range of olefins. 
Although cis-disubstituted olefins are typically better substrates giving excellent 
enantioselectivities, it was also successfully applied with various other alkenes. The proposed 
mechanism is thought to proceed through the catalytically active manganese(V)oxo species 
95, which is formed in the presence of an oxidant.
110
 The bulky tert-butyl groups at the 
backbone of the catalyst restrict the trajectory of the attacking olefin forcing it to approach the 
oxygen via the chiral diamine backbone. High selectivity can be explained by the 
maximization of stereochemical interaction between the ligand and incoming substrate in the 
transition state (Scheme 28).  
 
Scheme 28: Jacobsen catalyst 94 and the enantiofacial bias of its catalytically active species 95 
The chiral catalyst 94 was prepared in four steps from racemic trans-1,2-diaminocyclohexane 
(98) and 2,4-di-tert-butyl-phenol (96).
111
 The phenol 96 was formylated to obtain the 
corresponding salicylaldehyde 97. Efficient resolution of trans-1,2-diaminocyclohexane (98) 
with L(+)-tartaric acid gave enantiomerically pure (R,R)-1,2-diammoniumcyclohexane mono-
(+)-tartrate salt (99), which was then coupled to the salicylaldehyde 97 to afford the resulting 
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salen ligand 100. A final complexation reaction with Mn(OAc)2 in presence of NaCl yielded 
the desired chiral catalyst 94 (Scheme 29). 
 
Scheme 29: Synthesis of the (R,R)-salen-Mn(III)-complex 94 for the asymmetric Jacobsen 
epoxidation 
The epoxidation of -substituted 2-cyclopentenone 80 with NaOCl as oxidant, (R,R)-salen-
Mn(III)-complex 94 and 4-phenylpyridine N-oxide in a biphasic solution of CH2Cl2 and 
aqueous Na2HPO4-buffer was successful to give the desired product (S,S)-89 in 60% yield 
(Table 2). The enantiomeric excess was determined to be 90%. In optimization studies it was 
shown that the concentration of the oxidant has a substantial impact on the conversion. Best 
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results were obtained when a 2 M solution of NaOCl was used. The addition of the Lewis 
basic 4-phenylpyridine N-oxide turned out to be beneficial for a good conversion. Other 
oxidants such as iodosobenzene, dimethyldioxirane (DMDO) and hydrogen peroxide were 
screened exhibiting inferior results compared to NaOCl. 
Table 2: Jacobsen epoxidation reactions on 2-cyclopentenone 80 using different oxidants  
 
entry oxidant solvent yield [%] ee [%] 
1 NaOCl CH2Cl2 / aq. Na2HPO4 60 90 
2 PhIO MeCN 9 59 
3 DMDO CH2Cl2 16 19 
4 H2O2 H2O / MeCN - - 
 
The absolute stereochemistry of the obtained epoxyketone 89 was determined at a later stage 
of the synthesis. X-ray crystallographic investigations on downstream intermediates allowed 
to deduce the correct stereochemistry of the product to be the (S,S)-enantiomer (see chapter 
3.3.1, p. 41).  
The asymmetric epoxidation of 2-cyclopentenone derivatives has been an unsatisfying issue 
so far. Especially, -substituted cyclic enones as substrates represented an unresolved 
problem. With this achievement the first enantioselective epoxidation of an -substituted      
2-cyclopentenone compound succeeded giving the corresponding 2,3-epoxycyclopentanone in 
high ee and good yield. 
3.2.3. Asymmetric cyanohydrin reactions 
Subsequent investigations concentrated on the asymmetric cyanohydrin reaction. This 
approach should render further transformations possible, which lead to the envisaged chiral 
building block in a very elegant way. Initial experiments focused on the conversion of -
substituted 2-cyclopentenone 80 to a chiral cyanohydrin 101, which results in the formation of 
an allylic alcohol. Allylic alcohols are excellent substrates for the well known titanium 
alkoxide mediated Sharpless asymmetric epoxidation. Using chiral tartrate esters and alkyl 
hydroperoxides, enantioenriched epoxy alcohol 102 should be obtained (Scheme 30). 
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Scheme 30: Approach towards the chiral building block 102 
The cyanation of ketones is more challenging compared to the cyanation of aldehydes. The 
steric hindrance to cyanide attack and the lower electrophilicity of the carbonyl group are 
typically the main drawbacks. However, powerful methods have been developed in the last 
decades to overcome these problems and were reviewed elsewhere.
112-114
 Aromatic ketones 
and aliphatic methyl and ethyl ketones are excellent substrates for many privileged catalysts. 
Ketones such as the aromatic indanone and tetralone were frequently used as model 
substrates, however, simple cyclic ketones such as cyclopentenone were little addressed so 
far. Small differences in sterics and electronics adjacent to the carbonyl group require 
enhanced stereodifferentiating properties of the catalyst. Encouraged by a chiral Lewis base-
catalyzed asymmetric cyanation reported by Deng,
115
 attention was drawn to this promising 
concept since ,-disubstituted cyclopentanone and cyclohexanone derivatives could be 
converted to the corresponding cyanohydrins in excellent enantioselectivities using modified 
cinchona alkaloids as Lewis base catalysts (Figure 15). 
 
Figure 15: Cinchona alkaloids as chiral ligands for the cyanation of ketones 
Ethyl cyanoformate as cyanide source was employed. As the commonly used TMSCN is 
relatively expensive and highly toxic, ethyl cyanoformate reveals beneficial properties and is 
therefore more attractive. A proposed mechanism of this reaction is shown in scheme 31.  
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 Scheme 31: Proposed mechanism of the cyanation of ketones with alkaloid derived chiral 
catalysts by Deng et al. 
In the first step the cyanoformate 104 forms a chiral ion complex 105 with the chiral tertiary 
amine 103. Two diastereomeric intermediates 107a and 107b are generated with the ketone 
106 undergoing fast interconversion between each other. Transfer of the alkoxycarbonyl 
group from the N-acyl ammonium to the alkoxide at different rates gives rise to the optically 
enriched products 108a and 108b, respectively. The ee is therefore determined by a kinetic 
resolution in the last step. 
 
Scheme 32: Cyanation with ethyl cyanoformate and chiral cinchona alkaloid ligands 
-Substituted 2-cyclopentenone 80 showed no clean reaction upon treatment with ethyl 
cyanoformate and (DHQ)2AQN or DHQD-PHN (Scheme 32). At low temperatures the 
reactivity was too low giving no conversion, upon slow warming to 0 °C the starting material 
started to react nonspecifically to form many by-products. A non-chiral version with DABCO 
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instead of the alkaloid derived catalyst revealed a competing 1,4-addition. Additionally, 
cleavage of the TMS group was observed to set the highly reactive terminal alkyne free, 
which resulted in the formation of polymerization products. These observations indicate that 
alkynes and ,-unsaturated subunits are not well tolerated by this approach. 
A more versatile strategy with a broader substrate scope including ,-unsaturated derivatives 
was reported by Jacobsen,
116
 namely a thiourea catalyzed cyanosilylation reaction. Thiourea 
derived ligand 110 was developed, which proved to be general for a wide range of ketones 
(Figure 16). In presence of TMSCN and trifluoroethanol -bromo-2-cyclohexenone, for 
instance, was converted to the corresponding cyanohydrin exclusively. Hence, the 
applicability of this method for cyclic ,-unsaturated ketones is well exemplified. A 
cooperative mechanism, in which the thiourea activates the ketone and the tertiary amine 
activates the in situ formed HCN simultaneously, is thought to be the mode of activation.
117
 
 
Figure 16: Thiourea ligand 110 for the cyanosilylation by Jacobsen et al. and the proposed 
transition state 111 for the addition of HCN to acetophenone 
Investigations on the cyanosilylation of -substituted 2-cyclopentenone 80 showed no product 
formation (Scheme 33). The conversion was low even at elevated temperatures. Several 
activation agents were tested in an achiral approach. The chiral thiourea catalyst 110 was 
omitted and the ineffective trifluoroethanol was replaced by various additives. Thiourea, ZnI2, 
4-phenyl pyridine N-oxide, CsF, HMPA, DMF, DMSO, Et3N and Ph3PO showed no 
beneficial effects. Llittle conversion was detected using Me3NO, however, not giving 
preparatively useful results. Ammonium salts such as Et4NCN and Et4NF turned out to be 
powerful activating agents giving multiple decomposition products spontaneously. 
When the Jacobsen protocol was applied to -substituted 2,3-epoxycyclopentanone (S,S)-89, 
a rapid and highly selective formation of the corresponding TMS protected epoxy 
cyanohydrin 77 as a single product was observed (Scheme 33).  
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Scheme 33: Cyanosilylation reactions on 2-cyclopentenone 80 and 2,3-epoxycyclopentanone 
(S,S)-89 using Jacobsen’s protocol 
Surprisingly enough, this reaction proceeds extremely regioselectively while the epoxide 
moiety remains untouched, and with a very good diastereomeric ratio of 95:5. Interestingly, 
when the chiral catalyst 110 was replaced simply by thiourea, the diastereoselectivity was 
even better, albeit at the expense of reactivity. By the use of Et4NCN instead of thiourea the 
yield could even be raised to 72% with a still excellent diastereomeric ratio of 98:2 (Table 3). 
Table 3: Optimization of the cyanosilylation reaction of 2,3-epoxycyclopentanone (S,S)-89 
 
entry activator yield [%] dr 
1 catalyst 110, CF3CH2OH 62 95:5 
2 thiourea, CF3CH2OH 44 >99:1 
3 Et4NCN 72 98:2 
 
The obtained results are in accordance with the findings of Aljarilla et al.,
118
 who investigated 
the Bu4NCN-catalyzed cyanosilylation of cyclic ,-epoxyketones. However, obtained 
diastereoselectivities are in the case of the formation of 77 significantly higher. Even more 
interestingly, depending on the ringsize, reverse diastereoselectivities are obtained. 
Cyanosilylation of five-membered epoxyketones gave mainly the syn diastereomer, whereas 
the cyanosilylation of six-, seven- and eight-membered epoxyketones yielded mainly the anti 
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diastereomer with respect to the epoxide moiety. This could be confirmed by the 
stereochemical assignment of the product, which was done after deprotection of the TMS 
ether (see chapter 3.3.1, p. 41) giving the syn diastereomer predominantly. 
3.3. Subsequent transformations on the chiral building block 77 
Careful strategic considerations were necessary to successfully accomplish further 
transformations on the chiral building block 77. Stability and reactivity of the different 
functional groups under various reaction conditions have to be taken into account. Thus, 
several possibilities arise from this stage of the synthesis to proceed. 
 
Scheme 34: Possible routes towards cyclization precursor 74 
The combination of the chiral building block 77 with a benzoic acid derivative can proceed 
via addition of the terminal acetylene to the carbonyl function (path I, Scheme 34). This 
requires the removal of the TMS protecting group prior to the coupling step. Particularly the 
TMS ether plays a pivotal role in this context since its stability is strongly limited, even 
though it is essential for the stability of the cyanohydrin preventing a retro cyanation reaction 
under basic conditions, which would reinstall the ketone moiety with concomitant loss of the 
stereochemical information.  
On the other hand, further transformations on the chiral building block 77 prior to the 
coupling step, namely the hydrolysis of the nitrile to give the methyl ester and oxidative ring 
opening of the epoxide, would give rise to -hydroxyketone 114 (path II, Scheme 34). In this 
way, the differentiation of both TMS groups is circumvented. However, two acidic protons in 
direct proximity of the carbonyl group may interfere with the coupling step, which is typically 
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done under basic conditions. Alternatively, the coupling step can also be carried out prior to 
the oxidative ring opening.  
Both strategies were pursued in parallel. The results are described in the following. 
3.3.1. Differentiation of the TMS ether and TMS acetylene 
Amongst the frequently used silyl ethers the TMS ether is most susceptible to hydrolysis with 
either acid or base. A TMS acetylene is much more stable and tolerates acidic and to some 
extent also basic conditions. Hence, the selective deprotection of a TMS ether in presence of 
the TMS acetylene should be quite easy. The reverse way however, the selective deprotection 
of a TMS acetylene in presence of a TMS ether, is a rather difficult endeavor and has not been 
reported. No literature precedent could be found. 
Indeed, deprotection of the TMS ether 77 using a 1 M aqueous solution of H2SO4 in MeCN in 
a ratio of 1:1 proceeded smoothly to give the corresponding 2,3-epoxyalcohol 102 in 93% 
after recrystallization from diethyl ether and pentane (Scheme 35). 
 
Scheme 35: Cleavage of the TMS ether to generate the free alcohol 102 
The crystal structure of the alcohol 102 reveals the anticipated syn configuration of the 
alcohol functionality with respect to the epoxide with the nitrile pointing to the opposite 
direction. The absolute configuration was determined to correspond to the (1S, 2S, 3S)-isomer 
(Figure 17). 
 
Figure 17: Ortep plot of alcohol 102 
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Furthermore, the deprotection of the TMS acetylene from 2,3-epoxyalcohol 102 was 
investigated. Silyl groups are easily cleaved by fluoride ion, which is attributed to the high 
affinity of the fluoride ion for silicon. Treatment of the alcohol with TBAF as trihydrate or as 
an anhydrous solution in THF resulted in a fast conversion, however, all attempts to isolate 
the product 115 failed (Table 4, entries 1 and 2).
119
 This could be traced back to the mild 
basicity of fluoride in aqueous solutions and the even higher basicity of “naked” fluoride in 
anhydrous solutions, which might deprotonate the alcohol and lead to a back-reaction to the 
corresponding 2,3-epoxyketone 89. Under basic conditions polymerization products between 
the ketone and the deprotected terminal alkyne might have been formed. The same 
observations were made using K2CO3 in anhydrous MeOH, another frequently used method 
for the deprotection of TMS acetylenes (Table 4, entry 3).
119
 Hence, the focus was shifted to a 
silver mediated deprotection reaction, which allows a TMS cleavage under non-basic 
conditions with catalytic amounts of AgNO3.
120
 In this way, the deprotected acetylene 115 
could be obtained in 54% yield (Table 4, entry 4). 
Table 4: Deprotection of the TMS acetylene 102 
 
entry conditions yield [%] 
1 TBAF∙3H2O, THF, 0 °C, 10 min multiple products 
2 TBAF anhydrous, THF, 0 °C, 10 min multiple products 
3 K2CO3, MeOH, 0 °C, 10 min multiple products 
4 AgNO3, acetone/H2O, rt, 16 h 54
a
 
   a
 estimated by NMR 
 
Unfortunately, the planned coupling step with protected p-hydroxybenzaldehyde 116 with 
various bases such as LDA, n-butyl lithium or KOH failed (Scheme 36). The very low 
stability of the unprotected cyanohydrin 115 towards bases made further steps impossible.  
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Scheme 36: Unsuccessful coupling of alcohol 115 with p-hydroxybenzaldehyde 116 
Previous observations clearly emphasize the inevitable necessity of a protected alcohol 
functionality. Thus, a novel methodology is required to selectively cleave the TMS acetylene 
in presence of a TMS ether if further protecting group manipulations are supposed to be 
avoided. 
Since neither basic nor acidic conditions are tolerated, a very mild procedure is essential for 
the envisaged selectivity. Based on the previous results, studies were concentrated on the 
previously applied reaction using literature conditions with catalytic amounts of AgNO3 in 
acetone and H2O as a co-solvent (Scheme 37). 
 
Scheme 37: Literature conditions for the deprotection of TMS acetylenes
120
 
It was found to be effective for the cleavage of the TMS acetylene. However, a concomitant 
cleavage of the TMS ether was also observed. This can be explained by the in situ formation 
of nitric acid if H2O is present in the reaction mixture (Scheme 38). 
 
Scheme 38: Proposed mechanism for the Ag-catalyzed cleavage of TMS acetylenes 
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Consequently, if the reaction is carried out under anhydrous conditions, the catalytic cycle 
would be interrupted as TMSNO3 cannot be hydrolyzed. Necessarily, the reaction would have 
to be performed stoichiometrically in AgNO3. Indeed, using waterfree conditions and one 
equivalent of AgNO3, the selective cleavage of the TMS acetylene 77 was achieved keeping 
the silyl ether nonchanged (Scheme 39). Aqueous workup with a saturated solution of NH4Cl 
gave the deprotected acetylene 118 as single product in 80% yield after extraction. Further 
purification was not necessary due to the high purity of the isolated material. 
 
Scheme 39: Selective cleavage of the TMS acetylene in presence of a TMS ether to yield 118 
Using improved reaction conditions of a literature procedure,
120
 a selective deprotection of a 
TMS alkyne in presence of a TMS ether was achieved for the first time. This provides a novel 
and powerful tool for challenging applications in the synthesis of complex molecules. 
Further improvements of this reaction procedure using catalytic amounts of AgNO3 in 
buffered aqueous media should be considered and remain to be explored. 
3.3.2. Coupling reactions with benzaldehyde and benzoic acid derivatives 
Because of its acidity, the acetylene hydrogen can be abstracted with bases. However, the 
addition of the terminal alkyne to a carbonyl function under basic conditions is strongly 
limited by the stability of the TMS ether. Various bases have been screened to identify an 
appropriate reagent, which effectively deprotonates the alkyne, but which does not interfere 
with the other functional groups in the molecule. Isopropyl protected p-hydroxybenzaldehyde 
116 was used as reactant for the coupling experiments. Upon treatment with CsOH∙H2O, 
NaOtBu or n-butyl lithium multiple decomposition products were observed since they do not 
only deprotonate the alkyne, but also unspecifically attack the silyl ether, the nitrile or the 
epoxide moiety due to their significant nucleophilicity. The non-nucleophilic amine base 
DBU showed no conversion, which can be simply traced back to its insufficient basicity in 
THF. Sterically demanding bases like LiHMDS and LDA revealed initial product formation, 
however, the formation of many by-products did not make the reactions synthetically useful. 
Better results were obtained using t-butyl lithium in presence of TMEDA as complexation 
reagent for the lithium ion. After extensive optimization, it was possible to isolate the crude 
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propargylic alcohol 119 in 62% yield as a mixture of diastereomers with the TMS ether 
remaining intact. Subsequent oxidation of the alcohol using an excess of MnO2 in CH2Cl2 
afforded the corresponding ketone 113 as single stereoisomer in 92% yield (Scheme 40). 
 
Scheme 40: Reaction of terminal alkyne 118 with benzaldehyde 116 and subsequent oxidation 
of the alcohol 119 
Aiming for a further improvement of the coupling reaction, the Weinreb amide 121 of 
isopropyl protected p-hydroxy benzoic acid as reaction partner was envisaged. With respect to 
the principles of efficiency this approach would save one step directly establishing the desired 
carbonyl functionality. The amide was prepared from the corresponding aldehyde 116 by 
oxidation and subsequent treatment with N,O-dimethylhydroxylamine hydrochloride (Scheme 
41). 
 
Scheme 41: Synthesis of the Weinreb amide 121 from isopropyl protected p-hydroxy-
benzaldehyde 116 
In contrast to the aldehyde 116 the Weinreb amide 121 proved to be not reactive enough in 
the coupling reaction with terminal acetylene 118. No product formation was observed in this 
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case (Scheme 42). Further examinations with the appropriate ester or anhydride should be 
carried out to further enhance the accomplished results. 
 
Scheme 42: Attempted reaction of terminal alkyne 118 with Weinreb amide 121 
 
3.3.3. Ring opening reactions on the epoxide 
To evaluate whether the ring opening of the epoxide or the hydrolysis of the nitrile moiety in 
compound 77 prior to the coupling step with aldehyde 116 is superior to the present synthetic 
route (see chapter 3.3, p. 40), further investigations focused on ring opening reactions and 
were examined on the epoxide 102. Special attention has to be drawn to the stereochemical 
outcome of the reaction since the syn orientation of both hydroxy groups attached at the 
quaternary stereocenters must remain intact during this transformation where sterical and 
electronical factors play a crucial role. Under basic conditions the attack of hydroxide should 
predominantly occur at the secondary carbon due to minimized steric interactions giving the 
product with the correct stereochemical orientation. All attempts, however, to open the 
epoxide under basic conditions failed. Reactions were performed in buffered solutions in the 
pH range from 8 to12 (Scheme 44). In the lower pH range (8 to 10) a retro-cyanation reaction 
to the corresponding ketone 89 was observed predominantly, in even more basic media (pH > 
10) different reaction products of unknown structure were obtained. 
Under acidic conditions the more stable carbenium ion should be formed as a proton activates 
the epoxide prior to the attack of H2O. Since tertiary carbon centers stabilize a charged 
intermediate better than secondary carbon centers, the attack at the higher substituted carbon 
should be favored. However, sterical interactions should have also a strong impact on the 
product formation. Thus, the outcome of the reaction cannot be unambiguously predicted. 
During experiments on the hydrolysis of the nitrile under acidic conditions, ring-opened 
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products were formed, however, only as an inseparable mixture of multiple products (see 
chapter 3.3.4, p. 49). 
A highly elegant way to solve this synthetic problem was reported by Trost
88
 using a DMSO 
mediated oxidative ring opening reaction (Scheme 43). The key step is initiated by the 
activation of the epoxide 122 with triflic acid followed by a nucleophilic attack of DMSO. 
High regioselectivity was observed as the steric interactions were minimized. Upon treatment 
with Hünig’s base the -hydroxyketone 124 was installed with simultaneous loss of 
dimethylsulfide. 
 
Scheme 43: Oxidative ring opening reported by Trost
88
 
Treatment of epoxide 102 with triflic acid in DMSO resulted in a fast and quantitative 
consumption of the starting material. Addition of Hünig’s base, however, was incompatible 
with the cyanohydrin moiety. Experiments to trap the ring-opened structure prior to the 
oxidation step failed as well. Upon careful neutralization a back-reaction was observed 
restoring the epoxide starting material again. Alternatively, the Lewis acid Mg(OTf)2 instead 
of a Brønstedt acid was used to activate the epoxide. Chelation of the epoxide and the vicinal 
hydroxy group with Mg(OTf)2 was supposed to suppress the cyanide elimination as well as to 
enhance the regioselectivity of the nucleophilic attack. Unfortunately, Mg(OTf)2 turned out to 
be ineffective, no conversion could be observed.  
 
Scheme 44: Ring opening reactions under basic and oxidative conditions 
 
 
RESULTS AND DISCUSSION 
 
48 
 
Sharpless has reported the highly regioselective titanium isopropoxide-mediated ring opening 
of 2,3-epoxy alcohols with various nucleophiles.
121
 The efficient coordination of the alcohol 
with the metal center in a bidentate manner (see 129, Scheme 45) is thought to be the 
determining factor for the strong preference of the nucleophiles to attack at C3 of the epoxy 
alcohol (Scheme 45).  
 
Scheme 45: Regioselective ring opening of 2,3-epoxy alcohols with nucleophiles by Sharpless 
et al.
121
 
However, no 2,3-epoxyalcohols of cyclic compounds as substrates were examined in the 
literature precedents. In the present study acetate, benzoic acid and allyl alcohol were used as 
nucleophiles to open the epoxide (Table 5). No conversion was observed with acetate and 
benzoic acid. Upon warming slow decomposition of the starting material 102 occurred over 
time. With allyl alcohol the starting material was partially converted to ketone 89, which lacks 
the cyanohydrin unit. As epoxides in general are poor Lewis bases, cyclic epoxy alcohols in 
particular might be even worse substrates for an effective coordination by the Lewis acid. 
Consequently, the nucleophiles such as acetate, benzoic acid and allyl alcohol do not undergo 
a ring opening reaction with the non-activated substrate. 
Table 5: Ti(OiPr)4-mediated ring opening reactions using different nucleophiles 
 
entry conditions product 
1 NH4OAc, THF, rt, 24 h no conversion 
2 benzoic acid, THF, rt, 24 h no conversion 
3 allyl alcohol, rt, 1 h ketone 89 
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3.3.4. Hydrolysis and protecting group manipulations on the cyanohydrin 
The low stability of the cyanohydrin 102 has shown to be a great drawback for many 
applications, which have been addressed so far. Although important steps have been 
accomplished such us the selective deprotection of the TMS acetylene or the coupling step 
with benzaldehyde 116 and t-butyl lithium in presence of the silyl ether, many reactions with 
a potential for an effective and straightforward synthesis did not proceed as the cyanohydrin 
102 did not tolerate the required reaction conditions. Hence, a solution to this problem is 
desired to enable further steps in the proposed synthesis. 
Two possibilities can be considered to enhance the stability of this functional group. The 
acidic hydrolysis of the nitrile to the corresponding -hydroxy carboxylic acid or the 
corresponding ester transforms the very good leaving group CN to a stable substituent. Even 
more advantageous, it directly establishes the correct functionality found in the final natural 
product. Alternatively, a more stable protecting group can be introduced to mask the alcohol 
preventing the observed deprotonation under basic conditions and subsequent loss of the 
nitrile group. 
Various conditions were used to hydrolyze the nitrile to the carboxylic acid 131 or the 
corresponding ester 132, respectively (Table 6). With 4 M HCl no conversion was observed, 
under stronger acidic conditions using concentrated HCl in aqueous media or an anhydrous 
saturated solution of HCl in MeOH similar product mixtures were obtained in different ratios. 
The isolation and analysis of the obtained products was critical, nevertheless, no hydrolysis 
product could be identified, instead, ring-opened products were generated presumably by the 
nucleophilic addition of methanol or chloride (Table 6, entries 1-3). Since the removal of the 
silyl ether proceeds in 1 M sulfuric acid in acetonitrile, it is desirable to not only cleave the 
protecting group, but also to hydrolyze the nitrile in one single step. However, a 1 M solution 
of H2SO4 in MeCN turned out to be ineffective as the conversion was low after 22 h. Best 
results were achieved using a 3 M solution of H2SO4 instead, unfortunately, the resulting 
products could not be separated. NMR and IR data indicated that also ring-opened products 
were formed since no characteristic carbonyl signals, but broad OH signals were obtained. 
Harsher reaction conditions lead to the decomposition of the starting material (Table 6, entries 
4-6). Further experiments using PPTS or pTsOH in dry MeOH did not show any product 
formation after 22 h, slow decomposition was observed in the case of pTsOH if longer 
reaction times were applied. Moreover, the reaction with triflic acid resulted in a mixture of 
unidentified compounds (Table 6, entries 7-9). 
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Table 6: Hydrolysis experiments with nitrile 102 
 
entry conditions product 
1 4 M HCl / dioxane 1:1, reflux, 22 h no conversion 
2 
aq. conc. HCl / MeOH / dioxane 
1:1:1, reflux, 22 h 
multiple products 
3 
anhydr. sat. HCl in MeOH, reflux, 
22 h 
multiple products 
4 1 M H2SO4 / MeCN 1:1, reflux, 22 h low conversion 
5 3 M H2SO4 / MeCN 1:1, reflux, 22 h multiple products 
6 5 M H2SO4 / MeCN 2:1, reflux, 22 h decomposition 
7 PPTS (1.0 eq.), MeOH, reflux, 22 h no conversion 
8 pTsOH (0.1 eq.), MeOH, rt, 22 h no conversion 
9 TfOH (1.0 eq.), MeOH, reflux, 22 h multiple products 
 
None of the performed experiments gave satisfying results. The hydrolyzed product was not 
found, instead, competing epoxide opening reactions occurred due to the higher reactivity of 
the epoxide in contrast to the nitrile. Under acidic conditions the activation of the epoxide for 
a subsequent addition of a nucleophile prevails over the hydrolysis of the nitrile. The 
hydrolysis under basic conditions was not carried out due to the instability of the 
cyanohydrin. An interesting biocatalytic approach towards -hydroxy carboxylic acids was 
reported
122
 using bacterial cells of Rhodococcus erythropolis NCIMB 11540. Having a highly 
active nitrile hydratase / amidase enzyme system present, enantiopure cyanohydrins could be 
converted to the carboxylic acids in high yields and without racemization. Since both 
enzymes are not commercially available, this bioorganic strategy could not be pursued 
although it represents an alternative to chemical procedures, which provides access to the 
desired -hydroxy carboxylic acid as the crucial intermediate in the envisioned synthetical 
route. 
Alternatively, a new protection strategy was used since previous approaches have shown to be 
insufficient. The choice of the appropriate protecting group for the alcohol is determined by 
the orthogonality to the present functional groups in the substrate. Various protecting groups 
were taken into consideration. As one possibility the benzyl group was chosen since it can be 
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easily introduced under mild conditions and removed by hydrogenation in presence of a 
palladium catalyst (Table 7).  
Table 7: Attempted benzylation of alcohol 102 
 
entry conditions product 
1 BnBr, NaHCO3, DMF, rt decomposition 
2 BnBr, Ag2O, DMF, rt decomposition 
3 BnOH, Bi(OTf)3, CCl4, rt, 24 h no conversion 
4 BnCl, Ni(acac)2, reflux, 24 h decomposition 
5 
Bn-trichloroacetimidate, TfOH, CH2Cl2, 
rt, 30 min 
trace 133 
6 Bn-trichloroacetimidate, TfOH, THF, rt polymerization 
7 
Bn-trichloroacetimidate, TfOH, Et2O, 
rt, 30 min 
trace 133 
8 
Bn-trichloroacetimidate, TMSOTf, 
CH2Cl2, rt, 30 min 
trace 133 
9 
Bn-trichloroacetimidate, Sc(OTf)3, 
toluene, rt, 24 h 
no conversion 
10 
2-Benzyloxy-1-methylpyridinium 
triflate, MgO, C2H4Cl2, rt, 24 h 
ketone 89 
 
The benzyl protecting group is often introduced under basic conditions. As expected this was 
not successful because of the base-labile cyanohydrin functionality (Table 7, entry 1). Metal 
catalyzed methods using Ag2O,
123
 Bi(OTf)3
124
 or Ni(acac)2
125
 gave either unspecific product 
mixtures, or no conversion was observed (Table 7, entries 2-4). Benzyl-trichloroacetimidate 
allows for the benzylation under acidic conditions.
126,127
 Different solvents in combination 
with triflic acid were tested such as dichloromethane and diethyl ether, which gave traces of 
the desired protected alcohol 133. However, the conversion was too low to be preparatively 
useful (Table 7, entries 5 and 7). In THF polymerization occurred to give a colorless highly 
viscous gel (Table 7, entry 6). With TMSOTf the conversion could not be significantly 
increased (Table 7, entry 8), Sc(OTf)3
128
 showed to be ineffective to catalyze the protection 
reaction (Table 7, entry 9). Another reagent which allows for a benzylation under neutral 
conditions is 2-benzyloxy-1-methylpyridinium triflate (136).
129
 It was prepared from 2-
bromopyridine (134) in two steps via a literature known procedure (Scheme 46).
130
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Scheme 46: Synthesis of 2-benzyloxy-1-methylpyridinium triflate (136) 
Unfortunately, in presence of MgO as acid scavenger a retro-cyanation reaction was observed 
to yield ketone 89 predominantly (Table 7, entry 10). Although this method was also 
successfully tested on tertiary alcohols, it did not undergo the introduction of the benzyl group 
to the tertiary alcohol in substrate 102. As a conclusion, the protection of the tertiary alcohol 
in the densely functionalized framework proved to be challenging since the alcohol 
functionality is shielded by a sterically demanding environment, which prevents an effective 
formation of the ether bond. 
Thus, isobutylene was envisaged for the protection of 102 as t-butyl ether because it can be 
used as a gas and might alleviate the protection process. Moreover, t-butyl ethers are stable to 
most reagents except strong acids. 
Table 8: Experiments on the protection of alcohol 102 as t-butyl ether 137 
 
entry conditions product 
1 Isobutylene, PPTS, CH2Cl2, rt, 1 h no conversion 
2 Isobutylene, Amberlyst 15, CH2Cl2, rt, 1 h ketone 89 
3 Mg(ClO4)2, Boc2O, CH2Cl2, reflux, 24 h 
conversion low 
trace 137 + ketone 89 
 
When isobutylene was bubbled through the alcohol 102 containing mixture in presence of 
PPTS, no conversion was observed. Using Amberlyst 15,
131
 a polymer-bound acidic catalyst, 
ketone 89 was formed exclusively (Table 8, entries 1 and 2). Boc2O in combination with 
anhydrous magnesiumperchlorate was reported to give the t-butyl ether, not as expected the 
corresponding Boc-derivative.
132
 In fact, traces of the t-butyl ether were observed alongside 
with ketone 89. However, the reactivity was low leaving the starting material widely 
unconsumed (Table 8, entry 3). As noticed similarly to the previous approach, the t-butyl 
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group turned out to be too bulky for an efficient protection strategy. Thus, the rather slim 
methoxymethyl (MOM) group was chosen. 
Table 9: Experiments on the protection of alcohol 102 as MOM ether 138 
 
entry conditions product 
1 CH2(OMe)2, pTsOH, LiBr, reflux, 24 h no conversion 
2 CH2(OMe)2, Sc(OTf)3, CHCl3, reflux, 24 h no conversion 
3 CH2(OMe)2, P2O5, CHCl3, rt, 1 h ketone 89 
4 
MOM-2-pyridylsulfide, NaOAc, AgOTf, 
THF, rt, 24 h 
trace 138 + ketone 89 
 
The introduction of the methoxymethyl moiety under acidic conditions can be carried out 
using CH2(OMe)2 and a Lewis or Brønstedt acid. When para-toluenesulfonic acid was used, 
however, it was found to be ineffective to catalyze the desired transformation and no 
conversion was observed (Table 9, entry 1).
133
 Scandium triflate showed the same behavior 
(Table 9, entry 2).
134
 On the contrary, catalytic amounts of P2O5 gave the ketone 89 as single 
product (Table 9, entry 3).
135
 MOM-2-pyridylsulfide (140) was reported to protect alcohols 
under very mild conditions.
136
 The observed conversion was very low, but analytical data 
indicate that traces of the MOM ether were generated with a simultaneous formation of 
ketone 89. The reagent was synthesized from 2-mercaptopyridine (139) and 
dimethoxymethane in one step (Scheme 47).
136
 
 
Scheme 47: Synthesis of MOM-2-pyridylsulfide (140) 
Since the hydroxy group is poorly accessible for the introduction of a suitable protecting 
group, it can be expected that in turn it does not notably interfere in the downstream synthesis 
once the nitrile is hydrolyzed. Hence, a short-term protecting group was envisioned just for 
the hydrolysis of the nitrile. For that purpose, the synthesis of 1-methyl-1-methoxyethyl ether 
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141 was attempted. This protecting group is highly sensitive to acids, but more stable to 
bases. This strategy would allow for the mild hydrolysis of the nitrile under basic conditions 
and subsequent easy and quick removal of the protection group by an acidic workup 
procedure. 
Unfortunately, all attempts to generate the desired ether 141 failed. Both, pTsOH and POCl3 
in 2-methoxypropene
137
 gave no conversion (Table 10, entries 1 and 2). The same result was 
observed with 2,2-dimethoxypropane as a solvent (Table 10, entry 3).
138
  
Table 10: Experiments on the synthesis of 1-methyl-1-methoxyethyl ether 141 
 
entry conditions product 
1 CH2=C(Me)OMe, pTsOH, reflux, 24 h no conversion 
2 CH2=C(Me)OMe, POCl3, reflux, 24 h no conversion 
3 CMe2(OMe)2, pTsOH, reflux, 24 h no conversion 
 
Although it was not possible to improve the stability of the cyanohydrin so far, several 
synthetic problems in the studies towards the total synthesis of limnophilaspiroketone (15) 
could be solved. An important step included the enantioselective epoxidation of an -
substituted cyclopentenone derivative, which was achieved for the first time in high 
enantioselectivity and good yield. A subsequent diastereoselective cyanohydrin reaction was 
accomplished. Both key steps allow for the formation of quaternary stereocenters with the 
correct absolute configuration. The selective deprotection of a TMS acetylene in the presence 
of a TMS ether was carried out. The differentiation between both protecting groups has not 
been reported so far and represents a general and valuable tool in organic synthesis. It enabled 
the coupling of the terminal acetylene to a benzaldehyde derivative and provided access to an 
important intermediate in the proposed synthetic route. However, problems arised from the 
instability of the cyanohydrin moiety in compound 102. Since it turned out to be very base 
labile, ring opening reactions on the epoxide did not succeed. Further complications in 
downstream transformations such as the cyclization reaction under basic conditions can also 
be expected. Unfortunately, hydrolysis experiments on the nitrile and protecting group 
manipulations on the tertiary alcohol, which could have improved the stability of the 
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cyanohydrin, were not successful. Nevertheless, a solution to this drawback has to be found 
since the stability of the cyanohydrin is a prerequisite for further steps in the total synthesis. 
Thus, a new concept has to be figured out to overcome this problem. 
One possibility would be the use of chlorosulfonyl isothiocyanate, which is known to react 
with cyanohydrins to give 2,4-oxazolidinediones.
139
 This approach would provide a useful 
route to the preparation of -hydroxy carboxylic acid derivative 131 (Scheme 48). 
 
Scheme 48: Possible preparation of -hydoxy carboxylic acid derivative 131 via 
oxazolidinedione 142 
Alternatively, the use of different cyanide sources for the diastereoselective cyanohydrin 
reaction such as acyl cyanides or cyano formates enables the direct introduction of a 
protecting group at the alcohol oxygen. In that way, acetyl cyanide should give in presence of 
catalytic amounts of a Lewis base the acetylated cyanohydrin 144.
140
 Ethyl cyanoformate 
should result in the installation of the corresponding carbonate 143 (Scheme 49). 
 
Scheme 49: Possible cyanohydrin reaction with ethyl cyanoformate and acetyl cyanide 
Moreover, from carbonate 143 a cyclization to the corresponding dioxolane 145 might be 
possible, which would give the -hydroxy carboxylic acid 131 upon hydrolysis (Scheme 50). 
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Scheme 50: Possible cyclization of carbonate 143 and subsequent hydrolysis 
Efforts have to be made to evaluate these strategies, and the feasibility of the proposed 
transformations remains to be explored in the future.  
3.4. Limno-CP  a natural product derived model substrate 
To gain information on the chemical reactivity on the one hand and on biological properties of 
3(2H)-furanones on the other hand, the synthesis of the natural product derived model 
compound Limno-CP (146) (CP from cyclopentyl) was envisioned. It comprises the 
spirocyclic framework with the 3(2H)-furanone subunit and the phenolic substituent, which is 
also present in the natural product. The 5-membered ring, which is attached at the spiro 
carbon containing the second ,-unsaturated carbonyl moiety, and all the rest of the 
substituents, however, are replaced by a simple cyclopentane ring. Consequently, an achiral 
simplified scaffold was generated (Figure 18). 
 
Figure 18: Design of the natural product derived model substrate Limno-CP (146) 
This compound can be produced in a fast and straightforward reaction sequence. As discussed 
in the introductory part of this work (see chapter 1.6, p. 12) the spirocyclic framework can be 
installed via different ways. In this approach the 5-exo-trig cyclization of a 4-hydroxy-alk-2-
ynone was envisioned, which was already applied by Parker et al.
47
 in the total synthesis of 
bullatenone (16). The synthesis of the model compound focuses on the optimization of the 
reaction conditions, which are required for the formation of the spirocyclic 3(2H)-furanone 
moiety. The results from these experiments can then also be used for the synthesis of the 
natural product. Additionally, the investigations can provide a further insight into the 
mechanistic details of this reaction.  
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3.4.1. Synthesis of iPr-Limno-CP 
The synthesis of iPr-Limno-CP is closely related to a report by Shin et al., who applied this 
reaction sequence on similar compounds for the preparation of novel COX-2 inhibitors.
141
 
However, this methodology has never been applied to phenolic substrates. Therefore, the 
extension of this approach to phenolic substrates is envisioned in this study. 
To start with, p-hydroxybenzaldehyde (147) was protected as isopropyl ether (Scheme 51).
142
 
This protecting group was chosen since it can be selectively removed in presence of methoxy 
groups using boron trichloride. Methoxy functionalities are not prone to cleavage under these 
conditions. The orthogonal behavior is particularly important for the synthesis of methoxy 
substituted natural product limnophilaspiroketone (15). Furthermore isopropyl ethers are 
stable under physiological conditions and give rise to a second set of biologically interesting 
compounds, which can be implemented into biological testing.  
 
Scheme 51: Synthesis of iPr-Limno-CP 151 
Protected p-hydroxybenzaldehyde 116 was coupled to lithiated 1-ethynylcyclopentanol (148) 
to afford diol 149. Subsequent oxidation of the crude diol 149 with excess of MnO2 yielded 
ketone 150 in 72% yield over two steps. Until this stage of the reaction sequence no 
purification by column chromatography was required. A diethylamine mediated cyclization of 
the propargylic alcohol 150 in ethanol/water 9:1 gave the spiroketone 151 in 76% yield after a 
final recrystallization. With inexpensive starting materials and commercially available 
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standard reagents a facile synthesis of spiroketone 151 was achieved in four steps and very 
good total yield of 54%. All together, only two column chromatographic separations and one 
recrystallization were necessary for the whole sequence. 
3.4.2. Investigations on the formation of the spirocyclic framework 
Investigations were done to elucidate the underlying cyclization mechanism. Although a 
possible mechanism was proposed by Parker in the course of the total synthesis of 
bullatenone,
47
 the rational remains rather vague since no sound experiments were carried out 
to verify the assumptions.  
When literature conditions
141
 were applied, only poor yields were obtained initially (Table 11, 
entries 1-2). When H2O was added to the solvent, the product formation was significantly 
higher. A qualitative correlation based on un-optimized results is depicted in figure 19. 
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Figure 19: The crucial role of H2O. The conversion is strongly dependant on the H2O content 
in the solvent 
An optimum in the product formation is achieved when 10% H2O is used in ethanol. The 
impact of the solvent has not been discussed in previous reports, however, the outcome of the 
reaction is strongly influenced by the H2O content of the solvent. 
Only poor product formation was observed if diethylamine was replaced by triethylamine or if 
it was omitted at all (Table 11, entries 4-5). 
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Table 11: Formation of iPr-Limno-CP under various conditions 
entry Nuc / Base solvent T time  [h] yield [%] 
1 HNEt2 EtOH 100% rt 0.5 26 
2 HNEt2 EtOH 100% reflux 4 35 
3 HNEt2 EtOH/H2O 9:1 rt 0.5 90 
4 - EtOH/H2O 9:1 reflux 4 7 
5 NEt3 EtOH/H2O 9:1 reflux 4 8 
6 KOH EtOH/H2O 9:1 rt 0.5 35 
7 KOH EtOH/H2O 9:1 reflux 4 90 
 
These results indicate that HNEt2 acts as a nucleophile adding to the electrophilic carbon of 
the acetylene unit while H2O is needed as proton source for the addition process. Ring closure 
of intermediate 152 and subsequent loss of hydroxide in 153 lead to the formation of an 
iminium species 154, which is finally hydrolyzed to give the final product 151. The proposed 
mechanism is shown in scheme 52. 
 
Scheme 52: Reaction mechanism for the formation of iPr-Limno-CP (151) 
Interestingly, the presence of H2O alone is insufficient to catalyze this reaction, with strong 
bases, however, significant product formation was observed (Table 11, entries 6-7), albeit 
reflux conditions are required. In this case, the product 151 is formed via attack of hydroxide, 
ring closure and elimination of H2O giving the 3(2H)-furanone scaffold directly (Scheme 53). 
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Scheme 53: Reaction mechanism for the formation of iPr-Limno-CP (151) with KOH 
To summarize, the synthesis of the model compound iPr-Limno-CP (151) could be 
accomplished successfully. The 5-exo-trig cyclization of precursor 150 has not only proven to 
be a powerful methodology for the installation of the 3(2H)-furanone moiety, it also enabled 
the synthesis of the model compound in a multi-gram scale in 76% yield. The results from the 
experiments revealed interesting aspects of the reaction mechanism, which have not been 
discussed in the literature so far. Most importantly, the presence of water turned out to be 
essential for a sufficient conversion since it acts as a proton source for the addition of 
diethylamine to the triple bond. A nucleophile is imperatively required to mediate the 
reaction. HNEt2 has shown to be the better nucleophile than hydroxide since it effectively 
catalyzes the cyclization at room temperature within 30 minutes, whereas reflux conditions 
are necessary in the case of KOH to yield the same result. 
Starting from iPr-Limno-CP (151), the synthesis of different -substituted derivatives was 
envisioned. 
3.5. Synthesis of -substituted derivatives of Limno-CP 
The preparation of -substituted 3(2H)-furanones from one common precursor has not been 
systematically studied in the literature. Single examples are known as intermediates for 
various target molecules. However, to minimize synthetic work, it is highly desirable to gain 
access to many -substituted derivatives in simple one step modifications from one common 
precursor instead of finding different routes to every single derivative. Thus, one to three step 
transformations were envisaged for the generation of -substituted 3(2H)-furanones from iPr-
Limno-CP as starting material. This approach facilitates the generation of a library of such 
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spirocyclic -modified 3(2H)-furanones, which can be used for the analysis of their biological 
properties. 
3.5.1. Introduction of halogens 
A few examples of -halogen-3(2H)-furanones are reported in the literature. For the synthesis 
of phosphodiesterase 10-inhibitors a bromo-substituted 2,2-dimethyl-3(2H)-furanone 
derivative was prepared.
143
 In the group of Kirsch a protocol for the construction of iodo-
3(2H)-furanones was established
144
 and also -fluoro, -chloro and -bromo derivatives are 
known as part of a steroidal framework with anti-inflammatory activity.
145
 Furthermore, an -
fluoro-3(2H)-furanone, very similar to this target molecule, was described.
146
  
The -bromo- and -iodo-3(2H)-furanones are of particular interest since they are suitable 
starting materials for a further functionalization via metalation procedures such as palladium 
catalyzed coupling or bromine-lithium exchange reactions. Using common reaction 
procedures, -bromo-3(2H)-furanone 158 was obtained in 92% yield via a bromination-HBr 
elimination pathway.
147
 Likewise, the corresponding -iodo derivative 157 was prepared in 
72% yield using iodine and catalytic amounts of PDC (Scheme 54).
148
 
 
Scheme 54: Bromination and iodination of iPr-Limno-CP (151) 
Inspired by the high susceptibility of 3(2H)-pyrrolones towards electrophiles,
149
 a similar 
reactivity was anticipated for the corresponding 3(2H)-furanone even though the electron 
donating properties of oxygen are less prominent than in the case of nitrogen. Nevertheless, 
the additional electron donating effect of the phenol substituent and the electron withdrawing 
properties of the carbonyl moiety should lead to a partial negative charge at the -carbon of 
the ,-unsaturated carbonyl subunit, which might be sufficient for a reaction with 
electrophilic reagents. Indeed, -Br- 158 and -I-derivative 157 were accessible with N-
halosuccinimides as electrophilic halogen sources in very good yields of 88%. In the same 
manner, -chloro-3(2H)-furanone 159 was obtained in 91% yield using NCS in methanol 
(Scheme 55). 
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Scheme 55: Bromination, iodination and chlorination of iPr-Limno-CP (151) with N-
halosuccinimides 
The underlying mechanism can be explained as depicted in scheme 56. Addition of the 
halogen electrophile results in the formation of a positive charge, which can be stabilized by 
the oxygen and the phenol substituent. Subsequent deprotonation restores the ,-unsaturated 
carbonyl motif to give the -substituted compound. No additional base is required to induce 
the deprotonation step, the reaction proceeds smoothly without a significant formation of any 
side-products. 
 
Scheme 56: General mechanism for the halogenation of iPr-Limno-CP (151) with N-
halosuccinimides 
The generation of an -fluoro derivative has shown to be exceedingly more challenging. 
Nonetheless, the synthesis of fluorine-containing organic compounds has gained intensified 
attention in medicinal chemistry in the recent decades since many beneficial features can be 
attributed to the chemical properties of fluorine.
150
 The strong C-F bond can be utilized to 
increase the metabolic stability of the compounds. Fluorinated substructures substantially 
RESULTS AND DISCUSSION 
 
 63 
 
modulate the lipophilicity of the compounds, which is important for their capability to 
translocate cell membranes. Due to its similar size, hydrogen can be replaced by fluorine 
without notable steric differences. In contrast to steric parameters, the reactivity significantly 
differs from that of hydrogen. Fluorine is the most electronegative element and can therefore 
influence the reactivity of adjacent functional groups. Therefore, the implementation of 
fluorine into iPr-Limno-CP (151) is an attractive approach since it might have a strong impact 
on the reactivity of the ,-unsaturated carbonyl substructure. Two examples of -fluoro 
3(2H)-furanones are reported in the literature,
145,146
 however, the introduction of fluorine was 
done prior to the formation of the furanone framework. 
Based on the previous results with N-halosuccinimides, studies focused on electrophilic 
fluorinating reagents. Commercially available Selectfluor (161) is widely used
151
 since it is 
one of the most reactive reagents to date. It is safe, nontoxic, exceptionally stable and as non-
hygroscopic crystalline solid very easy to handle. However, its use is very much limited to 
polar solvents. In acetonitrile, DMF or acetone only complex mixtures were obtained at 0 °C 
(Table 12, entries 1, 3 and 4). Less polar solvents such as THF, chloroform, toluene or ethyl 
acetate gave the desired product, but only with very low conversions (Table 12, entries 5-8). 
When methanol was used as solvent, the addition of methanol to the -position of the ,-
unsaturated carbonyl subunit was detected amongst other side-products (Table 12, entry 2). 
Similar observations were taken advantage of in the glycosylation of glycals (Scheme 57).
152
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Table 12: Fluorination experiments with electrophilic fluorine sources 
 
entry electrophile solvent T t yield 
1 
 
MeCN 0 °C 1 h complex mixture 
2 MeOH 0 °C 1 h complex mixture 
3 DMF 0 °C 1 h complex mixture 
4 acetone 0 °C 1 h complex mixture 
5 THF reflux 16 h trace 
6 CHCl3 reflux 16 h trace 
7 toluene reflux 16 h trace 
8 EtOAc reflux 16 h trace 
9 
 
MeCN 0 °C 1 h complex mixture 
10 MeOH 0 °C 1 h complex mixture 
11 THF reflux 16 h 5% 
12 toluene reflux 16 h complex mixture 
 
 
Scheme 57: Glycosylation of glycals with selectfluor in presence of alcohols 
In presence of alcohols fluorinated derivatives of L-ascorbic acid 164
153
 and tetronic acid 
167
154
 were synthesized from corresponding bromo precursors 162 and 165 (Scheme 58). 
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Scheme 58: Synthesis of fluorinated L-ascorbic acid 164 and tetronic acid 167 from 
corresponding -bromo precursors 162 and 165 
In presence of an alcohol and Selectfluor the fluorinated addition products 163 and 166 were 
formed. Metal-bromine exchange was achieved with nBu3SnH, subsequent treatment with 
AcOH afforded the -fluorinated enones 164 and 167. Stannanes such as 168 were also used 
as precursors for the fluorination with Selectfluor via a metal-fluorine exchange reaction, 
another important strategy towards vinyl fluorides (Scheme 59).
155
 
 
Scheme 59: Fluorination strategy from stannanes 
Unfortunately, fluorination experiments starting from -bromo derivative 158 with 
Selectfluor in ethanol gave only complex product mixtures. All attempts to synthesize the 
stannane from the corresponding -bromo derivative 158 failed. The metalation approach is 
discussed in detail in chapter 3.5.4.  
To circumvent solubility problems, N-fluorobenzenesulfonimide  (NFSI) (170) was used. This 
reagent can also be applied in more non-polar solvents. In refluxing THF the -fluoro 
derivative 160 could be obtained after 16 h in 5% isolated yield (Table 12, entry 11). 87% of 
unreacted starting material was reisolated. If the reaction time was exceeded, bisfluorinated 
by-products were formed, which were inseparable due to very similar Rf values. In methanol, 
acetonitrile or toluene complex product mixtures were formed (Table 12, entries 9, 10 and 
12). 
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The lack of other suitable methodologies to form sp
2
-carbon-fluorine bonds directly has 
fueled the research on transition-metal-mediated reactions.
156
 Pd
IV
 intermediates from 
electrophilic fluorine sources have shown to be powerful precursors to aryl fluorides,
157-160
 
whereas Pd
II
 in 16 electron configuration is not an adequate intermediate as reductive 
elimination is disfavored. Also a 14 electron Pd
II
 complex has been reported using 
tBuBrettPhos and nucleophilic fluoride to catalyze the formation of aryl fluorides.
161
 Among 
other metals silver salts have been employed to fluorination reactions from aryl stannanes and 
boronic acids.
162,163
 Gold-mediated sp
2
-C-F bond constructions have been applied, but only 
from alkynes as starting materials using gold(I) N-heterocyclic carbene complexes,
164,165
 from 
-hydroxy-,-difluoroynones in presence of gold(I) chloride166 or from propargyl acetates as 
starting materials.
167,168
 
3.5.2. Introduction of carbon based substituents 
The -bromo-3(2H)-furanone 158 provides many possibilities for the formation of carbon-
carbon bonds. For example, the olefinic halide represents a starting material for a palladium 
catalyzed Suzuki coupling reaction, which has also been used by Shin et al. for the synthesis 
of COX-2 inhibitors.
141
 Under slightly different reaction conditions
169
 the corresponding -
phenyl derivative 171 was amenable from the halide precursor in 79% yield (Scheme 60). 
 
Scheme 60: Suzuki coupling reaction of derivative 158 
A microwave assisted cyanation reaction serves as a fast and efficient way for the preparation 
of nitrile 172 from bromide 158.
170
 This reaction is catalyzed by nickel cyanide, which is 
formed via in situ transmetalation from two equivalents of sodium cyanide and one equivalent 
of nickel bromide. The use of N-methyl-2-pyrrolidone (NMP) as solvent is required as the 
reaction is performed at an elevated temperature of 200 °C. However, in contrast to 
conventional heating, this can be done in a very easy and safe manner using a standard 
laboratory microwave instrument. Even more advantageous, it significantly enhances the 
reaction rate to obtain the nitrile 172 after 10 minutes in 89% yield (Scheme 61). 
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Scheme 61: Microwave assisted cyanation of -bromo-3(2H)-furanone 158 
An alternative route towards similar spirocyclic -CN-3(2H)-furanones via condensation of 
benzoic acid derivatives with ,-acetylenic γ-hydroxy nitriles was published recently.171 
Nitrile 172 should be a direct precursor for carboxylic acid derivatives. Indeed, nitrile 172 
could be hydrolyzed in basic media to give the corresponding amide 173 in 73% yield 
(Scheme 62).
172
 
 
Scheme 62: Hydrolysis of nitrile 172 to the corresponding amide 173 
To obtain the corresponding carboxylic acid 174 directly from the nitrile 172, prolonged 
reaction times and elevated temperatures have been applied since the hydrolysis of the amide 
to the carboxylic acid is much slower than the partial hydrolysis of the nitrile to the amide. 
However, amide 173 proved to be stable under basic conditions. Addition of H2O2 accelerated 
the first hydrolysis step, but had no impact on the second step (Table 13, entries 6 and 7). 
Thus, strong acids were applied to afford the carboxylic acid 174. Unfortunately, with HCl, 
H2SO4, H3PO4 or HBr partial cleavage of the isopropyl ether was observed instead, and 
product mixtures of the starting material, the amide and their deprotected phenol analogues 
were obtained (Table 13, entries 1-4). With glacial acetic acid, amide 173 was formed as 
single product (Table 13, entry 5). 
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Table 13: Hydrolysis experiments towards carboxylic acid 174 from nitrile 172 
entry reagents conditions product 
1 conc. HCl reflux, 24 h mixture of 
iPrO-protected amide 173, 
iPrO-protected nitrile 172, 
deprotected amide 205, 
deprotected nitrile 203 
2 H2SO4 98% reflux, 24 h 
3 H3PO4 100% reflux, 24 h 
4 HBr 48% reflux, 24 h 
5 glacial acetic acid reflux, 24 h amide 173 
6 12 M NaOH  rt, 1.5 h amide 173 
7 12 M NaOH + H2O2 rt, 5 min amide 173 
 
The formation of the carboxylic acid 174 from the nitrile 172 via hydrolysis under acidic or 
basic conditions was not successful. Hence, further investigations concentrated on alternative 
methodologies towards 174. Triethyloxonium tetrafluoroborate, commonly known as 
Meerwein´s salt, has proven to convert amides to the corresponding imidate esters, which 
yield the ethyl esters upon hydrolysis in dilute acid.
173
 In the present study however, no 
conversion was observed under various reaction conditions. Further methodologies were 
applied such as the reaction of amide with NaNO2 in acetic acid
174
 or with nitrosonium 
tetrafluoroborate in MeCN,
175
 albeit without significant conversion (Scheme 63). 
 
Scheme 63: Unsuccessful reactions towards carboxylic acid derivatives 174 and 175 
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From nitrile 172 other transformations should be possible to gain more structural diversity 
within the library of Limno-CP derivatives. Reduction experiments were carried out to 
establish an aldehyde functionality. In this matter, chemoselectivity issues have to be taken 
into account since the carbonyl group as well as the electron deficient double bond are prone 
to react with many reducing agents. Indeed, DIBAL-H, a very common reagent for the 
reduction of nitriles, gave the corresponding allylic alcohol 176 solely (Scheme 64).  
 
Scheme 64: Reduction of nitrile 172 to the corresponding allylic alcohol 176 
Since DIBAL-H gave the undesired product, the focus was shifted to metal catalyzed 
hydrogenations (Table 14). Raney nickel has been widely used for the conversion of nitriles to 
aldehydes or amines. Activated Raney-nickel in combination with formic acid
176
 or glacial 
acetic acid
177
 generates H2 in situ and catalyzes the reduction of the nitrile at the same time. 
Unfortunately, no conversion was observed even under relatively harsh conditions. Addition 
of H2 to the reaction mixture directly also failed. The same was observed when Raney-nickel 
was replaced by palladium on charcoal in ethyl acetate. 
Table 14: Metal catalyzed hydrogenation reactions 
 
entry catalyst conditions product 
1 Raney-Ni 75% HCOOH/EtOH 1:1, reflux, 24 h no conversion 
2 Raney-Ni 
AcOH, pyridine, Na3PO4∙12 H2O, 
reflux, 24 h 
no conversion 
3 Raney-Ni H2, EtOH, reflux, 24 h no conversion 
4 Pd / C H2, EtOAc, reflux, 24 h no conversion 
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3.5.3. Introduction of oxygen based substituents 
For the introduction of an alcohol functionality different epoxidation reactions on the double 
bond of the ,-unsaturated carbonyl moiety were performed. However, -oxo enol ethers are 
poor substrates for electrophilic as well as for nucleophilic epoxidation reagents since the 
electron-donating substituent on the one side and the electron-withdrawing carbonyl group on 
the other side of the C-C double bond result in an extended conjugated system. Hence, only a 
few epoxides of -oxo enol ethers are known. Moreover, they tend to rearrange to the 
corresponding 2-hydroxy-2-enones easily. Exactly this tendency to rearrange, however, 
should be utilized in this study. Under basic conditions the newly formed ,-epoxy ketone 
178 should therefore give the corresponding -hydroxy 3(2H)-furanone 179 directly by 
deprotonation. Alternatively, the hydrolysis of the epoxide to its corresponding diol followed 
by H2O elimination should yield the alcohol 179 in two consecutive steps (Scheme 65). 
 
Scheme 65: Strategy towards the -hydroxy-3(2H)-furanone 179 via an epoxidation reaction 
In the group of Adam et al. the epoxidation of -oxo enol ethers with dimethyldioxirane 
(DMDO) was investigated, which gave the products in quantitative yield.
178
 However, 
isolation and purification was not possible as the epoxides decomposed once they were 
warmed above 0 °C. 
In this study various epoxidation reagents were tested. The epoxidation of iPr-Limno-CP 
(151) with DMDO showed initially a good reactivity, but several products were formed, 
which could not be isolated. With mCPBA
179
 no conversion was observed, just unreacted 
starting material could be reisolated. The well known Weitz-Scheffer epoxidation,
180
 which 
gives usually good results for electron deficient olefins, showed promising product formation 
and gave -hydroxy Limno-CP (179) in 32% (Table 15). 
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 Table 15: Epoxidation reactions on iPr-Limno-CP (151) 
 
entry reagent conditions product 
1 DMDO (0.07 M in acetone) CH2Cl2, 78 °C, 1 h product mixture 
2 mCPBA CH2Cl2, 0 °C to rt, 16 h - 
3 H2O2 NaOH, MeOH, 0 °C to rt, 2.5 h 32%
a
 
 a
 estimated by NMR 
 
Alternatively, hydroboration and subsequent oxidation of the hydroboranes with hydrogen 
peroxide to the corresponding saturated -hydroxy ketone 180 was envisaged. Upon further 
oxidation the 1,2-diketone 181 would be formed, which would tautomerize to the desired 
unsaturated alcohol 179 (Scheme 66). 
 
Scheme 66: Strategy towards the -hydroxy-3(2H)-furanone 179 via hydroboration 
Steric and electronic aspects favor the addition of the borane at the -position of the enone. 
Being electrophilic in nature, the borane adds to the nucleophilic carbon of the double bond. 
As steric hindrance is also minimized, only the anti-Markovnikov regioisomer can be 
expected. To achieve the desired transformation, various reagents were applied (Table 16). 
With NaBH4 and iodine BH3 is formed in situ.
181
 BH3∙THF-complex was used as well as 
pinacol borane and 9-BBN. In general, the reactivity of the starting material was low towards 
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the borane reagents. This might be attributed to the electron deficient nature of the double 
bond, which is a poor substrate for an electrophilic addition reaction. Prolonged reaction times 
and high temperatures resulted in complex mixtures of inseparable products. 
Table 16: Hydroboration reactions on iPr-Limno-CP (151) 
 
entry reagent conditions product 
1 NaBH4, I2 THF, 0 °C to rt, 16 h no conversion 
2 BH3∙THF THF, 0 °C to rt, 16 h no conversion 
3 pinacol borane THF, 0 °C to rt, 16 h no conversion 
4 9-BBN THF, 0 °C to rt, 16 h no conversion 
 
Unfortunately, the synthesis of -hydroxy iPr-Limno-CP (179) from the unsubstituted 
derivative 151 could not be accomplished in simple one or two step modifications. In the 
literature, however, spirocyclic -hydroxy 3(2H)-furanones are known as part of 
steroids.
182,183
 But, steroid spiro enones were generated from prednisolone as starting material, 
which has already the alcohol functionality incorporated. Therefore, no additional 
manipulations for the introduction of the hydroxy functionality were required. 
3.5.4. Metalation approaches 
In order to gain access to a broad variety of -modified Limno-CP derivatives, a more 
versatile strategy was envisioned, which should allow for an easy and more general 
introduction of substituents. If it is possible to attach a metal center to the -position of the 
,-unsaturated carbonyl substructure, it should be possible to trap the metalated species with 
electrophiles (Scheme 67). 
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Scheme 67: Planned introduction of substituents via metalation approaches 
Via this approach the carboxylic acid 174 should be accessible using CO2 as electrophile, 
whereas dimethyl carbonate would give the methyl ester 182. The fluorinated derivative 160 
should be obtained with electrophilic fluorine reagents such as NFSI 170, even the hydroxy 
substituted compound 179 could be synthesized using methyl borate and hydrogen peroxide. 
In principle, any conceivable derivative could be synthesized provided that an adequate 
electrophile is available.  
The present studies concentrated first on the lithiation of the -bromo iPr-Limno-CP 
derivative (158) via a bromine lithium exchange reaction. Adding nBuLi to a solution of the 
starting material at 78 °C, however, turned out to be problematic since an unspecific product 
formation occurred. Even in very low concentrations as well as at temperatures of 120 °C, 
which can be achieved in solvent mixtures like THF:Et2O:hexanes 4:1:1, a substitution of the 
lithiated intermediate failed. As main products the dehalogenated compound 151 and a very 
unpolar product, which was identified to be the dehalogenated 1,2-addition product 183 in 
later studies (see chapter 3.6.1, p.78), were formed. Apparently, the protonation of the -
lithiated compound is very fast and superior to the addition of other electrophiles. Moreover, 
competing reaction pathways such as the addition of the butyl anion to the ,-unsaturated 
carbonyl moiety gives rise to 1,2-addition products. This reaction was sought to be suppressed 
by the use of other lithiation reagents. Unfortunately, LDA gave even more dehalogenated 
product 151 instead, tBuLi and PhLi lead to decomposition of the starting material (Scheme 
68).  
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Scheme 68: Lithiation by bromine lithium exchange from derivative 158 
Since a bromine lithium exchange failed, the access to stannylated iPr-Limno-CP via 
lithiation and subsequent stannylation with tributyltin chloride became impossible. As 
mentioned previously, stannanes, however, are important precursors of fluorinated 
compounds (Scheme 69).
184
 
 
Scheme 69: Known stannylation regime for the synthesis of fluorinated nucleotide 186
184
 
Encouraged by the successful palladium catalyzed Suzuki coupling of -bromo iPr-Limno-CP 
(158) with phenylboronic acid, a palladium mediated stannylation was envisaged. When 
hexamethylditin and a Pd
II
 catalyst were applied, which is in accordance with literature 
conditions, the reactivity of -iodo iPr-Limno-CP (157) turned out to be low. Only a very low 
conversion was observed. Extended reaction times under reflux conditions gave only 
inseparable product mixtures (Scheme 70). 
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Scheme 70: Pd-catalyzed stannylation of derivative 157  
Palladium was also used to achieve a metal catalyzed carbonylation.
185
 Carbon monoxide was 
used in presence of a Pd
II
 catalyst and MeOH to convert -bromo (158) or -iodo iPr-Limno-
CP (157) to the corresponding methyl ester 182. But, also in this case, the reaction did not 
occur at ambient temperature and with elevated temperatures the formation of multiple 
products was detected (Scheme 71). 
 
Scheme 71: Pd-catalyzed carbonylation of derivatives 157 and 158 
The group of Knochel has investigated the use of isopropyl magnesiumchloride for the 
metalation of halide 188 (Scheme 72).
186
 With various electrophiles a wide range of 
substituted 1,3-dioxin-4-ones 190 to 195 were synthesized. 
 
Scheme 72: Derivatization approach of halide 188 via Grignard reagent 189 by Knochel et. 
al.
186
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Isopropyl magnesiumchloride was prepared from 2-chloropropane via Grignard reaction in 
77% yield.
187
 The solution of iPrMgCl was determined to be 1.4 M using a literature known 
titration method.
188
 Upon addition of the magnesium reagent to -iodo iPr-Limno-CP (157) in 
THF at 40 °C immediate dehalogenation was observed. The corresponding -bromo iPr-
Limno-CP (158) was not as reactive as its -iodo counterpart and gave multiple products 
upon warming to room temperature. According to the literature, the reactivity of the 
magnesium reagent could be successfully regulated in presence of complexing agents. In this 
study the metalation process was suppressed completely with the tridentate ligand bis[2-(N,N-
dimethylamino)ethyl] ether (196)
189
 as well as with the bidentate chelator 1,2-
bis(dimethylamino)ethane (197). With the monodentate ligand N-methyl morpholine (198) 
little conversion occurred, albeit only the dehalogenated iPr-Limno-CP (151) was observed 
instead of the metalated compound (Scheme 73). 
 
Scheme 73: Attempted synthesis of Grignard reagents in presence of complexing agents 
A direct deprotonation of a 2(5H)-furanone was applied by Takeda et al. in the total synthesis 
of tetronolide with tBuLi.
190
 Hence, a lithiation by abstraction of a proton with alkyl lithium 
reagents was investigated. In this study tBuLi as well as PhLi gave only decomposition 
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products. LDA was found to be too weak resulting in no conversion. LDA was also reported 
to undergo a Baylis-Hilman type reaction with pyranones.
191
 This reactivity has not been 
described in the literature so far with 3(2H)-furanones. Indeed, when literature conditions 
were used to perform the analogous reaction with iPr-Limno-CP derivatives, no conversion 
was observed.  
Fast protonation of metalated species has shown to be a general drawback of this approach 
competing with the coupling reaction with electrophiles to form -substituted iPr-Limno-CP 
derivatives. Hence, no -modified product was obtained with either lithium, tin, palladium or 
magnesium reagents. 
In total, eight differently substituted iPr-Limno-CP derivatives could be generated in simple 
one to three step modifications from one common precursor. To complete the synthesis of 
natural product analogues, the removal of the isopropyl protecting group was required. 
3.5.5. Deprotection reactions 
For the regeneration of the phenol moiety from the masked isopropyl ethers a general protocol 
was found, which could be applied for each derivative similarly. Six equivalents of BCl3 in 
dichloromethane were necessary to achieve a complete deprotection. The phenol derivatives 
were obtained in excellent yields (Table 17). 
Table 17: Deprotection of iPr-Limno-CP derivatives 
 
entry starting material R time yield product 
1 151 H 16 h 99% 146 
2 160 F 3 h 98% 199 
3 159 Cl 16 h 95% 200 
4 158 Br 16 h 93% 201 
5 157 I 1 h 82% 202 
6 172 CN 40 h 98% 203 
7 171 Ph 16 h 94% 204 
8 173 CONH2 16 h 84% 205 
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During the reaction, a white polymer emerges, which is hard to separate from the product. 
Furthermore, the solubility of the product is limited to DMSO, EtOH and to some extent 
EtOAc, which complicates the extraction of the product from the heterogeneous reaction 
mixture. Nevertheless, it was found that the polymer can be effectively dissolved by the 
addition of THF. Removal of the solvents and final extraction of the product from an aqueous 
solution with large amounts of EtOAc succeeded to isolate the deprotected compounds. 
3.6. 1,2- versus 1,4-addition of nucleophiles 
The evaluation of the reactivity of the synthesized iPr-Limno-CP derivatives towards different 
nucleophiles is of central importance if Michael activity in biological systems is discussed. 
Although data of biological assays show a certain activity, the cellular pathway remains 
unclear as the observed effect may be triggered by different mechanisms at the same time and 
connot be unambiguously traced back to a 1,4-addition process. In turn, if it can be 
demonstrated by chemical experiments that the compounds undergo 1,4-addition, it might 
offer valuable clues which molecular pathway is taking place under physiological conditions. 
Hence, a proof of concept is desired if 1,4-addition is claimed to be the predominant 
activation process. The reactivity of the iPr-Limno-CP derivatives against various 
nucleophiles is discussed in the following chapter. 
3.6.1. 1,2-addition 
In the course of the derivatization experiments iPr-Limno-CP (151) has shown to react readily 
with alkyl lithium reagents. When nBuLi was added to a solution of unsubstituted 3(2H)-
furanone 151 at 78 °C, a very unpolar compound was formed immediately. By thorough 
NMR spectroscopic and mass spectrometric analysis the product was identified to be the 3-
butylidene-2,3-dihydrofurane 183. Mechanistically, this unexpected reaction outcome can be 
explained by a 1,2-addition of the butyl anion and subsequent H2O elimination to form the 
alkylidene motif (Scheme 74). 
 
Scheme 74: Formation of alkylidene compound 183 from iPr-Limno-CP (151) 
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This reaction proceeds very fast and quantitatively giving the product in 87% yield after 
aqueous workup as a mixture of E and Z isomers in very high purity (Figure 20). A full 
characterization of the compound has to be done quickly after isolation since the product is 
not stable at ambient temperature and decomposes within 30 minutes. Even at 20 °C slow 
decomposition processes are taking place. Fortunately, the product does not require further 
purification as the crude material is already sufficiently pure. 
 
Figure 20: Crude 
1
H NMR spectrum of alkylidene compounds 183a and 183b directly after 
aqueous workup 
The 
1
H NMR spectrum clearly shows the presence of E and Z isomers of the alkylidene 
product 183. For reasons of clarity the isomers are assigned with a and b since the E/Z 
nomenclature changes depending on which substituent X is attached at the olefinic carbon 
(Figure 21). 
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Figure 21: E and Z isomers of alkylidene compounds are assigned with a and b 
The stereochemistry of the C-C double bond was determined by 2D NMR techniques 
including NOESY and ROESY. In figure 22 the important NOEs are depicted for the 
unsubstituted derivatives 183a and 183b.  
 
Figure 22: Determination of the correct stereochemistry by means of NOE experiments  
A significant cross peak was detected between the proton of the cyclopentyl ring and the 
olefinic proton in the isomer 183a. This indicates the close distance of these protons to each 
other, which is only possible in the depicted double bond geometry of isomer 183a. In the 
case of isomer 183b a cross peak cannot be found since the olefinic proton is directed off the 
cyclopentyl ring. An a/b ratio of 95/5 was observed for the unsubstituted derivative 183. It 
can be assumed that the trajectory of the attacking nucleophile is not the determining factor 
for the stereochemical outcome of this reaction since the spatial environment is more or less 
identical for both sides of the carbonyl plane. The stereochemical preference for the isomer a 
might rather be attributed to the H2O elimination mode minimizing the steric repulsion 
between the butyl group and the cyclopentyl ring. 
The transformation of the carbonyl group of 3(2H)-furanones to an olefin with alkyl lithium 
reagents has not been described so far. Alternatively, this is commonly done under Wittig 
conditions. Hence, the scope of this reaction was further investigated (Table 18). With hexyl 
lithium the corresponding hexylidene derivatives 207a and 207b were formed in 91% yield 
and an a/b ratio of 95/5 (Table 18, entry 2). The addition reaction with MeLi, which leads to 
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the formation of the exomethylene group in 208, did not proceed cleanly, however, the 
product was formed in 38% yield as determined from a mixture by use of an internal standard 
(Table 18, entry 3). As negative control PhLi and tBuLi were used. Since the elimination 
process cannot occur due to the lack of cleavable protons, the failure of the reaction was 
anticipated. Indeed, only complex mixtures were obtained (Table 18, entries 4 and 5). In the 
reactions of nBuLi with -fluoro- 160, -chloro- 159 and -phenyl-substituted derivative 
171, where X is inert to the reaction conditions, the corresponding products could be detected, 
albeit in different a/b ratios (Table 18, entries 6,7 and 12). This observation does not allow for 
a simple explanation. Especially in the case of fluorine being similar in size to hydrogen, 
steric effects have to be excluded for the decreased isomeric ratio. Hence, electronic effects 
can be assumed to play a pivotal role. Interestingly, the alkylidene products 210a and 210b 
from the reaction of nBuLi with -chloro derivative 159 showed the reverse isomeric ratio as 
in the case of the other derivatives (Table 18, entry 7). In this case the bigger spatial demand 
of chlorine might be the reason for the opposite stereochemical preference. -Bromo iPr-
Limno-CP (158) and -iodo iPr-Limno-CP (157) yielded only dehalogenated product 151 as 
well as the dehalogenated alkylidene derivative 183a (Table 18, entries 8 and 9). This is in 
accordance with the results obtained in the metalation experiments and can explain why no 
metalated species were detected (see chapter 3.6.4, p. 74). In the case of -nitrile iPr-Limno-
CP (172) the competing addition of the butyl anion to the nitrile is believed to be the preferred 
reaction over the formation of the alkylidene product (Table 18, entry 10). With the amide 
173 only a low conversion was observed, which can be explained by the deprotonation of the 
amide-NH2 unit (Table 18, entry 11). 
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Table 18: Reaction of iPr-Limno-CP derivatives with alkyl lithium reagents
a 
 
entry X 
starting 
material 
RLi conversion products yield, a/b
b 
1 H  151 nBuLi quant. 183a, 183b 87%,
c
 95/5 
2 H  151 nHexLi quant. 207a, 207b 91%,
c
 95/5 
3 H  151 MeLi 94% 208 38% 
4 H  151 PhLi quant. -
d 
- 
5 H  151 tBuLi quant. -
d
 - 
6 F  160 nBuLi quant. 209a, 209b 52%, 65/35 
7 Cl  159 nBuLi quant. 210a, 210b 86%, 10/90 
8 Br  158 nBuLi quant. 183a, 151
e 
- 
9 I  157 nBuLi 89% 183a, 151
f
 - 
10 CN  172 nBuLi quant. -
g
 - 
11 CONH2  173 nBuLi < 5% not det.
h
 - 
12 Ph  171 nBuLi quant. 211a, 211b 33%, 60/40 
  a
 R’ contains (n-1) C-atoms from R. 
  b
 Determined by 
1
H NMR with hexamethyldisilane as internal standard. 
  c
 Isolated yield. 
  d
 Complex mixture. 
  e
 67% 151, 15% 183a. 
  f
 44% 151, 22% 183a, 11% 157. 
  g
 Addition products to the nitrile group. 
  h
 Not determined. 
 
Since storage of the alkylidene compounds is precluded due to their severe lability, a 
consecutive reaction was searched, which might render this transformation synthetically 
useful. Various electrophilic and nucleophilic reagents such as pTsOH, N-halosuccinimides, 
iodine or NaOMe were tested, but all attempts to trap the dihydrofuran failed. In contrast, 
hydrogenation using H2 and Pd/C in ethyl acetate succeeded. Not only both double bonds 
were hydrogenated readily, but also the benzyl ether was cleaved as it is well known from the 
deprotection of benzyl protected alcohols. The saturated tertiary alcohol 212 was received in 
89% yield as the only product (Scheme 75). 
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Scheme 75: Hydrogenation of alkylidene compounds 183a and 183b 
 
3.6.2. 1,4-addition 
To evaluate the reactivity of iPr-Limno-CP (151) with respect to a 1,4-addition pathway, 
various thiols were examined. The study started with naturally occurring thiols such as 
glutathione (GSH) or cysteine in MeOH. Chalcones have shown to undergo effectively 1,4-
additions in presence of triethylamine.
192
 Under the same conditions the addition to iPr-
Limno-CP (151) did not succeed. DMSO was used as solvent with variable amounts of H2O, 
however, the use of aqueous solvent mixtures is very much restricted due to solubility 
problems of iPr-Limno-CP. Dithiothreitol (DTT) was used in combination with a 
heterogeneous tungsten catalyst
193
 as well as thiophenol and DBU in THF.
194
 All attempts to 
perform a 1,4-addition with thiols failed. When butandithiol with catalytic amounts of pTsOH 
in benzene was used, conversion was observed once. Unfortunately, this reaction could not be 
reproduced revealing the high sensitivity to very small alterations in the reaction conditions, 
which shifts the equilibrium back to the left side (Scheme 76). 
 
Scheme 76: Addition of thiols to iPr-Limno-CP (151) 
Investigations focused then on the classical 1,4-addition with lithium dimethylcuprate 
(Gilman cuprate). As a test substrate 2,2-dimethyl-3(2H)-furanone (214) was chosen,
195
 which 
could be fully converted to its conjugate addition product 215 within minutes at 30 °C. 
Under the same conditions the 1,4-addition to iPr-Limno-CP (151) or -fluoro iPr-Limno-CP 
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(160), however, showed no conversion within 8 hours at 30 °C. Warming to 0 °C resulted in 
a slow decomposition of the starting material (Scheme 77). 
 
Scheme 77: 1,4-addition of Gilman cuprate to 2,2-dimethyl-3(2H)-furanone (214) and iPr-
Limno-CP derivatives 151 and 160 
Unfortunately, no 1,4-addition to iPr-Limno-CP (151) and its fluoro derivative 160 has been 
achieved so far. Evidence for a feasible 1,4-addition pathway remains to be produced to 
underline the results from biological tests. 
3.6.3. NMR analysis of the substitution effects on the Michael acceptor activity 
The impact of the substituents at the -position of the ,-unsaturated carbonyl moiety on the 
electronic properties of the Michael system can be estimated in comparing the 
13
C NMR 
chemical shifts (Table 19). Especially, the -carbon is of particular importance since it is the 
reactive center in a possible 1,4-addition. Its reactivity can be strongly influenced by its 
electrophilic nature. Indeed, the 
13
C NMR chemical shift of the -carbon could be 
significantly altered by the introduction of an adjacent functional group. In the case of -
fluoro Limno-CP (199) the effect is quite significant. From 183.0 ppm for the unsubstituted 
compound 146 the value could be shifted to 166.8 ppm. To the other direction only a small 
field shift to 185.3 ppm was achieved in the case of isopropyl protected nitrile 172. 
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Table 19: 
13
C NMR chemical shifts of iPr-Limno-CP derivatives 
X R
a
 compound C=O
b
 -C -C 
H OiPr 151 205.7 98.8 183.6 
F OiPr 160 193.4
c
 140.5
d
 167.2
e
 
Cl OiPr 159 199.2 104.9 175.6 
Br OiPr 158 200.0 92.2 176.9 
I OiPr 157 202.5 62.8 179.1 
CN OiPr 172 199.6 86.5 185.3 
CONH2 OiPr 173 193.0 95.1 179.7 
Ph OiPr 171 204.3 113.6 178.3 
H OH 146 203.8 97.3 183.0 
F OH 199 191.6
f
 139.4
g
 166.8
h
 
Cl OH 200 197.5 103.1 175.4 
Br OH 201 198.5 90.8 176.7 
I OH 202 201.9 63.3 178.8 
CN OH 203 199.0 84.8 185.1 
CONH2 OH 205 191.6 93.6 178.5 
Ph OH 204 202.8 112.3 177.9 
 
    a
 4-Substituent on the aromatic ring. 
    b
 Carbonyl carbon of 3(2H)-furanone. 
    c
 d, 
2
JCF = 10.1 Hz. 
    d
 d, 
1
JCF = 259.3 Hz. 
    e
 d, 
2
JCF = 13.7 Hz. 
    f
 d, 
2
JCF = 10.1 Hz. 
    g
 d, 
1
JCF = 256.5 Hz. 
    h
 d, 
2
JCF = 14.0 Hz. 
 
Compared to literature known Michael acceptors, the reactivity of Limno-CP derivatives is 
rather moderate. Typically, enone systems with chemical shifts of 120-170 ppm show 
intermediate to high reactivities in conjugate additions. Nonetheless, 2,2-dimethyl-3(2H)-
furanone (214), which readily reacts with cuprates in a 1,4-fashion, exhibits a 
13
C NMR 
chemical shift of 176.2 ppm for its -carbon. This shows that at least isopropyl protected -
fluoro Limno-CP (160) with a more up-field -carbon chemical shift of 167.2 ppm should be 
reactive enough for a Michael addition pathway. However, a conjugate addition was not 
observed experimentally. This can be explained by an increased steric hindrance in the -
position since the large phenyl group may interfere with the attacking nucleophile and inhibit 
the formation of a new bond with the -carbon. Consequently, the prediction of a potential 
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Michael acceptor activity can not only be based on 
13
C NMR chemical shifts. Particularly, if 
further demanding substituents are present, steric considerations are equally important and 
have to be taken into account. 
Despite of the low reactivity of Limno-CP derivatives towards conjugate addition, a 
modulation of the electronic properties of the Michael system was successfully achieved. 
With 
13
C NMR chemical shifts of 185.3 to 166.8 ppm for the -carbon the compounds are 
ranged at the top of other literature known biologically active compounds. Even though no 
Michael addition was observed experimentally, the low reactivity towards nucleophilic 
addition might even be beneficial in biological systems since cytotoxic side effects are 
suppressed gaining a higher selectivity for a certain target molecule. 
In summary, the reactivity of the synthesized iPr-Limno-CP derivatives towards different 
nucleophiles was investigated. It was shown that isopropyl protected Limno-CP (151) readily 
reacts with alkyl lithium reagents such as nBuLi, nHexLi and MeLi in a 1,2-addition-
elimination reaction to yield the corresponding alkylidene compounds. iPr-Limno-CP 
derivatives 160, 159 and 171, which are substituted with inert functional groups at the -
position of the ,-unsaturated carbonyl moiety, also react with butyl lithium in a 1,2-fashion. 
In contrast, the reactivity of iPr-Limno-CP derivatives with respect to a 1,4-addition was low. 
Neither thiols nor cuprates afforded 1,4-addition products. NMR spectroscopic analysis 
showed that Limno-CP derivatives cannot be considered as typical Michael acceptors. 
Nevertheless, it could be demonstrated that the introduction of -substituents had a significant 
effect on the 
13
C NMR chemical shifts of the -carbon as the reactive center of the enone 
system. 
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4. SUMMARY 
Compounds which possess an ,-unsaturated carbonyl moiety have been extensively 
investigated for their chemopreventive and cytoprotective potential. Especially, Michael 
acceptors with phenol substituents are reported to exhibit anti-inflammatory and antioxidative 
activities. 
NF-B and Nrf2 are important transcription factors of a complex signaling network, which 
mediate a multitude of different biological functions. However, they are also implicated in the 
pathogenesis of many inflammation-associated disorders and can therefore be addressed as 
molecular targets to alter or prevent undesired malignant events. 
 
Figure 23: Effect of ,-unsaturated carbonyl compounds on NF-B and Nrf2 mediated 
signaling 
Reactive cystein residues which are present in the transcription factors act as critical sensors 
for inducers and are involved in the fine-tuning of cellular homeostasis. Covalent 
modification or oxidation of the sulfhydryl groups by phenolic Michael acceptors results in an 
activation of anti-inflammatory Nrf2 and silencing of pro-inflammatory NF-B respectively. 
Suppression of NF-B leads to down-regulation of pro-inflammatory enzymes, interleukins 
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and adhesion molecules. Activation of Nrf2 induces the expression of detoxifying phase 2 
enzymes and other antioxidant and cytoprotective proteins. The modulation of the function of 
the transcription factors can abrogate oxidative and electrophilic stress as well as 
inflammatory tissue injury (Figure 23). 
 
Figure 24: Natural product limnophilaspiroketone (15) 
In this context the natural product limnophilaspiroketone (15), which belongs to the class of 
phenolic ,-unsaturated 3(2H)-furanones, was chosen as an attractive molecule for the 
investigation of its biological activity (Figure 24). Therefore, the total synthesis of 
limnophilaspiroketone (15) was envisioned in the present study.  
The synthesis started with simple cyclopent-2-enone (78), which could be converted into the 
chiral building block 77 in four steps. An enantioselective epoxidation and diastereoselective 
cyanohydrin reaction was applied to establish the desired stereochemistry (Scheme 78). Both 
key steps allowed for the formation of two quaternary stereocenters with the correct absolute 
configuration. 
 
Scheme 78: Synthesis of chiral building block 77 
The key intermediate 113 was obtained from chiral building block 77 in three steps (Scheme 
79), which included a selective deprotection of the TMS acetylene in presence of a TMS 
ether. With improved reaction conditions of a literature procedure
120
 a valuable and general 
strategy for the differentiation of both protecting groups was developed.  
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Scheme 79: Synthesis of ketone 113 from chiral building block 77 
Further experiments focused on ring opening reactions on the epoxide 102 (Figure 25). The 
instability of the cyanohydrin moiety, however, has shown to be a general drawback. To 
improve the stability of the cyanohydrin, investigations concentrated on the hydrolysis of the 
nitrile and on the introduction of an appropriate protecting group on the tertiary alcohol. The 
hydrolysis of the nitrile, however, could not be achieved under various reaction conditions. 
The protection of the alcohol as benzyl, t-butyl, MOM and 1-methyl-1-methoxyethyl ether 
was attempted, but could not be accomplished, presumably due to a high steric hindrance in 
the substrate. 
 
Figure 25: Attempted transformations on the cyanohydrin 102 
The synthesis of Limno-CP (146), a simplified natural product derived model compound, was 
carried out successfully. It was obtained from p-hydroxybenzaldehyde (147) in five steps in 
an overall yield of 54% (Scheme 80). Investigations on the formation of the spirocyclic 
framework revealed deeper insights in the mechanistic details of this cyclization reaction. 
 
Scheme 80: Synthesis of Limno-CP (146) 
In order to gain Michael acceptor specificity, tailor-made compounds are needed. This can be 
achieved by fine tuning the reactivity of the ,-unsaturated carbonyl unit. Thus, the 
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introduction of various substituents in -position was envisaged, which should have a strong 
influence on the electronic properties, and therefore on the reactivity of the enone moiety. 
From iPr-protected Limno-CP (151) a library of 16 different, in -position substituted 
compounds was synthesized (Scheme 81).  
 
Scheme 81: Synthesis of differently substituted Limno-CP derivatives 
NMR spectroscopic analysis was used to determine the electrophilicity of the -carbon of the 
,-unsaturated carbonyl subunit. It could be demonstrated that the introduction of halogen, 
cyano, phenyl and amide substituents at the -position has induced changes in the 13C NMR 
chemical shifts of the -carbon of the enone moiety. 
The altered electronic properties of the enone entity could not be correlated to the observed 
reactivity towards nucleophiles. The 
13
C NMR chemical shifts of the Limno-CP derivatives 
are not in the range of other typical Michael acceptors, furthermore, the sterically demanding 
phenyl substituent presumably suppresses an effective addition reaction. Hence, a 1,4-addition 
reaction with thiols or organocuprates was not observed (Scheme 82). In contrast, with 
Limno-CP derivatives bearing chemically inert substituents X alkyl lithium reagents 
effectively added in a 1,2-fashion to the carbonyl group, which lead to the corresponding 
alkylidene compounds.  
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Scheme 82: Reaction of iPr-Limno-CP derivatives towards various nucleophiles. RLi = nBuLi, 
nHexLi and MeLi for X = H, and nBuLi for X = F, Cl, Ph. R’ contains (n-1) C-atoms from R. 
So far no systematic studies on the biological properties of spirocyclic 3(2H)-furanones exist, 
especially, the influence of the substituents in -position of the ,-unsaturated carbonyl 
subunit on potential Michael acceptor and antioxidant activity is still not known. Test systems 
in which the activity in biological systems is measured depending on the nature of the 
substituents are on the way. The obtained results will give an insight into potential 
applications of 3(2H)-furanones in drug design. 
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5. EXPERIMENTAL PART 
5.1. General methods and materials 
All reagents were purchased from commercial sources and were used without further 
purification. Solvents of high purity were used and dried if waterfree conditions were 
necessary. The glassware was heated at 110 °C before use, all reactions were carried out 
under nitrogen atmosphere and monitored by TLC on silica gel plates 60 F254 by MERCK. 
Spots were detected under UV light (λ = 254 and 366 nm) or visualized by staining with 
vanillin-sulfuric acid (6 g vanillin in 100 mL 95% ethanol and 1 mL conc. sulfuric acid). 
Column chromatography was performed on silica gel Geduran Si 60 (0.063-0.200 mm) by 
MERCK. 
Melting points were determined on a Büchi SMP 20 apparatus as well as on a MPA 100 
Optimelt instrument (Stanford Research Systems). 
1
H NMR spectra were recorded on a Avance 300 (300 MHz), Avance 400 (400 MHz) and 
Avance III 600 (600 MHz) spectrometer (Bruker BioSpin GmbH). Chemical shifts are 
referenced to CDCl3 (7.26 ppm), DMSO-d6 (2.50 ppm) or D2O (4.79 ppm). Data are reported 
as follows: Chemical shifts δ in ppm, multiplicity (s = singulet, d = doublet, t = triplet, q = 
quartet, sext = sextet, sept = septet, m = multiplet, dt = doublet of a triplet, dd = double 
doublet, ddd = doublet of a double doublet), coupling constant (Hz). 
13
C NMR spectra were recorded on a Bruker Avance 300 (75 MHz), Avance 400 (100 MHz) 
and Avance III 600 (150 MHz) spectrometer. Chemical shifts δ are referenced to CDCl3 (77.0 
ppm) or DMSO-d6 (39.4 ppm) and are given in ppm. 
19
F-NMR spectra were recorded on a Bruker Avance 300 (282 MHz) spectrometer. Chemical 
shifts δ are given in ppm. 
IR spectroscopy was carried out on a Specac Golden Gate Diamond Single Reflection ATR 
System Excalibur Series FTS3000MX by BIO-RAD. Samples were measured as neat 
compounds. The wave numbers are reported in cm
-1
. 
Mass spectra were measured on Finnigan MAT SSQ 710 A, Finnigan MAT 95 or 
Thermoquest Finnigan TSQ 7000 instruments. Mass fragments are given, the values in 
brackets represent the peak intensities relative to the basic peak (100%). The molecular 
formula was proven by high resolution mass spectrometry (HR-MS). 
Elemental analysis was performed by the micro analytic section of the University of 
Regensburg on a Vario EL III instrument. 
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X-ray data were obtained from the crystallography laboratory of the University of Regensburg 
using a Stoe Imaging Plate Diffraction System (IPDS) (Stoe & Cie GmbH). 
Optical rotation was determined on a Krüss Optronic polarimeter at room temperature at a 
wavelength of λ = 589 nm (Na-D) in a 0.05 dm cell. The concentration is given in g/100 mL. 
Gas chromatography was performed on a Fisons GC 8000 instrument using a CP-Chiralsil-
DEX-CP column (column 110 °C, FID 250 °C). 
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5.2. Experimental procedures 
2-Iodo-cyclopent-2-enone (79)
89
 
 
Iodine (3.09 g, 12.2 mmol 1.0 eq.) dissolved in 75 mL CH2Cl2 was added dropwise to a 
solution of cyclopentenone (78) (1.00 g, 12.2 mmol, 1.0 eq.) in 75 mL CH2Cl2 and pyridine 
(0.521 mL, 6.58 mmol, 0.54 eq.) at 0 °C. The mixture was stirred for 16 h during which time 
the mixture was allowed to warm to room temperature. It was diluted with Et2O (100 mL) and 
washed successively with H2O (100 mL), 1 M HCl (100 mL), H2O (100 mL), saturated 
aqueous NaS2O3 solution (100 mL) and brine (100 mL). The mixture was dried over MgSO4 
and the solvent was evaporated under reduced pressure. The crude material was recrystallized 
from Et2O–pentane to afford 2-iodo-cyclopent-2-enone (79) as yellow crystals (1.72 g, 8.29 
mmol, 68%). 
Rf = 0.82 (SiO2, hexanesEtOAc, 1:1). 
1
H NMR (300 MHz, CDCl3):  = 2.492.52 (m, 2H, CH2), 2.762.78 (m, 2H, CH2), 8.02 (t, 
J = 2.8 Hz, 1H, CH). 
13
C NMR (75 MHz, CDCl3):  = 30.9, 31.2, 102.9, 169.4, 203.9. 
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2-Trimethylsilanylethynyl-cyclopent-2-enone (80) 
 
2-Iodo-cyclopent-2-enone (79) (1.50 g, 7.21 mmol, 1.0 eq.), trimethylsilylacetylene (1.20 mL, 
8.65 mmol, 1.2 eq.), bis(triphenylphosphine)palladium(II)-dichloride (0.253 g, 0.361 mmol, 
0.05 eq.) and CuI (0.137 g, 0.721 mmol, 0.1 eq.) were taken up in 20 mL anhydrous THF at 
0 °C. iPr2NH (3.1 mL, 22 mmol, 3.0 eq.) was added and the solution was stirred for 
30 minutes at 0 °C turning from yellow to black during the reaction. The reaction mixture was 
partitioned between Et2O (20 mL) and 1 M HCl (20 mL) and the aqueous layer was extracted 
with Et2O (3 × 20 mL). The combined organic layers were washed with brine (100 mL) and 
dried over MgSO4. The solvent was removed in vacuo and the crude product was purified by 
column chromatography (SiO2, hexanesEt2O, 3:1) to yield the pure acetylene 80 as brown 
crystals (1.17 g, 6.56 mmol, 91%). 
Rf = 0.59 (SiO2, hexanesEtOAc, 3:1); Mp 40 °C. 
1
H NMR (300 MHz, CDCl3):  = 0.22 (s, 9H, TMS), 2.44–2.47 (m, 2H, CH2), 2.68–2.73 (m, 
2H, CH2), 7.81 (t, J = 3.0 Hz, 1H, CH). 
13
C NMR (100 MHz, CDCl3):  = –0.2, 27.2, 34.0, 95.0, 101.9, 130.2, 166.2, 205.4. 
IR (neat): 2975, 2161, 1703, 1595, 1439, 1295, 1274, 1049, 1010, 929, 834, 790, 757, 701, 
663 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 178.1 (14) [M
+
], 164.1 (14), 163.1 (100) [M
+
-CH3]. 
HRMS (EI-MS) m/z (M
+
) calcd for C10H14SiO: 178.0814; found: 178.0810. 
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2-Trimethylsilanylethynyl-cyclopent-2-enone-dicobalthexacarbonyl (92) 
 
To a solution of the alkyne 80 (50.0 mg, 0.281 mmol, 1.0 eq.) in 2 mL anhydrous CH2Cl2 was 
added dicobalt octacarbonyl (0.149 g, 0.435 mmol, 1.55 eq.) at ambient temperature. After 15 
minutes the solvent was removed in vacuo and the crude product was purified by column 
chromatography (SiO2, hexanes–EtOAc, 20:1) to yield the protected alkyne 92 as black solid 
(0.111 g, 0.239 mmol, 85%). 
Rf = 0.71 (SiO2, hexanesEtOAc, 5:1); Mp > 400 °C. 
1
H NMR (400 MHz, CDCl3):  = 0.34 (s, 9H, TMS), 2.59–2.62 (m, 2H, CH2), 2.67–2.70 (m, 
2H, CH2), 7.66 (t, J = 2.9 Hz, 1H, CH). 
13
C NMR (100 MHz, CDCl3):  = 0.7, 27.0, 35.3, 83.4, 91.3, 144.3, 160.6, 199.8, 203.8. 
IR (neat): 2963, 2911, 2088, 1992, 1848, 1711, 1644, 1544, 1406, 1288, 1241, 1187, 1059, 
996, 928, 837, 755, 694, 608, 496, 450 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 435.8 (10) [M
+
-CO], 407.9 (31) [M
+
-2CO], 379.9 (35) [M
+
-3CO], 
351.9 (30) [M
+
-4CO], 323.9 (100) [M
+
-5CO], 295.9 (65) [M
+
-6CO], 237.0 (27), 178.1 (10) 
[M
+
-Co2(CO)6], 163.0 (78) [M
+
-CH3], 83.9 (48), 49.0 (48). 
Anal. Calcd for C16H14Co2O7Si: C, 41.40; H, 3.04. Found: C, 41.47; H, 3.14. 
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2-Bromo-cyclopent-2-enone (81) 
 
To an ice cold solution of cyclopent-2-enone (78) (5.10 mL, 60.9 mmol, 1.0 eq.) in 30 mL 
anhydrous CH2Cl2 was added dropwise a solution of bromine (3.12 mL, 60.9 mmol, 1.0 eq.) 
in 30 mL CH2Cl2. After stirring for 10 minutes at 0 °C, a solution of triethylamine (12.7 mL, 
91.4 mmol, 1.5 eq.) in 30 mL CH2Cl2 was added slowly at this temperature. The mixture was 
allowed to warm to ambient temperature. After 3 hours the mixture was filtered through a pad 
of Celite and the solvent was evaporated. Purification of the crude product by flash column 
chromatography (SiO2, hexanes–EtOAc 9:1) afforded 2-bromo-cyclopent-2-enone (81) 
(7.74 g, 48.1 mmol, 79%). 
Rf = 0.50 (SiO2, hexanesEtOAc, 3:1). 
1
H NMR (300 MHz, CDCl3):  = 2.522.54 (m, 2H, CH2), 2.682.72 (m, 2H, CH2), 7.78 (t, 
J = 2.9 Hz, 1H, CH). 
13
C NMR (75 MHz, CDCl3):  = 28.0, 32.4, 126.2, 161.8, 201.8. 
1,2:4,5-Di-O-isopropylidene-D-erythro-2,3-hexodiulo-2,6-pyranose (85)
108
 
 
D-Fructose (83) (9.00 g, 50.0 mmol, 1.7 eq.) and dimethoxypropane (3.61 mL, 29.4 mmol, 
1.0 eq.) were dissolved in 175 mL acetone. The mixture was cooled in an ice bath for 15 
minutes, then HClO4 (2.00 mL, 35.3 mmol, 1.2 eq.) was added in one portion. The resulting 
suspension was stirred at 0 °C for 5 hours. The mixture was neutralized with concentrated 
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aqueous NH3 solution and the solvent was removed in vacuo. The remaining white solid was 
dissolved in 100 mL CH2Cl2 and washed with brine (2 × 25 mL), dried over MgSO4 and 
concentrated to approximately 40 mL. Recrystallization from boiling hexane (100 mL) 
yielded the alcohol 84 as fine white needles. 
The obtained alcohol 84 (1.00 g, 3.84 mmol, 1.0 eq.) and freshly powdered 3Å molecular 
sieves (1.40 g) were suspended in 12 mL anhydrous CH2Cl2. PCC (2.07 g, 9.61 mmol, 2.5 
eq.) was added portionwise over 10 minutes and the mixture was stirred at room temperature 
for 15 hours. Diethyl ether (20 mL) was added with vigorous stirring and the mixture was 
filtered through a pad of Celite. The brown filtrate was concentrated to dryness and the 
remaining solid was purified by column chromatography (SiO2, hexanes–EtOAc, 1:1). The 
isolated product was recrystallized from boiling hexane to yield catalyst 85 (0.377 g, 1.46 
mmol, 38%) as white needles. 
Rf = 0.67 (SiO2, hexanesEtOAc, 1:1); []D
 20
 121.5 (c 1.00, CHCl3). 
1
H NMR (300 MHz, CDCl3):  = 1.40 (s, 6H, CH3), 1.46 (s, 3H, CH3), 1.55 (s, 3H, CH3),  
3.99 (d, J = 9.5 Hz, 1H, 1-CH), 4.12 (d, J = 13.5 Hz, 1H, 6-CH), 4.39 (dd, J = 13.5, 2.2 Hz, 
1H, 6-CH), 4.54 (ddd, J = 5.6, 2.1, 0.8 Hz, 1H, 5-CH), 4.61 (d, J = 9.5 Hz, 1H, 1-CH), 4.73 
(d, J = 5.6 Hz, 1H, 4-CH). 
13
C NMR (75 MHz, CDCl3):  = 25.98, 26.03, 26.5, 27.1, 60.0, 70.0, 75.9, 77.9, 104.1, 110.6, 
113.8, 196.9. 
(R,R)-1,2-Diammoniumcyclohexane mono-(+)-tartrate (99)
111
 
 
A 250 mL flask was charged with 50 mL H2O and L(+)-tartaric acid (15.0 g, 0.100 mol, 
1.0 eq.). The mixture was stirred vigorously and racemic trans-1,2-diaminocyclohexane (98) 
(23.8 mL, 0.200 mol, 2.0 eq.) was added carefully in one portion. When the slurry was 
completely dissolved, glacial acetic acid (10 mL) was added. During the addition the 
temperature rose to 90 °C. The mixture was allowed to cool to 5 °C within 3 hours with 
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stirring. This temperature was maintained for another hour and the precipitate was collected 
by filtration and washed with ice cold water (10 mL) and methanol (4 × 10 mL). The product 
was dried at 45 °C under reduced pressure to yield the tartrate 99 as white crystals (16.9 g, 
64.0 mmol, 64%). 
[]D
 20
 12.2 (c 1.00, H2O). 
1
H NMR (300 MHz, D2O):  = 1.28–1.54 (m, 4H, CH2), 1.72–1.84 (m, 2H, CH2), 2.10–2.14 
(m, 2H, CH2),  3.30–3.35 (m, 2H, CH, NCH), 4.30 (s, 2H, CH, OCH). 
13
C NMR (75 MHz, D2O):  = 22.8, 29.4, 52.2, 73.9, 178.5. 
3,5-Di-tert-butylsalicylaldehyde (97)
111
 
 
2,4-Di-tert-butylphenol (96) (63.0 g, 0.305 mol, 1.0 eq.) and urotropine (85.6 g, 0.611 mol, 
2.0 eq.) were dissolved in 150 mL glacial acetic acid. The mixture was heated to 130 °C and 
maintained at that temperature for 3 hours. Then, the mixture was cooled to 80 °C and 
150 mL of a 33% (w/w) aqueous solution of H2SO4 was added. The mixture was refluxed for 
another hour. The mixture was allowed to cool to room temperature and extracted with Et2O 
(3 × 100 mL). The combined organic layers were concentrated and 50 mL MeOH was added 
to the crude product. Precipitation was completed in an ice bath and the product was collected 
by vacuum filtration. Recrystallization from MeOH afforded the aldehyde 97 as yellowish 
solid (14.3 g, 61.0 mmol, 20%). 
Rf = 0.59 (SiO2, hexanesEtOAc, 9:1). 
1
H NMR (300 MHz, CDCl3):  = 1.33 (s, 9H, CH3, tBu), 1.43 (s, 9H, CH3, tBu), 7.35 (d, 
J = 2.5 Hz, 1H, CH, Ar), 7.59 (d, J = 2.4 Hz, 1H, CH, Ar), 9.87 (s, 1H, COH), 11.65 (s, 1H, 
OH). 
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13
C NMR (75 MHz, CDCl3):  = 29.2, 31.3, 34.2, 35.0, 120.0, 127.8, 131.9, 137.6, 141.6, 
159.1, 197.4. 
(R,R)-N,N’-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine (100)111 
 
The mono-(+)-tartrate salt 99 (8.00 g, 30.3 mmol, 1.0 eq.) and K2CO3 (8.37 g, 60.5 mmol, 2.0 
eq.) were dissolved in 40 mL H2O. The mixture was stirred until dissolution was complete, 
then 160 mL EtOH were added. The reaction mixture was heated to reflux and a solution of 
aldehyde 97 (14.2 g, 60.5 mmol, 2.0 eq.) in 67 mL EtOH was added dropwise within 30 
minutes. The resulting solution was refluxed for 2 hours. 40 mL H2O was added and the 
mixture was cooled to 0 °C and maintained at that temperature for 3 hours. The yellow solid 
was collected by vacuum filtration and washed with 25 mL EtOH. The crude product was 
taken up with 135 mL CH2Cl2 and the organic solution was washed with H2O (2 × 80 mL) 
and brine (120 mL) and finally dried over MgSO4. The solvent was removed to yield the pure 
salen ligand 100 (14.4 g, 26.3 mmol, 87%) as yellow solid. 
Rf = 0.76 (SiO2, hexanesEtOAc, 10:1); []D
 20
 –323.4 (c 1.00, CH2Cl2). 
1H NMR (300 MHz, CDCl3):  = 1.24 (s, 18H, CH3, tBu), 1.41 (s, 18H, CH3, tBu), 1.41–1.50 
(m, 2H, CH2), 1.68–1.79 (m, 2H, CH2), 1.86–1.97 (m, 4H, CH2), 3.28–3.37 (m, 2H, NCH), 
6.99 (d, J = 2.4 Hz, 1H, CH, Ar), 7.30 (d, J = 2.4 Hz, 1H, CH, Ar), 8.31 (s, 2H, CH, N=CH), 
13.73 (s, 2H, OH). 
13
C NMR (75 MHz, CDCl3):  = 24.3, 29.4, 31.4, 33.3, 34.0, 34.9, 72.4, 117.8, 126.0, 126.7, 
136.3, 139.8, 158.0, 165.8. 
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(R,R)-N,N’-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamino manganese(III) 
chloride (94)
111
 
 
A solution of manganese acetate tetrahydrate (13.4 g, 54.9 mmol, 3.0 eq.) in 100 mL EtOH 
was heated to reflux and a solution of the salen ligand 100 (10.0 g, 18.3 mmol, 1.0 eq.) in 
50 mL toluene was added dropwise within 45 minutes at this temperature. The mixture was 
refluxed for 2 hours, then air was bubbled through the mixture using a simple commercially 
available aquarium pump for another hour under reflux conditions. Then, brine (20 mL) was 
added and the solution was cooled to ambient temperature, washed with H2O (3 × 120 mL) 
and brine (100 mL) and dried over MgSO4. The solvent was removed under reduced pressure 
and the black residue was taken up with 60 mL CH2Cl2 and 60 mL heptane. After careful 
removal of CH2Cl2 by rotary evaporation, the resulting slurry was stirred for 1 hour in an ice 
bath. Vacuum filtration and drying under high vacuum at 60 °C afforded catalyst 94 (9.99 g, 
15.7 mmol, 86%) as black crystals. 
The complex does not exhibit an interpretable NMR spectrum because of its paramagnetic 
nature. 
MS (ESI): m/z = 599.3 [M-Cl]
+
. 
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(1S,5S)-1-Trimethylsilanylethynyl-6-oxa-bicyclo[3.1.0]hexan-2-one (89) 
 
To a stirred solution of ketone 80 (2.10 g, 11.8 mmol, 1.0 eq.), (R,R)-Mn(III)-salen complex 
94 (0.749 g, 1.18 mmol, 0.1 eq.) and 4-phenylpyridine-N-oxide (0.404 g, 2.36 mmol, 0.2 eq.) 
in 25 mL CH2Cl2 was added a 2 M aqueous solution of NaOCl (0.05 M in Na2HPO4, pH = 
11.3 adjusted with 1 M aqueous HCl) (88.4 mL, 0.177 mol, 15 eq.) at 0 °C. The mixture was 
allowed to warm to ambient temperature while stirring was continued for 16 hours. The 
organic layer was separated and the aqueous layer was extracted with CH2Cl2 (3 × 50 mL). 
The combined organic layers were washed with brine (150 mL) and dried over MgSO4. After 
evaporation of the solvent the crude material was purified by column chromatography (SiO2, 
hexanes–EtOAc 10:1). The epoxide 89 (1.40 g, 7.19 mmol, 61%, 90% ee, determined by GC) 
was obtained as colorless oil. 
Rf  = 0.5 (SiO2, hexanes–EtOAc, 5:1); []D
 20
 –8.0 (c 1.00, CH2Cl2). 
1
H NMR (300 MHz, CDCl3):  = 0.20 (s, 9H, TMS), 2.03–2.43 (m, 4H, CH2), 4.14 (s, 1H, 
CH). 
13
C NMR (75 MHz, CDCl3):  = –0.4, 22.2, 30.7, 54.4, 66.3, 93.8, 96.0, 204.2. 
IR (neat): 2961, 2180, 1752, 1393, 1251, 1076, 1053, 995, 843, 761, 674, 632, 537, 497, 412 
cm
-1
. 
MS (EI, 70 eV): m/z (%) = 194.1 (55) [M
+
], 179.0 (97) [M
+
-CH3], 151.0 (29), 137.0 (41), 
123.0 (32), 109.0 (75), 75.0 (100). 
HRMS (EI-MS) m/z (M
+
) calcd for C10H14SiO2: 194.0763; found: 194.0760. 
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(1S,2S,5S)-1-Trimethylsilanylethynyl-2-trimethylsilanyloxy-6-oxa-bicyclo[3.1.0]hexane-
2-carbonitrile (77) 
 
To a solution of ketone 89 (0.170 g, 0.875 mmol, 1.0 eq.) in 4.4 mL anhydrous CH2Cl2 was 
added TMSCN (0.219 mL, 1.75 mmol, 2.0 eq.) at room temperature. Then, a solution of 
Et4NCN (13.7 mg, 87.5 µmol, 0.1 eq.) in 4.4 mL CH2Cl2 was added. The mixture was stirred 
for 1 hour at ambient temperature. The solvent was removed and the crude product was taken 
up with diethylether (10 mL), washed with water (2 × 10 mL), dried (MgSO4) and 
concentrated. The residue was purified by column chromatography (SiO2, hexanes–EtOAc 
20:1) to obtain cyanohydrin 77 (0.185 g, 0.630 mmol, 72%, dr = 98:2, determined by GC) as 
colorless oil. 
Rf  = 0.3 (SiO2, hexanes–EtOAc, 5:1); []D
20
 –6.8 (c 1.00, CH2Cl2). 
1
H NMR (300 MHz, CDCl3):  = 0.21 (s, 9H, TMS), 0.30 (s, 9H, OTMS), 1.75 (ddd, J = 12.7, 
10.9, 7.7, 1H, CH), 1.95 (dddd, J = 14.4, 10.7, 7.6, 1.1, 1H, CH), 2.10–2.20 (m, 2H, CH), 3.72 
(s, 1H, CH, epox). 
13
C NMR (75 MHz, CDCl3):  = –0.5, 1.2, 24.4, 33.9, 56.2, 59.3, 63.0, 94.7, 96.2, 119.1. 
IR (neat): 2962, 2176, 1399, 1399, 1253, 1194, 1153, 1045, 984, 946, 843, 760, 705, 632, 
588, 545, 500, 416 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 278.1 (12), 179.1 (16), 75.1 (18), 73.1 (100). 
HRMS (EI-MS) m/z (M
+
) calcd. for C14H23NO2Si2: 293.1267; found: 293.1267. 
 
 
 
 
 
 
 
EXPERIMENTAL PART 
 
104 
 
(1S,2S,5S)-2-Hydroxy-1-trimethylsilanylethynyl-6-oxa-bicyclo[3.1.0]hexane-2-
carbonitrile (102) 
 
TMS ether 77 (0.500 g, 1.70 mmol, 1.0 eq.) was dissolved in 25 mL MeCN and 25 mL of a 
1 M solution of aqueous H2SO4 were added. The mixture was stirred at room temperature for 
5 minutes, diluted with EtOAc (25 mL) and extracted with EtOAc (3 × 25 mL). The 
combined organic layers were washed with brine (50 mL) and dried over MgSO4. The solvent 
was evaporated and the crude material was recrystallized from diethylether–pentane to give 
the alcohol 102 (0.351 g, 1.58 mmol, 93%) as colorless crystals. 
Rf  = 0.3 (SiO2, hexanes–EtOAc, 5:1). 
1
H NMR (300 MHz, CDCl3):  = 0.23 (s, 9H, TMS), 1.77 (ddd, J = 13.3, 11.0, 7.9 Hz, 1H, 
CH), 1.97–2.05 (m, 1H, CH), 2.19 (dd, J = 14.7, 7.9 Hz, 1H, CH), 2.87 (s, 1H, CH), 3.82 (s, 
1H, CH, epox). 
13
C NMR (75 MHz, CDCl3):  = –0.5, 24.7, 32.6, 59.3, 64.0, 76.0, 94.5, 96.0, 118.3. 
IR (neat): 3351, 2962, 2178, 1418, 1386, 1313, 1246, 1198, 1122, 1094, 1041, 982, 927, 907, 
838, 759, 701, 654, 600, 551, 499 cm
-1
. 
MS (CI, NH3): m/z = 212.1 [M+NH4
+
-HCN]. 
Anal. Calcd for C11H15NO2Si: C, 59.69; H, 6.83; N, 6.33. Found: C, 59.78; H, 6.80; N, 6.04. 
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(1S,2S,5S)-1-Ethynyl-2-trimethylsilanyloxy-6-oxa-bicyclo[3.1.0]hexane-2-carbonitrile 
(118) 
 
To a solution of the TMS protected alkyne 77 (0.550 g, 1.87 mmol, 1.0 eq.) in 50 mL 
anhydrous acetone was added AgNO3 (0.446 g, 2.62 mmol, 1.4 eq.). The reaction flask was 
covered with aluminium foil and the reaction mixture was stirred for 2 hours in the dark at 
ambient temperature. Saturated aqueous NH4Cl solution (50 mL) was added and the mixture 
was extracted with EtOAc (5 × 30 mL). The combined organic layers were washed with brine 
(100 mL) and dried over MgSO4. The solvent was removed in vacuo to yield the pure 
deprotected acetylene 118 (0.332 g, 1.50 mmol, 80%) as brownish solid. 
Rf  = 0.6 (SiO2, hexanes–EtOAc, 5:1). 
1
H NMR (300 MHz, CDCl3):  = 0.29 (s, 9H, OTMS), 1.76 (ddd, J = 12.7, 10.8, 7.6 Hz, 1H, 
CH), 1.97 (dddd, J = 14.4, 10.3, 7.7, 1.1 Hz, 1H, CH), 2.21-2.13 (m, 2H, CH), 2.61 (s, 1H, 
CH, alkyne), 3.74 (s, 1H, CH, epox). 
13
C NMR (75 MHz, CDCl3):  = 1.2, 24.5, 33.4, 59.0, 62.4, 75.3, 76.3, 76.9, 118.9. 
IR (neat): 3256, 2964, 2126, 1440, 1397, 1314, 1254, 1195, 1137, 1045, 984, 931, 841, 758, 
724, 697, 636, 605, 573, 520, 475, 429 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 206.0 (34) [M
+
-CH3], 179.1 (20), 154.0 (46), 151.1 (34), 129.0 
(27), 126.1 (23), 101.1 (21), 84.0 (31), 75.1 (45), 73.1 (100). 
HRMS (EI-MS) m/z (M
+
) calcd. for C11H14NO2Si: 220.0794; found: 220.0795. 
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4-Isopropoxybenzaldehyde (116)
142
 
 
2-Bromopropane (45.3 g, 0.368 mol, 4.5 eq.) and K2CO3 (37.3 g, 0.270 mmol, 3.3 eq.) were 
added to a solution of p-hydroxybenzaldehyde (147) (10 g, 81.9 mmol, 1.0 eq.) in 90 mL 
DMF. The mixture was stirred for 2 hours at 55 °C, then cooled to ambient temperature and 
quenched with H2O (50 mL). The aqueous layer was extracted with EtOAc (3 × 100 mL) and 
the combined organic layers were washed with H2O (5 × 100 mL) and dried over MgSO4. 
Removal of the solvent in vacuo yielded the protected benzaldehyde 116 as yellowish liquid 
(13.0 g, 79.4 mmol, 97%). 
Rf = 0.6 (SiO2, hexanesEtOAc, 4:1). 
1
H NMR (300 MHz, CDCl3):  = 1.38 (d, J = 6.1 Hz, 6H, CH3, iPr), 4.67 (sept, J = 6.1 Hz, 
1H, CH, iPr), 6.97 (d, J = 8.8 Hz, 2H, CH, Ar), 7.82 (d, J = 8.9 Hz, 2H, CH, Ar), 9.87 (s, 1H, 
CHO). 
13
C NMR (75 MHz, CDCl3):  = 21.8, 70.2, 115.5, 129.4, 131.9, 163.1, 190.7. 
(1S,2S,5S)-1-[3-Hydroxy-3-(4-isopropoxy-phenyl)-prop-1-ynyl]-2-trimethylsilanyloxy-6-
oxa-bicyclo[3.1.0]hexane-2-carbonitrile (119) 
 
To a solution of the terminal alkyne 118 (0.250 g, 1.13 mmol, 1.0 eq.) and TMEDA 
(0.187 mL, 1.24 mmol, 1.1 eq.) in 25 mL anhydrous THF was added a 1.6 M solution of 
tBuLi in pentane (0.777 mL, 1.24 mmol, 1.1 eq.) dropwise at –78 °C. Aldehyde 116 (0.185 g, 
1.13 mmol, 1.0 eq.) was added and after 5 minutes the mixture was diluted with 25 mL 
saturated NH4Cl solution and extracted with EtOAc (3 × 50 mL). The combined organic 
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extracts were washed with brine (100 mL), dried over MgSO4 and the solvent was removed in 
vacuo. The crude product 119 (yellow oil, 62%) can be used without further purification. A 
purified example of the product (column chromatography, SiO2, hexanes–EtOAc, 5:1) 
showed the following analytical data: 
Rf  = 0.4 (SiO2, hexanes–EtOAc, 3:1). 
1
H NMR (300 MHz, CDCl3):  = 0.25 (s, 9H, TMS, diast. 0.27), 1.33 (d, J = 6.1 Hz, 6H, CH3, 
iPr), 1.72–1.83 (m, 1H, CH), 1.92–2.03 (m, 1H, CH), 2.14–2.22 (m, 1H, CH), 3.75 (s, 1H, 
CH, epox, diast. 3.76), 4.56 (sept, J = 6.1 Hz, 1H, iPr), 5.48 (s, 1H, CHOH, diast. 5.50), 6.89 
(d, J = 8.7 Hz, CH, Ar), 7.47 (d, J = 8.7 Hz, CH, Ar). 
13
C NMR (75 MHz, CDCl3):  = 1.1, 21.9, 24.5, 33.4, 59.3, 62.6, 64.2, 69.9, 77.2, 77.9, 87.9, 
115.9, 119.1, 128.3, 131.5, 158.2. 
IR (neat): 3443, 2977, 1751, 1610, 1509, 1449, 1384, 1302, 1244, 1194, 1150, 1119, 1069, 
1043, 1009, 955, 921, 843, 758, 732, 632, 569, 474 cm
-1
. 
MS (ESI): m/z = 367.9 [MH
+
-H2O], 403.0 [M+NH4
+
]. 
Anal. Calcd for C18H20NO3Si: C, 66.23; H, 6.18; N, 4.29. Found: C, 64.92; H, 7.18; N, 2.99. 
(1S,2S,5S)-1-[3-(4-Isopropoxy-phenyl)-3-oxo-prop-1-ynyl]-2-trimethylsilanyloxy-6-oxa-
bicyclo[3.1.0]hexane-2-carbonitrile (113) 
 
A suspension of alcohol 119 (75.0 mg, 0.195 mmol, 1.0 eq.) and MnO2 (0.169 g, 1.95 mmol, 
10 eq.) in 2 mL anhydrous CH2Cl2 was stirred at ambient temperature for 16 hours. The 
suspension was filtered through a pad of Celite and the solvent was removed under reduced 
pressure to yield the pure ketone 113 (68.6 mg, 0.179 mmol, 92%). 
Rf  = 0.6 (SiO2, hexanes–EtOAc, 5:1). 
1
H NMR (300 MHz, CDCl3):  = 0.30 (s, 9H, TMS), 1.37 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.78–
1.89 (m, 1H, CH), 2.00–2.12 (m, 1H, CH), 2.21–2.29 (m, 2H, CH), 3.90 (s, 1H, CH, epox), 
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4.67 (sept, J = 6.1 Hz, 1H, CH, iPr), 6.93 (d, J = 8.9 Hz, 2H, CH, Ar), 8.15 (d, J = 8.9 Hz, 2H, 
CH, Ar). 
13
C NMR (75 MHz, CDCl3):  = 1.1, 21.9, 24.8, 33.3, 59.1, 63.0, 70.4, 77.1, 83.4, 84.4, 
115.3, 118.9, 129.1, 132.3, 163.5, 174.9. 
IR (neat): 2978, 2221, 1752, 1640, 1594, 1506, 1314, 1251, 1161, 1106, 1065, 1043, 1001, 
926, 869, 842, 755, 688, 632, 578, 470 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 383.1 (57) [M
+
], 326.1 (62), 121.0 (100), 73.1 (86). 
HRMS (EI-MS) m/z (M
+
) calcd. for C21H25NO4Si: 383.1553; found: 383.1552. 
4-Isopropoxybenzoic acid (120) 
 
Benzaldehyde 116 (5.00 g, 30.5 mmol, 1.0 eq.) and NaOH (48.7 mg, 1.22 mmol, 0.04 eq.) 
were suspended in 60 mL H2O. A solution of KMnO4 (3.61 g, 22.8 mmol, 0.75 eq.) in 
100 mL H2O was added slowly at room temperature and the mixture was heated to 60 °C for 
6 hours. The hot solution was filtered and acidified to pH 3 by addition of concentrated HCl. 
The filtrate was cooled in an ice bath, and the precipitate was collected by vacuum filtration 
and washed with cold H2O (10 mL). The crude product was recrystallized from 
methylcyclohexane to yield benzoic acid 120 (3.13 g, 17.4 mmol, 57%) as white crystals. 
Rf  = 0.12 (SiO2, hexanes–EtOAc, 5:1). 
1
H NMR (300 MHz, CDCl3):  = 1.37 (d, J = 6.1 Hz, 6H, CH3, iPr), 4.66 (sept, J = 6.1 Hz, 
1H, CH, iPr), 6.91 (d, J = 8.9 Hz, 2H, CH, Ar), 8.04 (d, J = 8.9 Hz, 2H, CH, Ar). 
13
C NMR (75 MHz, CDCl3):  = 21.9, 70.1, 115.1, 121.1, 132.4, 162.5, 171.6. 
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N-methoxy-N-methyl-4-(isopropoxy)-benzamide (121) 
 
A solution of benzoic acid 120 (0.500 g, 2.77 mmol, 1.0 eq.) in 15 mL anhydrous CH2Cl2 was 
treated with N,O-dimethylhydroxylamine hydrochloride (0.406 g, 4.16 mmol, 1.5 eq.), EDC 
(0.797 g, 4.16 mmol, 1.5 eq.) and DMAP (0.508 g, 4.16 mmol, 1.5 eq.) and the mixture was 
stirred at ambient temperature for one hour. Brine (15 mL) was added and the mixture was 
extracted with EtOAc (3 × 15 mL). The combined organic layers were washed successively 
with a 5% solution of HCl (15 mL) and brine (15 mL), dried over MgSO4 and the solvent was 
removed in vacuo. Column chromatographic purification (SiO2, CH2Cl2–EtOAc, 3:1) 
afforded the Weinreb amide 121 (0.564 g, 2.52 mmol, 91%) as white solid. 
Rf  = 0.70 (SiO2, CH2Cl2–EtOAc, 2:1); Mp 51 °C. 
1
H NMR (300 MHz, CDCl3):  = 1.35 (d, J = 6.1 Hz, 6H,CH3, iPr), 3.35 (s, 3H, CH3), 3.56 (s, 
3H, CH3), 4.60 (sept, J = 6.1 Hz, 1H, CH, iPr), 6.86 (d, J = 8.9 Hz, 2H, CH, Ar), 7.70 (d, 
J = 8.9 Hz, 2H, CH, Ar). 
13
C NMR (75 MHz, CDCl3):  = 21.9, 33.9, 60.8, 69.8, 114.7, 125.5, 130.5, 159.9, 169.4. 
IR (neat): 2978, 2935, 1633, 1604, 1508, 1462, 1420, 1372, 1299, 1248, 1180, 1106, 1063, 
977, 950, 888, 840, 792, 755, 684, 617, 559, 505 cm
-1
. 
MS (ESI): m/z = 224.1 [MH
+
]. 
HRMS (EI-MS) m/z (M
+
) calcd. for C12H17NO3+Na
+
: 246.1101; found: 246.1103. 
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2-Benzyloxypyridine (135)
130
 
 
Benzyl alcohol (1.00 g, 9.25 mmol, 1.0 eq.), 2-bromopyridine (134) (1.08 mL, 11.1 mmol, 
1.2 eq.), powdered KOH (1.66 g, 29.6 mmol, 3.2 eq.) and 18-crown-6 (0.122 g, 0.462 mmol, 
0.05 eq.) in 10 mL anhydrous toluene were refluxed for 3 hours with azeotropic removal of 
H2O (Dean-Stark apparatus). H2O (10 mL) was added and the mixture was extracted with 
toluene (3 × 10 mL). The organic layer was washed with brine (30 mL) and dried over 
MgSO4. Evaporation of the solvent gave the crude product, which was purified by distillation 
under reduced pressure. 2-Benzyloxypyridine (135) was obtained as colorless liquid (1.37 g, 
7.40 mmol, 80%). 
Rf  = 0.68 (SiO2, hexanes–EtOAc, 5:1). 
1
H NMR (300 MHz, CDCl3):  = 5.39 (s, 2H, CH2), 6.81 (d, J = 8.3 Hz, 1H, CH, Ar), 6.87–
6.91 (m, 1H, CH, Ar), 7.29–7.41 (m, 3H, CH, Ar), 7.46–7.49 (m, 2H, CH, Ar), 7.56–7.62 (m, 
1H, CH, Ar), 8.19 (dd, J = 5.0, 1.3 Hz, 1H, CH, Ar). 
2-Benzyloxy-1-methyl-pyridinium triflate (136)
129
 
 
MeOTf (0.746 mL, 6.80 mmol, 1.05 eq.) was added to an ice cold solution of 2-
benzyloxypyridine (135) (1.20 g, 6.49 mmol, 1.0 eq.) in 6.5 mL anhydrous toluene. The ice 
bath was removed and the mixture was stirred for 5 hours. The solvent was removed under 
reduced pressure to obtain triflate 136 as white solid in quantitative yield (2.26 g, 6.49 mmol, 
100%). 
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1
H NMR (300 MHz, CDCl3):  = 4.04 (d, J = 6.3 Hz, CH3), 5.53 (d, J = 3.5 Hz, 2H, CH2), 
7.34–7.49 (m, 6H, CH, Ar), 7.66 (d, J = 8.8 Hz, 1H, CH, Ar), 8.27–8.34 (m, 1H, CH, Ar), 
8.46–8.48 (m, 1H, CH, Ar). 
13
C NMR (75 MHz, CDCl3):  = 42.0, 74.5, 112.1, 119.0, 128.5, 129.1, 129.6, 132.4, 143.8, 
148.0, 159.6. 
2-Methoxymethylsulfanylpyridine (140)
136
 
 
To a solution of 2-mercaptopyridine (139) (2.50 g, 22.5 mmol, 1.0 eq.) in 10 mL 
dimethoxymethane was added boron trifluoride diethyl etherate (3.13 mL, 24.7 mmol, 1.1 eq.) 
at 0 °C. The mixture was allowed to warm to ambient temperature and it was stirred for 4 
hours. NaHCO3 (10 mL) was added and the mixture was extracted with CH2Cl2 (3 × 10 mL), 
washed with brine (10 mL) and dried over MgSO4. Evaporation of the solvent gave the crude 
product, which was purified by distillation under reduced pressure. Methoxymethyl-
sulfanylpyridine (140) was obtained as clear yellow oil (1.85 g, 11.9 mmol, 53%). 
Rf  = 0.43 (SiO2, hexanes–EtOAc, 5:1). 
1
H NMR (300 MHz, CDCl3):  = 3.30 (s, 3H, CH3), 5.22 (s, 2H, CH2), 6.90–6.94 (m, 1H, CH, 
Ar), 7.17–7.20 (m, 1H, CH, Ar), 7.38–7.43 (m, 1H, CH, Ar), 8.35–8.37 (m, 1H, CH, Ar). 
13
C NMR (75 MHz, CDCl3):  = 56.6, 73.6, 120.1, 122.8, 136.3, 149.5, 157.7. 
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1-[3-Hydroxy-3-(4-isopropoxy-phenyl)-prop-1-ynyl]-cyclopentanol (149) 
 
To a suspension of 1-ethynylcyclopentanol (148) (5.00 g, 45.4 mmol, 1.3 eq.) in 100 mL THF 
was added dropwise a 1.6 M solution of nBuLi in n-hexane (45.8 mL, 73.3 mmol, 2.1 eq.) at 
78 °C. After stirring for 30 minutes aldehyde 116 (5.64 g, 34.4 mmol, 1.0 eq.) was added 
dropwise and the solution was allowed to warm to room temperature. After 1.5 hours the 
solvent was removed and the residue dissolved in H2O (100 mL). The solution was 
neutralized with 1 M HCl and extracted with CH2Cl2 (3 × 100 mL). The organic layer was 
washed with H2O (100 mL), dried (MgSO4) and the solvent evaporated. Crude diol 149 
(yellow solid, 8.82 g) was used without further purification. A purified example (SiO2, 
hexanesEtOAc, 4:1) of the product showed the following analytical data:  
Rf = 0.1 (SiO2, hexanesEtOAc, 4:1); Mp 108 °C. 
1
H NMR (300 MHz, CDCl3):  = 1.33 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.671.88 (m, 4H, CH2), 
1.902.00 (m, 4H, CH2), 2.46 (s, 1H, OH), 2.78 (s, 1H, OH), 4.54 (sept, J = 6.1 Hz, 1H, CH, 
iPr), 5.41 (s, 1H, CH, CHOH), 6.86 (d, J = 8.7 Hz, 2H, CH, Ar), 7.41 (d, J = 8.6 Hz, 2H, CH, 
Ar). 
13
C NMR (75 MHz, CDCl3):  = 22.0, 23.4, 42.2, 64.1, 69.9, 74.4, 83.0, 90.2, 115.8, 128.1, 
132.6, 157.9. 
IR (neat): 3273, 2973, 2870, 1609, 1506, 1381, 1240, 1180, 1122, 994, 958, 844, 812, 728, 
631, 597, 567, 530 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 274.2 (100) [M
+
], 214.1 (33), 185.1 (66), 157.0 (48), 147.0 (36), 
121.0 (82), 120.1 (68), 107.0 (64), 95.1 (32), 55.1 (24). 
HRMS (EI) m/z (M
+
) calcd for C17H22O3: 274.1569; found: 274.1567. 
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3-(1-Hydroxy-cyclopentyl)-1-(4-isopropoxy-phenyl)-propynone (150) 
 
A suspension of 8.82 g crude diol 149 and an excess of MnO2 (27.8 g, 0.320 mol, 7.0 eq.) in 
200 mL CH2Cl2 were stirred for 1.5 hours at ambient temperature. The suspension was 
filtered through a pad of Celite, evaporated to dryness and the product purified by flash 
column chromatography (SiO2, hexanes–EtOAc, 6:1) to give ketone 150 as yellow solid 
(6.76 g, 24.8 mmol, 72% over two steps).  
Rf = 0.4 (SiO2, hexanesEtOAc, 5:1); Mp 82 °C. 
1
H NMR (300 MHz, CDCl3):  = 1.37 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.771.95 (m, 4H, CH2), 
2.032.19 (m, 5H, CH2, OH), 4.66 (sept, J = 6.1 Hz, 1H, CH, iPr), 6.91 (d, J = 8.9 Hz, 2H, 
CH, Ar), 8.07 (d, J = 8.9 Hz, 2H, CH, Ar). 
13
C NMR (75 MHz, CDCl3):  = 21.9, 23.6, 42.4, 70.3, 74.4, 81.1, 96.4, 115.1, 129.5, 132.1, 
163.1, 176.5. 
IR (neat): 3339, 2973, 2208, 1618, 1583, 1505, 1385, 1318, 1260, 1170, 1106, 1003, 946, 
844, 757, 692, 632, 575 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 272.2 (68) [M
+
], 201.2 (40), 173.1 (100), 121.1 (66). 
HRMS (EI) m/z (M
+
) calcd for C17H20O3: 272.1412; found: 272.1411. 
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2-(4-Isopropoxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (151) 
 
To a solution of ketone 150 (1.86 g, 6.83 mmol, 1.0 eq.) in 35 mL EtOHH2O 9:1 was added 
dropwise diethylamine (0.750 g, 10.3 mmol, 1.5 eq.) at room temperature. After 30 minutes 
the solvent was removed and the crude product purified by flash column chromatography 
(SiO2, hexanes–EtOAc, 20:1). Recrystallization from hexanes yielded iPr-Limno-CP (151) as 
light yellow crystals (1.42 g, 5.21 mmol, 76%).  
Rf = 0.45 (SiO2, hexanesEtOAc, 3:1); Mp 93 °C. 
1
H NMR (300 MHz, CDCl3):  = 1.37 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.90-2.14 (m, 8H, CH2), 
4.65 (sept, J = 6.1 Hz, 1H, CH, iPr), 5.88 (s,1H, CH), 6.94 (d, J = 8.9 Hz, 2H, CH, Ar), 7.75 
(d, J = 8.9 Hz, 2H, CH, Ar). 
13
C NMR (100 MHz, CDCl3):  = 21.9, 25.7, 37.1, 70.2, 98.2, 98.8, 115.6, 121.3, 129.1, 
161.6, 183.6, 205.7. 
IR (neat): 2972, 1674, 1603, 1562, 1499, 1429, 1366, 1298, 1253, 1182, 1109, 1074, 1051, 
948, 893, 820, 666 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 272.1 (40) [M
+
], 231.1 (62), 189.0 (100), 118.0 (86). 
HRMS (EI-MS) m/z (M
+
) calcd for C17H20O3: 272.1412; found: 272.1410. 
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3-Fluoro-2-(4-isopropoxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (160) 
 
A solution of furanone 151 (300 mg, 1.10 mmol, 1.0 eq.) and N-fluorobenzenesulfonimide 
(170) (382 mg, 1.21 mmol, 1.1 eq.) in 30 mL anhydrous THF was heated under reflux for 16 
hours. The solution was evaporated in presence of SiO2 and purified by flash column 
chromatography (SiO2 (dryload), hexanes–EtOAc, 20:1 to 5:1) to obtain -fluoro-furanone 
160 as a white solid (17.0 mg, 58.6 µmol, 5%). Additionally, 261 mg (0.958 mmol, 87%) of 
starting material 151 could be reisolated.  
Rf = 0.36 (SiO2, hexanesEtOAc, 5:1); Mp 94 °C. 
1
H NMR (300 MHz, CDCl3):  = 1.38 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.96-2.11 (m, 8H, CH2), 
4.66 (sept, J = 6.1 Hz, 1H, CH, iPr), 6.97 (d, J = 9.0 Hz, 2H, CH, Ar), 7.90 (d, J = 9.0 Hz, 2H, 
CH, Ar). 
13
C NMR (100 MHz, CDCl3):  = 21.8, 25.5, 37.3, 70.2, 96.2 (d, J = 7.1 Hz), 115.7, 119.4 (d, 
J = 5.1 Hz), 129.3 (d, J = 6.6 Hz), 140.5 (d, J = 259.3 Hz), 161.6 (d, J = 1.8 Hz), 167.2 (d, 
J = 13.7 Hz), 193.4 (d, J = 10.1 Hz). 
19
F NMR (282 MHz, CDCl3):  = 181.0. 
IR (neat): 2970, 1701, 1616, 1566, 1511, 1432, 1404, 1385, 1306, 1259, 1178, 1153, 1118, 
948, 885, 837, 745, 647, 632, 517, 490, 445 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 290.1 (34) [M
+
], 249.1 (12), 220.0 (16), 207.0 (100), 136.0 (11), 
121.0 (12). 
HRMS (EI-MS) m/z (M
+
) calcd for C17H19FO3: 290.1318; found: 290.1321. 
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3-Chloro-2-(4-isopropoxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (159) 
 
A stirred solution of furanone 151 (200 mg, 0.734 mmol, 1.0 eq.) and N-chlorosuccinimide 
(118 mg, 0.881 mmol, 1.2 eq.) in 10 mL MeOH was refluxed for 16 hours. After removal of 
the solvent and addition of saturated aqueous NaHCO3 solution (10 mL) the mixture was 
extracted with EtOAc (5 × 10 mL), the organic layer washed with brine (50 mL), dried 
(MgSO4) and the solvent evaporated. Purification by flash column chromatography (SiO2, 
hexanes–EtOAc, 10:1) gave -chloro-furanone 159 (204 mg, 0.665 mmol, 91%) as light 
yellow crystals.  
Rf = 0.62 (SiO2, hexanesEtOAc, 5:1); Mp 94 °C. 
1
H NMR (300 MHz, CDCl3):  = 1.38 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.95-2.18 (m, 8H, CH2), 
4.66 (sept, J = 6.1 Hz, 1H, CH, iPr), 6.97 (d, J = 9.0 Hz, 2H, CH, Ar), 8.15 (d, J = 9.0 Hz, 2H, 
CH, Ar). 
13
C NMR (100 MHz, CDCl3):  = 21.8, 25.5, 37.4, 70.2, 96.8, 104.9, 115.4, 120.4, 130.3, 
161.7, 175.6, 199.1. 
IR (neat): 2977, 1698, 1603, 1561, 1501, 1428, 1351, 1298, 1261, 1188, 1086, 949, 926, 834, 
747, 631, 445 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 306.1 (24) [M
+
], 265.1 (12), 225.0 (31), 223.0 (100), 152.0 (18), 
121.0 (14). 
HRMS (EI-MS) m/z (M
+
) calcd for C17H19ClO3: 306.1023; found: 306.1025. 
 
 
 
 
 
 
EXPERIMENTAL PART 
 
 117 
 
3-Bromo-2-(4-isopropoxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (158) 
 
Method A: To a stirred solution of furanone 151 (500 mg, 1.84 mmol, 1.0 eq.) in 20 mL 
MeCN was added at 0 °C N-bromosuccinimide (359 mg, 2.02 mmol, 1.1 eq.) in portions. 
After 30 minutes saturated aqueous NaHCO3 solution (20 mL) was added and the mixture 
extracted with CH2Cl2 (3 × 20 mL). The organic layer was washed with brine (50 mL), dried 
(MgSO4) and the solvent removed. Recrystallization from EtOAc gave -bromo-furanone 
158 (570 mg, 1.62 mmol, 88%) as white crystals. 
Method B: A solution of furanone 151 (500 mg, 1.84 mmol, 1.0 eq.) in 15 mL CH2Cl2 was 
treated with a solution of bromine (293 mg, 1.84 mmol, 1.0 eq.) in 5 mL CH2Cl2 at 0 °C. 
After 20 minutes a solution of triethylamine (557 mg, 5.51 mmol, 3.0 eq.) in 3 mL CH2Cl2 
was added dropwise to the mixture. The solution was stirred for 1 hour at 0 °C and 2 hours at 
room temperature, before it was diluted with H2O (20 mL) and extracted with CH2Cl2 (2 × 
25 mL). The organic layer was washed with brine (50 mL), dried (MgSO4) and the solvent 
evaporated. Purification by flash column chromatography (SiO2, hexanes–EtOAc, 10:1) 
afforded -bromo-furanone 158 (592 mg, 1.69 mmol, 92%). 
Rf = 0.58 (SiO2, hexanesEtOAc, 5:1); Mp 94 °C. 
1
H NMR (300 MHz, CDCl3):  = 1.38 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.95-2.18 (m, 8H, CH2), 
4.66 (sept, J = 6.1 Hz, 1H, CH, iPr), 6.97 (d, J = 9.1 Hz, 2H, CH, Ar), 8.19 (d, J = 9.1 Hz, 2H, 
CH, Ar). 
13
C NMR (100 MHz, CDCl3):  = 21.8, 25.5, 37.5, 70.2, 92.2, 96.8, 115.3, 120.7, 130.5, 
161.6, 176.9, 200.0. 
IR (neat): 2954, 1696, 1601, 1556, 1497, 1425, 1347, 1293, 1256, 1187, 1106, 1070, 951, 
919, 831, 746 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 350.0 (26) [M
+
], 309.0 (15), 269.0 (84), 267.0 (84), 145.0 (100), 
121.0 (29). 
HRMS (EI-MS) m/z (M
+
) calcd for C17H19BrO3: 350.0518; found: 350.0512. 
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3-Iodo-2-(4-isopropoxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (157) 
 
Method A: A stirred solution of furanone 151 (100 mg, 0.367 mmol, 1.0 eq.) and N-
iodosuccinimide (90.9 mg, 0.404 mmol, 1.1 eq.) in 10 mL MeCN was refluxed for 16 hours. 
Saturated aqueous NaHCO3 solution (10 mL) was added and the mixture extracted with 
EtOAc (3 × 20 mL). The organic layer was washed with brine (50 mL), dried (MgSO4) and 
the solvent removed. Recrystallization from EtOAc gave -iodo-furanone 157 (592 mg, 
1.49 mmol, 88%) as light yellow crystals. 
Method B: To a solution of furanone 151 (50 mg, 0.18 mmol, 1.0 eq.) in 1.2 mL CH2Cl2 was 
added iodine (70 mg, 0.28 mmol, 1.5 eq.) and pyridinium dichromate (21 mg, 55 µmol, 
0.3 eq.). The reaction flask was covered with aluminium foil and the mixture stirred for 3 
hours at room temperature. Remaining solids were filtered off and the filtrate washed with 
H2O (2 mL), saturated aqueous Na2S2O3 solution (2 mL) and brine (2 mL). The organic layer 
was dried (MgSO4) and the solvent evaporated. Purification by flash column chromatography 
(SiO2, hexanes–EtOAc, 10:1) afforded -iodo-furanone 157 (52 mg, 0.13 mmol, 72%). 
Rf = 0.57 (SiO2, hexanesEtOAc, 5:1); Mp 135 °C. 
1
H NMR (300 MHz, CDCl3):  = 1.37 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.95-2.16 (m, 8H, CH2), 
4.66 (sept, J = 6.1 Hz, 1H, CH, iPr), 6.96 (d, J = 9.0 Hz, 2H, CH, Ar), 8.21 (d, J = 9.0 Hz, 2H, 
CH, Ar). 
13
C NMR (100 MHz, CDCl3):  = 21.8, 25.4, 37.6, 62.8, 70.2, 96.4, 115.2, 121.2, 130.9, 
161.6, 179.1, 202.5. 
IR (neat): 2955, 1677, 1599, 1545, 1491, 1422, 1342, 1291, 1253, 1175, 1107, 1060, 950, 
915, 832, 747 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 398.0 (37) [M
+
], 357.0 (14), 315.0 (62), 145.0 (100), 121.0 (17). 
HRMS (EI-MS) m/z (M
+
) calcd for C17H19IO3: 398.0379; found: 398.0379. 
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2-(4-Isopropoxy-phenyl)-4-oxo-1-oxa-spiro[4.4]non-2-ene-3-carbonitrile (172) 
 
In a microwave glass tube with a magnetic stirring bar was placed -bromo-furanone 158 
(0.200 g, 0.569 mmol, 1.0 eq.), NaCN (55.8 mg, 1.14 mmol, 2.0 eq.) and NiBr2 (0.124 g, 
0.569 mmol, 1.0 eq.) in 4 mL N-methylpyrrolidinone. The sealed reaction vessel was put into 
the cavity of a CEM Discover S microwave synthesis system reactor using a non-contact, 
infrared sensor for temperature control and heated up to 200 °C. Once the temperature was 
reached the brown mixture was held at 200 °C for 10 minutes. Then, the green mixture was 
allowed to cool down to room temperature, diluted with H2O (2 mL) and extracted with 
EtOAc (3 × 5 mL). The organic layer was washed with H2O (5 × 5 mL), dried (MgSO4) and 
the solvent evaporated. Purification by flash column chromatography (SiO2, hexanes–EtOAc, 
8:1) gave nitrile 172 as white crystals (0.151 g, 0.507 mmol, 89%). 
Rf = 0.6 (SiO2, hexanesEtOAc, 5:1); Mp 126 °C. 
1
H NMR (300 MHz, CDCl3):  = 1.39 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.95-2.20 (m, 8H, CH2), 
4.69 (sept, J = 6.1 Hz, 1H, CH, iPr), 7.00 (d, J = 9.1 Hz, 2H, CH, Ar), 8.19 (d, J = 9.0 Hz, 2H, 
CH, Ar). 
13
C NMR (100 MHz, CDCl3):  = 21.8, 25.6, 37.3, 70.7, 86.5, 100.2, 113.4, 115.9, 119.0, 
131.0, 163.6, 185.3, 199.6. 
IR (neat): 2984, 2221, 1706, 1603, 1578, 1504, 1429, 1387, 1314, 1261, 1190, 1156, 1127, 
1102, 951, 842, 758 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 297.2 (21) [M
+
], 255.2 (7), 214.1 (100), 143.1 (20), 121.0 (9). 
HRMS (EI-MS) m/z (M
+
) calcd for C18H19NO3: 297.1365; found: 297.1362. 
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2-(4-Isopropoxy-phenyl)-4-oxo-1-oxa-spiro[4.4]non-2-ene-3-carboxylic acid amide (173) 
 
Nitrile 172 (0.100 g, 0.336 mmol, 1.0 eq.) was dissolved in 9 mL of a 1:1 solution of 12 M 
NaOH–dioxane and stirred at room temperature for 1.5 hours. After dilution with 1 M HCl 
(5 mL) and extraction with EtOAc (3 × 10 mL), the organic layer was washed with brine 
(30 mL), dried (MgSO4) and the solvent evaporated. Recrystallization from EtOAc gave 
amide 173 as white crystals (77.4 mg, 0.246 mmol, 73%). 
Rf = 0.47 (SiO2, hexanesEtOAc, 5:1); Mp 175 °C. 
1
H NMR (300 MHz, CDCl3):  = 1.35 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.84-1.94 (m, 6H, CH2), 
2.07-2.18 (m, 2H, CH2), 4.63 (sept, J = 6.1 Hz, 1H, CH, iPr), 6.03 (s, 1H, NH), 6.89 (d, 
J = 8.9 Hz, 2H, CH, Ar), 7.92 (d, J = 8.9 Hz, 2H, CH, Ar), 9.28 (s, 1H, NH). 
13
C NMR (100 MHz, CDCl3):  = 22.0, 25.4, 36.7, 69.8, 95.1, 99.7, 114.3, 130.4, 131.3, 
161.2, 179.7, 189.0, 193.0. 
IR (neat): 3321, 3183, 2966, 1597, 1483, 1245, 1184, 1121, 1045, 947, 931, 855, 830, 792, 
652, 608, 545, 480 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 315.2 (47) [M
+
], 272.2 (23), 232.1 (100), 138.0 (86), 121.0 (73), 
95.0 (33). 
HRMS (EI-MS) m/z (M
+
) calcd for C18H21NO4: 315.1471; found: 315.1467. 
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2-(4-Isopropoxy-phenyl)-3-phenyl-1-oxa-spiro[4.4]non-2-en-4-one (171) 
 
-Bromo-furanone 158 (20 mg, 57 µmol, 1.0 eq.) was dissolved in 0.32 mL toluene and 
0.10 mL EtOH. Pd2(dba)3 (2.6 mg, 2.9 µmol, 0.05 eq.), PPh3 (1.5 mg, 5.7 µmol, 0.1 eq.) and 
PhB(OH)2 (8.3 mg, 68 µmol, 1.2 eq.) were added. After stirring for 10 minutes 7.5 µL 
diethylamine and 0.10 mL H2O were added and the mixture refluxed for 20 hours. The 
solution was diluted with EtOAc (3 mL) and washed successively with 0.2 M NaOH (2 mL), 
0.05 M HCl (2 mL) and brine (2 mL). The organic layer was dried (MgSO4) and the solvent 
removed. Purification by flash column chromatography (SiO2, hexanes–EtOAc, 6:1) afforded 
-phenyl-furanone 171 as colorless crystals (16 mg, 45 µmol, 79%). 
Rf = 0.33 (SiO2, tolueneMeOH, 99:1); Mp 119 °C. 
1
H NMR (300 MHz, CDCl3):  = 1.34 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.922.21 (m, 8H, CH2), 
4.57 (sept, J = 6.1 Hz, 1H, CH, iPr), 6.80 (d, J = 9.0 Hz, 2H, CH, Ar), 7.277.39 (m, 5H, CH, 
Ar), 7.59 (d, J = 9.0 Hz, 2H, CH, Ar). 
13
C NMR (100 MHz, CDCl3):  = 21.9, 25.7, 37.5, 70.0, 96.8, 113.6, 115.1, 121.9, 127.3, 
128.6, 129.7, 130.3, 130.6, 160.8, 178.3, 204.3. 
IR (neat): 2969, 1686, 1603, 1486, 1384, 1252, 1168, 1106, 1045, 948, 835, 695, 623, 514, 
447 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 348.2 (98) [M
+
], 307.2 (75), 265.1 (100), 194.1 (58), 165.0 (24), 
121.0 (18). 
HRMS (EI-MS) m/z (M
+
) calcd for C23H24O3: 348.1725; found: 348.1727. 
 
 
 
 
EXPERIMENTAL PART 
 
122 
 
Deprotection of isopropyl ethers: 
The protected furanone (8.0 – 20 mg, 28 µmol – 57 µmol, 1.0 eq.) was dissolved in 0.5 mL 
anhydrous CH2Cl2 and 6.0 eq. of a 1 M solution of BCl3 in n-hexane were added slowly at 
78 °C to the solution. The solution was warmed to room temperature and stirred until the 
reaction was complete (1 to 40 hours). THF (0.5 mL) and 1 M HCl (0.5 mL) were added and 
the solvent removed. The residue was taken up in EtOAc (10 mL) and H2O (10 mL), 
extracted with EtOAc (3 × 10 mL) and the organic layer dried (MgSO4). Absorption on SiO2 
was done from a solution of EtOH and purification achieved by flash column chromatography 
(SiO2 (dryload), hexanes–EtOAc–EtOH, 40:10:1 and/or CHCl3–EtOH, 25:1) to yield the 
deprotected furanones. 
2-(4-Hydroxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (146) 
 
10 mg (37 µmol) of 151 gave after 16 hours reaction time 8.4 mg (36 µmol, 99%) of 146 as 
white solid. 
Rf = 0.15 (SiO2, hexanesEtOAc, 5:1); Mp 231 °C. 
1
H NMR (300 MHz, DMSO-d6):  = 1.731.94 (m, 8H, CH2), 6.13 (s, 1H, CH), 6.90 (d, 
J = 8.7 Hz, 2H, CH, Ar), 7.77 (d, J = 8.7 Hz, 2H, CH, Ar), 10.44 (s,1H, OH). 
13
C NMR (75 MHz, DMSO-d6):  = 25.1, 36.4, 97.3, 97.4, 115.7, 119.3, 129.2, 161.7, 183.0, 
203.8. 
IR (neat): 2918, 2728, 2609, 1638, 1548, 1501, 1431, 1366, 1234, 1161, 1051, 895, 789, 592 
cm
-1
. 
MS (EI, 70 eV): m/z (%) = 230.1 (26) [M
+
], 189.0 (86), 118.0 (100), 89.1 (13), 44.0 (16), 40.1 
(32). 
HRMS (EI-MS) m/z (M
+
) calcd for C14H14O3: 230.0943; found: 230.0944. 
 
 
EXPERIMENTAL PART 
 
 123 
 
3-Fluoro-2-(4-hydroxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (199) 
 
8.0 mg (28 µmol) of 160 gave after 3 hours reaction time 6.7 mg (27 µmol, 98%) of 199 as 
white solid. 
Rf = 0.33 (SiO2, hexanes–EtOAc, 2:1); Mp 208 °C. 
1
H NMR (300 MHz, DMSO-d6):  = 1.801.99 (m, 8H, CH2), 6.98 (d, J = 8.8 Hz, 2H, CH, 
Ar), 7.78 (d, J = 8.8 Hz, 2H, CH, Ar), 10.61 (s,1H, OH). 
13
C NMR (150 MHz, DMSO-d6):  = 24.8, 36.5, 95.5 (d, J = 7.6 Hz), 116.2, 117.1 (d, J = 5.0 
Hz), 129.2 (d, J = 6.2 Hz), 139.4 (d, J = 256.5 Hz), 162.0 (d, J = 1.2 Hz), 166.8 (d, J = 14.0 
Hz), 191.6 (d, J = 10.1 Hz). 
19
F NMR (282 MHz, DMSO-d6):  = 181.5. 
IR (neat): 3121, 2946, 1675, 1563, 1508, 1414, 1285, 1154, 1107, 961, 843, 743, 581, 512, 
413 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 248.2 (47) [M
+
], 220.2 (18), 207.1 (100), 136.1 (23), 121.1 (29). 
HRMS (EI-MS) m/z (M
+
) calcd for C14H13FO3: 248.0849; found: 248.0853. 
3-Chloro-2-(4-hydroxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (200) 
 
10 mg (33 µmol) of 159 gave after 16 hours reaction time 8.2 mg (31 µmol, 95%) of 200 as 
white solid. 
Rf = 0.43 (SiO2, hexanesEtOAc, 2:1); Mp 209 °C. 
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1
H NMR (300 MHz, DMSO-d6):  = 1.812.00 (m, 8H, CH2), 6.98 (d, J = 8.9 Hz, 2H, CH, 
Ar), 8.03 (d, J = 8.9 Hz, 2H, CH, Ar), 10.65 (s,1H, OH). 
13
C NMR (75 MHz, DMSO-d6):  = 24.9, 36.7, 96.1, 103.0, 115.9, 118.3, 130.2, 162.1, 175.3, 
197.5. 
IR (neat): 3139, 2924, 1670, 1606, 1552, 1489, 1370, 1284, 1170, 1095, 933, 837, 744, 659, 
505, 450 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 264.1 (35) [M
+
], 225.0 (30), 223.0 (100) [M
+
-C3H5], 152.0 (33), 
145.1 (16), 121.0 (24). 
HRMS (EI-MS) m/z (M
•+
) calcd for C14H13ClO3: 264.0553; found: 264.0548. 
3-Bromo-2-(4-hydroxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (201) 
 
20 mg (57 µmol) of 158 gave after 16 hours reaction time 16 mg (53 µmol, 93%) of 201 as 
white solid. 
Rf = 0.48 (SiO2, hexanesEtOAc, 2:1); Mp 216 °C. 
1
H NMR (300 MHz, DMSO-d6):  = 1.752.03 (m, 8H, CH2), 6.97 (d, J = 8.9 Hz, 2H, CH, 
Ar), 8.07 (d, J = 8.9 Hz, 2H, CH, Ar), 10.63 (s, 1H, OH). 
13
C NMR (75 MHz, DMSO-d6):  = 24.9, 36.8, 90.8, 96.0, 115.7, 118.7, 130.5, 162.0, 176.7, 
198.5. 
IR (neat): 3158, 2958, 1666, 1603, 1552, 1484, 1361, 1281, 1235, 1171, 1079, 921, 846, 747, 
665, 597, 438 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 308.0 (32) [M
+
], 268.9 (79), 267.0 (82), 145.0 (100), 121.0 (28). 
HRMS (EI-MS) m/z (M
+
) calcd for C14H13BrO3: 308.0048; found: 308.0047. 
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2-(4-Hydroxy-phenyl)-3-iodo-1-oxa-spiro[4.4]non-2-en-4-one (202) 
 
20 mg (50 µmol) of 157 gave after 1 hour reaction time 15 mg (41 µmol, 82%) of 202 as 
white solid. 
Rf = 0.43 (SiO2, hexanesEtOAc, 2:1); Mp 201 °C. 
1
H NMR (300 MHz, DMSO-d6):  = 1.761.98 (m, 8H, CH2), 6.96 (d, J = 8.8 Hz, 2H, CH, 
Ar), 8.08 (d, J = 8.8 Hz, 2H, CH, Ar), 10.55 (s,1H, OH). 
13
C NMR (75 MHz, DMSO-d6):  = 25.0, 36.9, 63.3, 95.5, 115.5, 119.6, 130.8, 161.7, 178.8, 
201.9. 
IR (neat): 3139, 2923, 1656, 1600, 1545, 1476, 1352, 1279, 1231, 1168, 1070, 915, 841, 746, 
665, 594, 523, 450 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 355.9 (65) [M
+
], 314.9 (80), 145.0 (100), 121.0 (17). 
HRMS (EI-MS) m/z (M
+
) calcd for C14H13IO3: 355.9909; found: 355.9902. 
2-(4-Hydroxy-phenyl)-4-oxo-1-oxa-spiro[4.4]non-2-ene-3-carbonitrile (203) 
 
10 mg (34 µmol) of 172 gave after 40 hours reaction time 8.4 mg (33 µmol, 98%) of 203 as 
white solid. 
Rf = 0.35 (SiO2, hexanesEtOAc, 2:1); Mp 255 °C. 
1
H NMR (300 MHz, DMSO-d6):  = 1.822.07 (m, 8H, CH2), 7.04 (d, J = 8.9 Hz, 2H, CH, 
Ar), 8.05 (d, J = 8.9 Hz, 2H, CH, Ar), 11.09 (s,1H, OH). 
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13
C NMR (75 MHz, DMSO-d6):  = 24.9, 36.5, 84.8, 99.8, 113.7, 116.4, 117.3, 131.0, 164.2, 
185.1, 199.0. 
IR (neat): 3200, 2972, 2231, 1701, 1605, 1559, 1505, 1382, 1286, 1170, 1117, 956, 845, 707, 
665, 575, 510 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 255.1 (20) [M
+
], 214.1 (100) [M
+
-C3H5], 143.0 (45), 121.0 (13). 
HRMS (EI-MS) m/z (M
+
) calcd for C15H13NO3: 255.0895; found: 255.0889. 
2-(4-Hydroxy-phenyl)-4-oxo-1-oxa-spiro[4.4]non-2-ene-3-carboxylic acid amide (205) 
 
10 mg (32 µmol) of 173 gave after 16 hours reaction time 7.3 mg (27 µmol, 84%) of 205 as 
white solid. 
Rf = 0.09 (SiO2, hexanesEtOAc, 5:1); Mp 190 °C. 
1
H NMR (300 MHz, DMSO-d6):  = 1.801.99 (m, 8H, CH2), 6.75 (d, J = 8.7 Hz, 2H, CH, 
Ar), 7.68 (d, J = 8.7 Hz, 2H, CH, Ar), 9.00 (s, 1H, NH), 9.28 (s, 1H, NH), 10.01 (s,1H, OH). 
13
C NMR (300 MHz, DMSO-d6):  = 24.9, 36.1, 93.5, 97.4, 113.9, 129.7, 131.1, 160.6, 178.5, 
187.1, 191.6. 
IR (neat): 3283, 3057, 2962, 1610, 1581, 1452, 1274, 1244, 1024, 1000, 934, 789, 710, 636, 
605, 525, 480, 440 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 273.1 (38) [M
+
], 232.0 (49) [M
+
-C3H5], 138.0 (43), 121.0 (100), 
93.0 (37), 65.1 (44). 
HRMS (EI-MS) m/z (M
+
) calcd for C15H15NO4: 273.1001; found: 273.0994. 
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2-(4-Hydroxy-phenyl)-3-phenyl-1-oxa-spiro[4.4]non-2-en-4-one (204) 
 
10 mg (29 µmol) of 171 gave after 16 hours reaction time 8.3 mg (27 µmol, 94%) of 204 as 
white solid. 
Rf = 0.45 (SiO2, hexanesEtOAc, 2:1); Mp 221 °C. 
1
H NMR (300 MHz, DMSO-d6):  = 1.792.04 (m, 8H, CH2), 6.77 (d, J = 8.8 Hz, 2H, CH, 
Ar), 7.227.25 (m, 2H, CH, Ar), 7.297.46 (m, 5H, CH, Ar), 10.35 (s, 1H, OH). 
13
C NMR (75 MHz, DMSO-d6): 25.2, 36.8, 95.8, 112.3, 115.4, 119.8, 127.2, 128.4, 129.4, 
130.0, 130.6, 161.0, 177.9, 202.8. 
IR (neat): 3260, 2919, 1670, 1604, 1562, 1483, 1397, 1287, 1219, 1168, 1052, 841, 701, 594, 
524, 450 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 306.1 (48) [M
+
], 265.1 (100) [M
+
-C3H5], 194.1 (51), 121.0 (16). 
HRMS (EI-MS) m/z (M
+
) calcd for C20H18O3: 306.1256; found: 306.1252. 
Reactions with alkyl lithium reagents: 
With nBuLi: 
To a stirred solution of 3(2H)-furanone (5.0 – 20 mg, 14 – 73 µmol, 1.0 eq.) in 1.0 mL 
anhydrous THF was added 1.0 eq. of a 1.6 M solution of nBuLi in n-hexane dropwise at 
78 °C. Then H2O (0.5 mL) was added, the mixture warmed to room temperature, diluted 
with saturated aqueous NaHCO3 solution (0.5 mL) and extracted with EtOAc (3 × 1.0 mL). 
The organic layer was washed with brine (3 mL), dried (MgSO4) and the solvent evaporated 
to give the dihydrofuran, which decomposes within hours even at –20 °C. The yield was 
determined by dissolving the crude material in 600 µL of a 3.77 mM solution of 
hexamethyldisilane (internal standard) in CDCl3 or a 1.89 mM solution of hexamethyldisilane 
in CDCl3–benzene-d6 1:1 in the case of phenyl compound 211a, 211b. Yields of compounds 
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183a, 183b and 207a, 207b are isolated yields of homogeneous materials without internal 
standard, but were verified by using the internal standard. 
4-Butylidene-2-(4-isopropoxyphenyl)-1-oxaspiro[4.4]non-2-ene (183a, 183b) 
 
20 mg (73 µmol, 1.0 eq.) of 151 gave 20 mg (64 µmol, 87%, a/b 95:5) of 183a, 183b as a 
colorless oil. 
Rf = 0.97 (SiO2, hexanesEtOAc, 5:1). 
1
H NMR (600 MHz, CDCl3): 183a:  = 0.93 (t, J = 7.3 Hz, 3H, CH3, Bu), 1.34 (d, J = 6.1 Hz, 
6H, CH3, iPr), 1.43 (sext, J = 7.3 Hz, 2H, CH2, Bu), 1.61-1.66 (m, 2H, CH2), 1.78-1.85 (m, 
2H, CH2), 1.90-1.96 (m, 2H, CH2), 2.06-2.10 (m, 2H, CH2), 2.13 (q, J = 7.3 Hz, 2H, CH2, 
Bu), 4.57 (sept, J = 6.1 Hz, 1H, CH, iPr), 4.76 (dt, J = 7.4, 0.7 Hz, 1H, CH, Bu), 5.97 (d, 
J = 0.8 Hz, 1H, CH), 6.85 (d, J = 8.9 Hz, 2H, CH, Ar), 7.56 (d, J = 8.9 Hz, 2H, CH, Ar); 
183b:  = 0.93 (t, J = 7.3 Hz, 3H, CH3, Bu), 1.34 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.43 (sext, 
J = 7.3 Hz, 2H, CH2, Bu), 1.61-1.66 (m, 2H, CH2), 1.78-1.85 (m, 2H, CH2), 1.90-1.96 (m, 2H, 
CH2), 2.06-2.10 (m, 2H, CH2), 2.13 (q, J = 7.3 Hz, 2H, CH2, Bu), 4.57 (sept, J = 6.1 Hz, 1H, 
CH, iPr), 5.13 (t, J = 8.0 Hz, 1H, CH, Bu), 5.72 (s, 1H, CH), 6.85 (d, J = 8.9 Hz, 2H, CH, Ar), 
7.49 (d, J = 8.9 Hz, 2H, CH, Ar). 
13
C NMR (150 MHz, CDCl3): 183a:  = 13.8, 22.0, 23.4, 24.9, 31.5, 42.4, 69.9, 96.3, 97.5, 
110.7, 115.6, 123.9, 126.8, 147.7, 158.4, 159.0. 
IR (neat): 2927, 1609, 1504, 1245, 1119, 1058, 953, 833, 770, 638, 601 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 312.3 (56) [M
+
], 283.2 (100), 241.2 (21), 121.0 (40). 
HRMS (EI-MS) m/z (M
+
) calcd for C21H28O2: 312.2089; found: 312.2087. 
 
 
 
EXPERIMENTAL PART 
 
 129 
 
4-Butylidene-3-fluoro-2-(4-isopropoxy-phenyl)-1-oxa-spiro[4.4]non-2-ene (209a, 209b) 
 
7.7 mg (27 µmol, 1.0 eq.) of 160 gave 4.6 mg (14 µmol, 52%, a/b 65:35) of 209a, 209b. 
Rf = 0.81 (SiO2, hexanesEtOAc, 5:1). 
1
H NMR (600 MHz, CDCl3): 209a:  = 0.93 (t, J = 7.4 Hz, 3H, CH3, Bu), 1.34 (d, J = 6.1 Hz, 
6H, CH3, iPr), 1.41-1.49 (m, 2H, CH2, Bu), 1.58-1.68 (m, 3H, CH2), 1.77-2.02 (m, 5H, CH2), 
2.34 (q, J = 7.5 Hz, 1H, CH2, Bu), 4.58 (sept, J = 6.0 Hz, 1H, CH, iPr), 4.80 (t, J = 8.0 Hz, 
1H, CH, Bu), 6.89 (d, J = 9.0 Hz, 2H, CH, Ar), 7.62 (d, J = 8.9 Hz, 2H, CH, Ar); 209b: 
 = 0.96 (t, J = 7.4 Hz, 3H, CH3, Bu), 1.34 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.41-1.49 (m, 2H, 
CH2, Bu), 1.58-1.68 (m, 3H, CH2), 1.77-2.02 (m, 5H, CH2), 2.14 (q, J = 7.5 Hz, 1H, CH2, 
Bu), 4.57 (sept, J = 6.0 Hz, 1H, CH, iPr), 5.16 (t, J = 8.1 Hz, 1H, CH, Bu), 6.89 (d, J = 9.0 
Hz, 2H, CH, Ar), 7.59 (d, J = 8.9 Hz, 2H, CH, Ar). 
13
C NMR (150 MHz, CDCl3): 209a, 209b:  = 13.6, 13.8, 22.0, 23.7, 23.8, 24.5, 25.0, 29.3, 
29.4, 39.9, 42.5, 69.9, 93.9 (d, J = 6.2 Hz), 94.6 (d, J = 8.4 Hz), 111.9 (d, J = 4.0 Hz), 112.6 
(d, J = 7.6 Hz), 115.6, 122.0 (d, J = 5.8 Hz), 126.8 (d, J = 6.3 Hz), 127.0 (d, J = 6.9 Hz), 
137.8 (d, J = 12.8 Hz), 137.9 (d, J = 14.8 Hz), 138.2 (d, J = 19.5 Hz), 141.1 (d, J = 21.2 Hz), 
142.5 (d, J = 255.8 Hz), 143.8 (d, J = 257.5 Hz), 157.8, 158.0. 
19
F NMR (282 MHz, CDCl3): 209a, 209b:  = 174.4, 170.7. 
MS (EI, 70 eV): m/z (%) = 330.2 (81) [M
+
], 301.2 (100), 259.1 (23), 121.0 (29). 
HRMS (EI-MS) m/z (M
+
) calcd for C21H27FO2: 330.1995; found: 330.1993. 
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4-Butylidene-3-chloro-2-(4-isopropoxy-phenyl)-1-oxa-spiro[4.4]non-2-ene (210a, 210b) 
 
5.0 mg (16 µmol, 1.0 eq.) of 159 gave 4.9 mg (14 µmol, 86%, a/b 10:90) of 210a, 210b. 
Rf = 0.61 (SiO2, hexanesEtOAc, 5:1). 
1
H NMR (600 MHz, CDCl3): 210a:  = 0.95 (t, J = 7.4 Hz, 3H, CH3, Bu), 1.34 (d, J = 6.1 Hz, 
6H, CH3, iPr), 1.47 (sext, J = 7.4 Hz, 2H, CH2, Bu), 1.792.10 (m, 8H, CH2), 2.58 (q, J = 7.5 
Hz, 2H, CH2, Bu), 4.59 (sept, J = 6.1 Hz, 1H, CH, iPr), 4.88 (t, J = 7.9 Hz, 1H, CH, Bu), 6.89 
(d, J = 9.0 Hz, 2H, CH, Ar), 7.86 (d, J = 9.0 Hz, 2H, CH, Ar); 210b:  = 0.96 (t, J = 7.4 Hz, 
3H, CH3, Bu), 1.34 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.47 (sext, J = 7.4 Hz, 2H, CH2, Bu), 
1.792.10 (m, 8H, CH2), 2.16 (q, J = 7.3 Hz, 2H, CH2, Bu), 4.59 (sept, J = 6.1 Hz, 1H, CH, 
iPr), 5.26 (t, J = 8.1 Hz, 1H, CH, Bu), 6.89 (d, J = 9.0 Hz, 2H, CH, Ar), 7.86 (d, J = 9.0 Hz, 
2H, CH, Ar). 
13
C NMR (150 MHz, CDCl3): 210b:  = 13.9, 22.0, 23.9, 25.2, 29.2, 40.0, 69.8, 95.3, 104.9, 
114.4, 115.3, 122.5, 128.5, 143.3, 150.5, 158.4. 
MS (EI, 70 eV): m/z (%) = 346.2 (76) [M
+
], 317.1 (100), 121.0 (46). 
HRMS (EI-MS) m/z (M
+
) calcd for C21H27ClO2: 346.1700; found: 346.1696. 
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4-Butylidene-2-(4-isopropoxy-phenyl)-3-phenyl-1-oxa-spiro[4.4]non-2-ene (211a, 211b) 
 
5.0 mg (14 µmol, 1.0 eq.) of 171 gave 1.8 mg (4.7 µmol, 33%, a/b 60:40) of 211a, 211b. 
1
H NMR (600 MHz, CDCl3benzene-d6, 1:1): 211a:  = 0.61 (t, J = 7.4 Hz, 3H, CH3, Bu), 
1.01 or 1.03 or 1.05 (d, J = 6.0 Hz, 6H, CH3, iPr), 1.071.16 (m, 2H, CH2, Bu), 1.501.54 (m, 
2H, CH2, Bu), 1.571.65 (m, 2H, CH2), 1.671.76 (m, 2H, CH2), 1.861.98, (m, 2H, CH2), 
2.132.18 (m, 2H, CH2), 4.16 (sept, J = 6.1 Hz, 1H, CH, iPr), 4.74 (t, J = 7.9 Hz, 1H, CH, 
Bu), 6.49 or 6.52 or 6.54 (d, J = 8.9 Hz, 2H, CH, Ar), 7.067.29 (m, 7H, CH, Ar); 211b: 
 = 0.78 (t, J = 7.4 Hz, 3H, CH3, Bu), 1.01 or 1.03 or 1.05 (d, J = 6.0 Hz, 6H, CH3, iPr), 
1.191.26 (m, 2H, CH2, Bu), 1.571.65 (m, 2H, CH2), 1.671.76 (m, 2H, CH2), 1.861.98, 
(m, 2H, CH2), 1.992.04 (m, 2H, CH2, Bu), 2.132.18 (m, 2H, CH2), 4.11 (sept, J = 6.1 Hz, 
1H, CH, iPr), 4.83 (t, J = 8.0 Hz, 1H, CH, Bu), 6.49 or 6.52 or 6.54 (d, J = 8.9 Hz, 2H, CH, 
Ar), 7.067.29 (m, 7H, CH, Ar). 
MS (EI, 70 eV): m/z (%) = 388.3 (89) [M
+
], 359.2 (100), 121.0 (91). 
HRMS (EI-MS) m/z (M
+
) calcd for C27H32O2: 388.2402; found: 388.2404. 
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With nHexLi: 
4-Hexylidene-2-(4-isopropoxyphenyl)-1-oxaspiro[4.4]non-2-ene (207a, 207b) 
 
To a stirred solution of furanone 151 (5.0 mg, 18 µmol, 1.0 eq.) in 0.5 mL anhydrous THF 
was added dropwise a 2.45 M solution of nHexLi in n-hexane (9.0 µL, 22 µmol, 1.2 eq.) at 
78 °C. Workup and isolation see nBuLi-case. Furans 207a, 207b were obtained as a 
colorless oil (6.2 mg, 18 µmol, 91%, a/b 95:5). 
Rf = 0.88 (SiO2, hexanesEtOAc, 5:1). 
1
H NMR (300 MHz, CDCl3): 207a:  = 0.90 (t, J = 7.0 Hz, 3H, CH3, Hex), 1.301.34 (m, 
10H, CH3, iPr, CH2, Hex), 1.381.43 (m, 2H, CH2, Hex), 1.601.66 (m, 2H, CH2), 1.771.84 
(m, 2H, CH2), 1.891.97 (m, 2H, CH2), 2.06-2.10 (m, 2H, CH2), 2.14 (q, J = 7.4 Hz, 2H, CH2, 
Hex), 4.57 (sept, J = 6.1 Hz, 1H, CH, iPr), 4.76 (dt, J = 7.3, 0.3 Hz, 1H, CH, Hex), 5.96 (d, 
J = 0.6 Hz, 1H, CH), 6.85 (d, J = 8.8 Hz, 2H, CH, Ar), 7.56 (d, J = 8.8 Hz, 2H, CH, Ar); 
207b:  = 0.90 (t, J = 7.0 Hz, 3H, CH3, Hex), 1.301.34 (m, 10H, CH3, iPr, CH2, Hex), 
1.381.43 (m, 2H, CH2, Hex), 1.601.66 (m, 2H, CH2), 1.771.84 (m, 2H, CH2), 1.891.97 
(m, 2H, CH2), 2.062.10 (m, 2H, CH2), 2.14 (q, J = 7.4 Hz, 2H, CH2, Hex), 4.57 (sept, J = 6.1 
Hz, 1H, CH, iPr), 5.12 (t, J = 8.0 Hz, 1H, CH, Hex), 5.71 (s, 1H, CH), 6.85 (d, J = 8.8 Hz, 
2H, CH, Ar), 7.49 (d, J = 8.8 Hz, 2H, CH, Ar). 
13
C NMR (75 MHz, CDCl3): 207a:  = 14.1, 22.0, 22.6, 24.9, 29.5, 30.0, 31.5, 42.4, 69.9, 
96.2, 97.5, 111.0, 115.6, 123.9, 126.8, 147.5, 158.4, 158.9. 
IR (neat): 2924, 1608, 1503, 1245, 1179, 1119, 1057, 952, 834, 770, 637, 601 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 340.3 (38) [M
+
], 284.2 (20), 283.2 (100) [M
+
-C4H9], 241.1 (19), 
163.1 (17), 121.0 (35). 
HRMS (EI-MS) m/z (M
+
) calcd for C23H32O2: 340.2402; found: 340.2397. 
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With MeLi: 
2-(4-Isopropoxy-phenyl)-4-methylene-1-oxa-spiro[4.4]non-2-ene (208) 
 
To a stirred solution of furanone 151 (75 mg, 18 µmol, 1.0 eq.) in 0.5 mL anhydrous THF was 
added dropwise a 1.6 M solution of MeLi in Et2O (12 µL, 18 µmol, 1.0 eq.) at 78 °C. 
Workup and isolation see nBuLi-case. Furan 208 was obtained in 38% yield (1.9 mg, 7.0 
µmol). 
Rf = 0.92 (SiO2, hexanesEtOAc, 5:1). 
1
H NMR (300 MHz, CDCl3):  = 1.34 (d, J = 6.1 Hz, 6H, CH3, iPr), 1.652.15 (m, 8H, CH2), 
4.38 (s, 1H, CH, Me), 4.58 (sept, J = 6.1 Hz, 1H, CH, iPr), 4.69 (s, 1H, CH, Me), 5.88 (s, 1H, 
CH), 6.86 (d, J = 8.9 Hz, 2H, CH, Ar), 7.55 (d, J = 8.9 Hz, 2H, CH, Ar). 
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With PhLi and tBuLi: 
The reactions of 1.0 eq. furanone 151 with 1.0 eq. of a 1.8 M solution of PhLi in Bu2O and 
1.0 eq. of a 1.6 M solution of tBuLi in pentane, respectively, were carried out as described in 
the nBuLi case. No defined addition product was observed.  
1-{1-[2-(4-Isopropoxy-phenyl)-ethyl]-pentyl}-cyclopentanol (212) 
 
To a stirred solution of furans 183a, 183b (20 mg, 64 µmol, 1.0 eq.) in 0.5 mL anhydrous 
EtOAc was added 10% Pd/C (6.8 mg, 6.4 µmol, 0.1 eq.) at room temperature. The mixture 
was stirred under H2-atmosphere for 2 hours. Filtration and evaporation of the solvent gave 
pure tertiary alcohol 212 as a colorless oil (18 mg, 57 µmol, 89%). 
Rf = 0.61 (SiO2, hexanesEtOAc, 5:1). 
1
H NMR (300 MHz, CDCl3):  = 0.91 (t, J = 7.1 Hz, 3H, CH3), 1.311.35 (m, 11H, CH3, iPr), 
1.401.44 (m, 1H), 1.531.66 (m, 9H), 1.761.83 (m, 3H), 2.54 (ddd, J = 13.8, 10.8, 6.1 Hz, 
1H, CH, Bz), 2.69 (ddd, J = 13.8, 11.0, 5.3 Hz, 1H, CH, Bz), 4.57 (sept, J = 6.1 Hz, 1H, CH, 
iPr), 6.81 (d, J = 8.6 Hz, 2H, CH, Ar), 7.09 (d, J = 8.6 Hz, 2H, CH, Ar). 
13
C NMR (75 MHz, CDCl3):  = 14.1, 22.1, 23.3, 23.8, 30.8, 31.2, 33.5, 34.3, 38.6, 38.7, 
47.2, 69.9, 86.2, 115.9, 129.2, 135.0, 155.9. 
IR (neat): 3421, 2928, 1509, 1239, 632, 536, 497 cm
-1
. 
MS (EI, 70 eV): m/z (%) = 318.2 (6) [M
+
], 162.1 (100), 120.0 (74), 107.0 (43). 
HRMS (EI-MS) m/z (M
+
) calcd for C21H34O2: 318.2559; found: 318.2559. 
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6. APPENDIX 
6.1. NMR spectra 
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2-Iodo-cyclopent-2-enone (79) 
 
1
H NMR 
 
 
13
C NMR 
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2-Trimethylsilanylethynyl-cyclopent-2-enone (80) 
 
1
H NMR 
 
 
13
C NMR 
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2-Trimethylsilanylethynyl-cyclopent-2-enone-dicobalthexacarbonyl (92) 
 
1
H NMR 
 
 
13
C NMR 
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2-Bromo-cyclopent-2-enone (81) 
 
1
H NMR 
 
 
13
C NMR 
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1,2:4,5-Di-O-isopropylidene-D-erythro-2,3-hexodiulo-2,6-pyranose (85) 
 
1
H NMR 
 
 
13
C NMR 
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(R,R)-N,N’-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine (100) 
 
1
H NMR 
 
 
13
C NMR 
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(1S,5S)-1-Trimethylsilanylethynyl-6-oxa-bicyclo[3.1.0]hexan-2-one (89) 
 
1
H NMR 
 
 
13
C NMR 
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(1S,2S,5S)-1-Trimethylsilanylethynyl-2-trimethylsilanyloxy-6-oxa-bicyclo[3.1.0]hexane-
2-carbonitrile (77) 
 
1
H NMR 
 
 
13
C NMR 
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(1S,2S,5S)-2-Hydroxy-1-trimethylsilanylethynyl-6-oxa-bicyclo[3.1.0]hexane-2-
carbonitrile (102) 
 
1
H NMR 
 
 
13
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(1S,2S,5S)-1-Ethynyl-2-trimethylsilanyloxy-6-oxa-bicyclo[3.1.0]hexane-2-carbonitrile 
(118) 
 
1
H NMR 
 
 
13
C NMR 
 
APPENDIX 
 
146 
 
4-Isopropoxybenzaldehyde (116) 
 
1
H NMR 
 
 
13
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(1S,2S,5S)-1-[3-Hydroxy-3-(4-isopropoxy-phenyl)-prop-1-ynyl]-2-trimethylsilanyloxy-6-
oxa-bicyclo[3.1.0]hexane-2-carbonitrile (119) 
 
1
H NMR 
 
 
13
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(1S,2S,5S)-1-[3-(4-Isopropoxy-phenyl)-3-oxo-prop-1-ynyl]-2-trimethylsilanyloxy-6-oxa-
bicyclo[3.1.0]hexane-2-carbonitrile (113) 
 
1
H NMR 
 
 
13
C NMR 
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4-Isopropoxybenzoic acid (120) 
 
1
H NMR 
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N-methoxy-N-methyl-4-(isopropoxy)-benzamide (121) 
 
1
H NMR 
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1-[3-Hydroxy-3-(4-isopropoxy-phenyl)-prop-1-ynyl]-cyclopentanol (149) 
 
1
H NMR 
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3-(1-Hydroxy-cyclopentyl)-1-(4-isopropoxy-phenyl)-propynone (150) 
 
1
H NMR 
 
 
13
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2-(4-Isopropoxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (151) 
 
1
H NMR 
 
 
13
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3-Fluoro-2-(4-isopropoxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (160) 
 
1
H NMR 
 
 
13
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19
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3-Chloro-2-(4-isopropoxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (159) 
 
1
H NMR 
 
 
13
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3-Bromo-2-(4-isopropoxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (158) 
 
1
H NMR 
 
 
13
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APPENDIX 
 
158 
 
3-Iodo-2-(4-isopropoxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (157) 
 
1
H NMR 
 
 
13
C NMR 
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2-(4-Isopropoxy-phenyl)-4-oxo-1-oxa-spiro[4.4]non-2-ene-3-carbonitrile (172) 
 
1
H NMR 
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2-(4-Isopropoxy-phenyl)-4-oxo-1-oxa-spiro[4.4]non-2-ene-3-carboxylic acid amide (173) 
 
1
H NMR 
 
 
13
C NMR 
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2-(4-Isopropoxy-phenyl)-3-phenyl-1-oxa-spiro[4.4]non-2-en-4-one (171) 
 
1
H NMR 
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2-(4-Hydroxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (146) 
 
1
H NMR 
 
 
13
C NMR 
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3-Fluoro-2-(4-hydroxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (199) 
 
1
H NMR 
 
 
13
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19
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3-Chloro-2-(4-hydroxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (200) 
 
1
H NMR 
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3-Bromo-2-(4-hydroxy-phenyl)-1-oxa-spiro[4.4]non-2-en-4-one (201) 
 
1
H NMR 
 
 
13
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2-(4-Hydroxy-phenyl)-3-iodo-1-oxa-spiro[4.4]non-2-en-4-one (202) 
 
1
H NMR 
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2-(4-Hydroxy-phenyl)-4-oxo-1-oxa-spiro[4.4]non-2-ene-3-carbonitrile (203) 
 
1
H NMR 
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2-(4-Hydroxy-phenyl)-4-oxo-1-oxa-spiro[4.4]non-2-ene-3-carboxylic acid amide (205) 
 
1
H NMR 
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2-(4-Hydroxy-phenyl)-3-phenyl-1-oxa-spiro[4.4]non-2-en-4-one (204) 
 
1
H NMR 
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4-Butylidene-2-(4-isopropoxyphenyl)-1-oxaspiro[4.4]non-2-ene (183a, 183b) 
 
1
H NMR 
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APPENDIX 
 
172 
 
4-Butylidene-3-fluoro-2-(4-isopropoxy-phenyl)-1-oxa-spiro[4.4]non-2-ene (209a, 209b) 
 
1
H NMR 
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4-Butylidene-3-chloro-2-(4-isopropoxy-phenyl)-1-oxa-spiro[4.4]non-2-ene (210a, 210b) 
 
1
H NMR 
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4-Butylidene-2-(4-isopropoxy-phenyl)-3-phenyl-1-oxa-spiro[4.4]non-2-ene (211a, 211b) 
 
1
H NMR 
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4-Hexylidene-2-(4-isopropoxyphenyl)-1-oxaspiro[4.4]non-2-ene (207a, 207b) 
 
1
H NMR 
 
 
13
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2-(4-Isopropoxy-phenyl)-4-methylene-1-oxa-spiro[4.4]non-2-ene (208) 
 
1
H NMR 
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1-{1-[2-(4-Isopropoxy-phenyl)-ethyl]-pentyl}-cyclopentanol (212) 
 
1
H NMR 
 
 
13
C NMR 
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6.2. GC spectra 
 
Peak Retention time Area Area% 
1 12.888 1.933 5.11 
2 13.294 35.924 94.89 
 
 
 
 
Peak Retention time Area Area% 
1 33.165 56.503 100 
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6.3. X-ray data 
 
Table 20.  Crystal data and structure refinement for 102. 
Crystal Data  
Empirical formula C11H15NO2Si 
Formula weight 221.33 
Crystal size 0.4214 × 0.2658 × 0.1386 mm 
Crystal description prism 
Crystal colour colorless 
Crystal system Orthorhombic 
Space group P212121 
Unit cell dimensions a = 6.49140(8) Å  = 90° 
 b = 10.67865(15) Å  = 90° 
 c = 17.9430(2) Å  = 90° 
Volume  1243.80(3) Å
3
 
Z, Calculated density  4,  1.182 Mg/m
3
 
Absorption coefficient  1.527 mm
-1
 
F000 472 
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Data Collection  
Measurement device type Xcalibur, Ruby, Gemini ultra 
Measurement method \w scans 
Temperature 123 K 
Wavelength 1.54184 Å 
Monochromator graphite 
range for data collection 4.82 to 72.94° 
Index ranges  -7 ≤ h ≤ 7, -12 ≤ k ≤ 13, -22 ≤ l ≤ 21 
Reflections collected / unique  9139 / 2441 [Rint = 0.0291] 
Reflections greater I>2\s(I) 2391 
Absorption correction  Analytical 
Max. and min. transmission  0.818 and 0.597 
  
  
Refinement   
Refinement method Full-matrix least-squares on F
2
 
Hydrogen treatment  
Data / restraints / parameters 2441 / 0 / 142 
Goodness-of-fit on F
2
 1.065 
Final R indices [I>2(I)] R1 = 0.0253, wR2 = 0.0685 
R indices (all data)  R1 = 0.0259, wR2 = 0.0689 
Absolute structure parameter 0.00(2) 
Largest diff. peak and hole 0.188 and -0.169 e/Å
3
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Table 21: Atomic coordinates (× 10
4
) and equivalent isotropic displacement parameters 
(A
2
 × 10
3
) for 102. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 x y z U(eq) 
Si(1) 3139(1) 9579(1) 8196(1) 29(1) 
O(1) 38(2) 11059(1) 11159(1) 39(1) 
O(2) -740(2) 8370(1) 10726(1) 34(1) 
N(1) -2492(2) 12339(1) 9697(1) 47(1) 
C(1) -1491(2) 10605(1) 10674(1) 30(1) 
C(2) -871(2) 9437(1) 10233(1) 27(1) 
C(3) -2578(2) 8534(1) 10276(1) 33(1) 
C(4) -4349(2) 9096(2) 10695(1) 37(1) 
C(5) -3378(2) 10179(2) 11131(1) 37(1) 
C(6) -2078(2) 11589(1) 10124(1) 35(1) 
C(7) 580(2) 9518(1) 9623(1) 28(1) 
C(8) 1711(2) 9594(1) 9092(1) 30(1) 
C(9) 2516(3) 11054(2) 7698(1) 45(1) 
C(10) 2160(3) 8191(1) 7687(1) 40(1) 
C(11) 5951(2) 9444(2) 8367(1) 43(1) 
H(1O) 820(30) 11507(19) 10927(11) 46 
H(3) -2850 7957 9849 39 
H(4A) -4974 8476 11037 45 
H(4B) -5420 9406 10348 45 
H(5A) -2949 9896 11633 45 
H(5B) -4373 10875 11187 45 
H(9A) 3042 11768 7983 55 
H(9B) 1019 11129 7644 55 
H(9C) 3158 11043 7204 55 
H(10A) 659 8249 7640 48 
H(10B) 2521 7430 7962 48 
H(10C) 2782 8162 7189 48 
H(11A) 6419 10162 8662 52 
H(11B) 6235 8668 8640 52 
H(11C) 6683 9432 7889 52 
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